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This dissertation is presented in an alternative format. Following the General 
Introduction, a Literature Review on topics related to the dissertation research is presented. 
A manuscript prepared for publication is complete in itself with an abstract, introduction, 
material and methods, results, discussion, and references cited. A General Conclusion 
follows the paper and presents in brief the major finding and conclusion of the dissertation 
research. References cited in the General Introduction and Literature Review are listed 
following the General Conclusion. 
Background and Signiflcance 
Fatty acid desaturation occurs in plants, animals, insects, microbes, and fungi. The 
need for an organism to modify preformed or de novo synthesized lipids is multifactorial. 
The correct ratio and amount of the various fatty acids are important in maintaining 
metabolic functions in all organisms related to reproduction, inflammation, and immunology 
from both a metabolite and from a structural membrane integrity viewpoint. A primary 
ftmction of fatty acid desaturases is to maintain proper membrane fluidity as other nutritional, 
environmental, or physiological changes occur. The ratio of 18:0 to 18;l(n-9) is an example 
of a factor influencing cell membrane fluidity. Aging, obesity, cancer, diabetes, and heart 
disease all have been associated with changes in membrane fatty acid composition (Spector, 
1985). 
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There are three types of fatty acid desaturases—acyl-Coenzyme A (CoA) desaturases, 
acyl-carrier protein (ACP) desaturases, and acyl-Iipid desaturases (Murata and Wada, 1995). 
Acyl-ACP desaturases are found in the stroma of plant tissue (McKeon and Stumpf, 1982). 
Acyl-CoA desaturases are found in the endoplasmic reticulum membrane of animal cells, 
yeast, and other fiingal cells (Holloway, 1983). Acyl-lipid desaturases are found bound to 
the endoplasmic reticulum and the chloroplast membranes of plant cells (Schmidt and Heinz, 
1993) and the thylakoid membranes of cyanobacterial cells (Wada et al., 1993). This review 
will focus on modes of regulation of acyl-CoA desaturases and mechanisms of acyl-ACP 
desaturases of plants and the acyl-CoA desaturases of animals, yeast, and other fungi. The 
underlying thought behind this review and research project is on modifying the fatty acid 
composition of organisms for improving food quality or for production of lipids with 
increased industrial value. 
Type and amount of dietary fat have been linked to several disease states, including 
atherosclerosis (Phillipson et al., 1985), insulin-resistant diabetes (Storlien et al., 1987), and 
certain types of cancers (Cave, 1991; Welsch, 1992). Fatty acids can exert their influence on 
disease in the long-term by changing the fatty acid composition of membranes and altering 
the physical character of the membrane and the proteins that are associated with the 
membrane (Spector and York, 1985). More recently, immediate effects of dietary fatty acids 
on nuclear events that govern gene transcription have been examined (Jump et al., 1995). 
Clarke and Jump (1996a) authored a review on the effects of polyunsaturated fatty acid 
(PUFA) regulation of hepatic gene transcription, with particular emphasis on 20:4(n-6). In 
that review, they focused on proof that the newly cloned fatty acid-activated nuclear factor. 
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named peroxisome proliferator-activated receptor (PPAR), acts independently of a yet-to-be 
identified PUFA response factor in controlling lipid-responsive genes. 
As the effects of specific fatty acids on disease conditions are detemiined, the need to 
modify fatty acid composition of the human diet will increase. Many examples of such 
modifications are already evident in plant-derived oils such as high-18:l(n-9) soybean oil and 
low-22:l(n-9) (emcic acid) canola oil. Animal products, the major source of both fat and 
protein in typical human diets, supply 55% of dietaiy fat, 64% of dietary saturated fatty acids, 
and 70% of dietary protein (National Livestock and Meat Board, A Dietary Pattern and Intake 
Report, 1994). The major sources of animal fat in the American diet are beef, pork, and milk 
fat, which all contain around 50% saturated fatty acids. Changing fatty acid composition of 
muscle tissue in monogastric animals is fairly easy compared with that of ruminants because 
dietary fatty acids are absorbed and used in membrane synthesis and for energy storage in the 
same form that they exist in the diet. In ruminants, however, dietary imsaturated fatty acids are 
saturated in the highly reductive rumen before absorption (Ashes et al., 1997). Thus, ruminant 
fatty acid desaturase systems control milk and meat fatty acid composition. 
Gibson's 1991 review summarizes the potential genetic means for changing fatty acid 
composition in milk fat. There are modest differences of milk fatty acid composition 
between and within breeds, indicating that traditional breeding practices could use selection 
criteria to develop genetic strains to produce milk with specific fatty acid composition. 
Another approach would be to manipulate the genes responsible for fatty acid synthesis. 
Despite the probable nature of success in significantly modifying the fatty acids in milk via 
traditional or modem methods, the costs associated with such efforts would not be regained 
4 
by producers or processors. Therefore, the likehhood of designing specific strains of cows 
for specific niche markets is unhkely in the near future. 
Modifying plants to make fatty acids for special industrial or nutritional applications 
has been attempted with limited success through traditional plant breeding efforts. More 
recently, transgenic approaches, as described initially by Somerville and Browse (1991), 
have been employed to shuttle desirable characteristics of oil production fi-om one plant to 
another plant that is easier to grow or that produces more triacylglycerol. Cahoon et al. 
(1997a) have redesigned acyl-carrier protein (ACP) desaturases to learn about the chain-
length and positional specificity of this class of soluble desaturases in plants. In one 
experiment, A®-palmitoyl-ACP desaturase was mutated by replacing key amino acids firom 
A^-stearoyl ACP-desaturase sequence, creating a new series of enzymes capable of 
desaturating substrates with different number of carbon atoms or at different positions in the 
acyl chain. 
In comparing the soluble stearoyl-ACP desaturase (S ACPD) systems in plants and the 
membrane bound steroyl-CoA desaturase (SCD) system in animals, there are similarities and 
striking differences (Figure 1). Similarities include insertion of a double bond at the 
position of 18:0 to form 18:l(n-9) and the requirement of O2 and an electron transport system 
to keep the oxidation/reduction of the terminal desaturase (the desaturase enzyme excluding 
accessory proteins and enzymes) operational. While plant systems rely on ferredoxin and 
NADPH-ferredoxin-oxidoreductase for their electron transport system, mammals rely on 
cj^ochrome bs and NADH-cytochrome bs reductase. The favored substrates, acyl-CoA in 
animals and acyl-ACP in plants, are both soluble substrates. Both plant and mammalian A'-
desaturases have similar Km and Vmax values for stearoyl-CoA, but the kinetics of the plant 
Comparison of Desaturase Optimal Cofactors 
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Figure 1. Cofactor requirements of plant and mammalian fatty acid desaturases. 
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enzyme indicate that stearoyl-CoA would have to be at or above the critical micellar 
concentration for significant amounts of 18:l(n-9) synthesis to occur (Enoch et al., 1976). 
But, because of the low concentration of stearoyl-CoA in plant tissue, the plant enzyme acts 
ahnost entirely on stearoyl-ACP. 
The objectives of the present study were as follows: (1) prepare mammalian 
expression constructs by using both cDNAs for SCD and SACPD, (2) determine if both SCD 
and SACPD are transcribed and translated in mammalian cells in cultiare, and (3) determine 
if expression of the exogenous desaturases causes changes in fatty acid composition of the 
cells. The results of this study will provide further insight about expressing plant cDNAs in 
mammalian systems and, in this specific case, if proteins native to plants can utilize animal 
cofactors and substrates to function. Modifying fatty acid composition of plants has already 
been accomplished by utilizing the tools of molecular biology. This research will provide 
foundational information toward determining the feasibility of using genetic engineering to 





The enzymology of fatty acid desaturases of both plant and animal systems was 
initiated in the 1960s. When the plant and animal desaturases are compared, they have similar 
Km and Vmax for stearoyl-CoA, but again it was determined that, for the plant enzyme to work 
appreciably well on stearoyl-CoA, the substrate concentration has to be above the critical 
micellar concentration for stearoyl-CoA (McKeon and Stumpf 1982). Shanklin and 
Somerville (1991) proposed that, despite the known difference in primary sequences of plant 
and mammalian fatty acid desaturase enzymes, the chemical mechanisms were probably 
similar. The membrane-bovmd animal enzymes proved to be much more difficult to work 
with than the soluble plant acyl-ACP desaturases, and much of the reaction mechanism data 
that has been collected has been from soluble, plant-derived enzymes. 
Animal Systems 
Jones et al. (1969) described the requirement of Upids by the microsomal SCD system 
from hen hver. Microsomal preparations when extracted with aqueous acetone lost enzyme 
activity. But, when the extracted preparations were mixed with phospholipids, 
triacylglycerols, and fatty acids, the enzyme regained activity. This experimentation also 
demonstrated a requirement for oxygen and reduced pyridine nucleotide. In 1974, 
Strittmatter et al. purified rat liver microsomal SCD to homogeneity and determined that it 
contained one molecule of non-heme iron, which is important in the mechanism as it reacts 
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with oxygen and reduced cytochyrome bs. These studies reiterated the importance of 
reduced cytochrome bs and phosphoHpids. Based on an estimated turnover number of about 
21 reactions per enzyme molecule per minute and the activity in induced rat liver 
microsomes, Strittmatter estimated that 0.7-0.8% of the hepatic microsomal protein was 
SCD. 
Gurr and Robinson (1970) partially purified the liver microsomal SCD from hen 
liver. A soluble form of the desaturase was prepared by extracting it from freeze-dried 
microsomes with high ionic strength phosphate buffer or non-ionic detergents. By removing 
some of the microsomal phospholipids with gentle acetone extractions, relative desaturation 
of the preparation increased, but, when more than about 75% of the phospholipids were 
extracted, relative activity decreased. However, reconstitution by the addition of micellar 
phospholipid could not restore activity. 
A method of purification of SCD from rat liver is provided in a 1978 article by 
Strittmatter and Enoch. The method employs induction of the enzyme by fasting and 
refeeding rats a high-carbohydrate diet followed by enzyme solubilization with a detergent 
solution of Triton X-lOO-calcium deoxycholate. By using this procedure, the authors were 
able to increase the specific activity by greater that 150-fold, which proved useful in isolating 
enzyme for future kinetic studies. 
Okayasu et al. (1981) partially purified and characterized the A®-desaturase from rat 
liver microsomes. Triton X-100 solubilization, followed by several rounds of column 
chromatography and ultimately cytochrome bs-Sepharose affinity chromatography, resulted 
in a homogeneous preparation with a single polypeptide of 66 kDa. In a reconstituted 
system, it was determined that, besides the terminal desaturase, NADH, O2, linoleoyl-CoA, 
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lipid or detergent, NADH-cytochrome bs reductase, and cytochrome bs were required for 
enzyme activity. Interestingly, NADPH and cytochrome P450 reductase could replace NADH 
and cytochrome bs reductase and the reaction would proceed at about 60% of optimal 
activity. Under ideal conditions, the Km was 45 nM and the Vmax was 83 nmol/min*mg 
protein. 
Enoch et al. (1976) did a thorough investigation concerning the mechanism of rat 
liver SCD by using various substrates and in vitro conditions to better understand the 
enzyme. By combining the three purified proteins required for stearoyl-CoA desaturation— 
NADH-cytochrome bj reductase, cytochrome bs, and the terminal desaturase—into egg 
lecithin vesicles, a functional electron transport system with active S CD-activity was 
available. It is assumed that, because hydrophilic chelating agents could strip the iron from 
the desaturase, that the active site of the enzyme was oriented on the surface of the vesicle 
and outward into the aqueous environment. Thus, the cytochrome bs and the active portion 
of its reductase also must be oriented outwardly. Acyl-CoA derivatives 9 to 20 carbons long 
bind to the enzyme, but derivatives 12 to 19 long carbons are required for desaturase activity. 
The dependence of the CoA moiety for enzyme recognition and activity is suggested by the 
decreased activity obtained with dephospho or deamino analogs of stearoyl-CoA. Inhibitor 
studies with 9,10-substituted acyl-CoA derivatives indicate that carbons 9 and 10 must be in 
the eclipsed (gauche) conformation at the active site. It was determined that stearoyl-CoA is 
first integrated into the membrane before it becomes available for the desaturase by mixing 
stearoyl-CoA with dimyristoyl lecithin liposomes and desaturase-dimyristoyl lecithin 
liposomes followed by separation by using gel filtration. Even when mixed in the ratio of 20 
mol stearoyl-CoA/lOO mol lecithin, 56% of the stearoyl-CoA was found in the liposome. 
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When egg yolk lecithin was used for vesicle formation, SCD activity was twice that when 
dimyristoyl lecithin was used, possibly because of differences in length of the membrane-
forming hydrocarbon tails but, most probably, because of decreased lateral diffusion in a 
more rigid vesicle when dimyristoyl lecithin was used. This experiment also indicated that in 
vivo differences might exist in desaturase activity based on fatty acid composition of the 
membranes. 
Jeffcoat et al. (1977) studied the properties of rat liver SCD in a crude microsomal 
system and in a partially purified system. Bovine serum albumin (BSA) and cytoplasmic rat 
Hver preparations increased activity of the crude preparation but did not stimulate activity in 
the partially purified preparations. It was surmised that BSA acts to protect the acyl-CoA 
fi-om thioesterases in the crude preparations. Fourteen-, 15-, 16-, 17-, 18-, and 19-carbon 
acyl-CoA were tested for specificity by the partially purified enzyme and, as was expected 
fi-om previous work, the order of preference was 18-, 16-, and 19-carbon acyl-CoAs. Based 
on amino acid analysis of the purified enzyme, SCD was foimd to be more hydrophobic, and 
therefore more likely buried deeper in the membrane, than NADH-cytochrome bs reductase 
and cytochrome bs. 
Prasad et al. (1980) demonstrated that the A^-desatiu-ase of chicken liver endoplasmic 
reticulum was located on the cytosolic face of the membrane by using antibodies specific to 
the terminal desaturase. Linoleoyl-CoA desaturase was demonstrated to be on the cytosolic 
side of the endoplasmic reticulum in rat liver as determined by trypsin digestion, antibody 
inhibition, and using sodium deoxycholate to destroy the permeability barrier of the 
endoplasmic reticulimi (Fujiwara et al., 1984). The other proteins necessary for terminal 
desaturase activity—^NADH-cytochrome bj reductase and cytochrome bs—are integral 
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membrane proteins that have hydrophilic active sites (De Pierre and Emster, 1977) and that 
must be oriented to interact with the active site of the desaturases. 
Pollard et al. (1980) screened various CoA-esters to determine the chain-length 
specificities of A^- and A^-desaturases. Delta-9 cis,\l cis fatty acids of chain length 14-22 
were all substrates for A®-desaturase, ranging from 74% desaturation for the 22-carbon acid 
to 13% desaturation for 18;2(n-6), the "native" substrate. Delta-5-desaturase is most active 
with the 20-carbon acids with cis double bonds. The A^-desaturase is under much more 
stringent chain-length control than is the A®-desaturase as demonstrated by 20-, 18-, and 17-
carbon A^-fatty acids having 55%, 7.5%, and 3% A^-desaturation, respectively, under in vitro 
conditions. 
Fujiwara et al. (1983) confirmed by using a A®-desaturase monospecific antibody that 
A^-, A®-, and A^-desaturases were definitely different enzymes. Immunodiffusion was used to 
test the reactivity of the antibody to A^-desaturase in liver microsomes. Then, partially 
purified A®-desaturase was tested without success. Also, the antibody inhibited A^-desaturase 
activity, but not A^- or A^-desaturase activity, confirming the uniqueness of the other two 
desaturase from A^-desaturase. 
Several accessory proteins that support fatty acid desaturation in animal cells have 
been identified. Jones and Gaylor (1979) screened the crude cytosohc fraction from rat liver 
in search of proteins that stimulated SCD. One such protein with an approximate mass of 
26,500 Da was purified 1,100-fold. This unidentified protein stimulated the reaction but did 
not bind 18:l(n-9) or 18:0, nor did it change the ratio between O2 consumed per NADH 
oxidized per stearoyl-CoA desaturated. Because it does not seem to interact with the 
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substrate or product and does not change the Km, the authors speculated that this unidentified 
protein may somehow act to organize the mutlienzyme complex in the membrane. Catala 
(1986) describes the properties of a smaller 12 kDa protein partially purified fi-om rat liver 
that binds 18;l(n-9) preferentially to 18:0. When this protein is added to an in vitro A®-
desaturase assay, the reaction is stimulated unless the protein is first saturated with 18:l(n-9), 
in which case, it has no positive effect on the reaction. A lipoprotein-like cj^osolic particle 
has been studied by Leikin and Brenner (1986) that is crucial for optimal A^-desaturase 
activity. The particle has a protein to lipid ratio of 1.22, with fi:ee fatty acids and 
phosphatidylcholine as its main lipid components. When microsome are washed extensively, 
this factor is removed along with much of the A^-desaturase activity. Activity can be restored 
in vitro by adding the isolated factor back to the reaction. The factor has been demonstrated 
to remove the product of the A^-desaturase reaction, 18:3(n-6), in a specific manner and 
transport it away fi-om the microsome where it could otherwise inhibit the enzyme. The 
factor does not fimction by increasing delivery of the substrate to the enzyme because 
transport occurred equally with and without the factor. Leikin and Brenner provided data 
supporting a cytosolic factor for A®- (1986) and A^-desaturases (1989) firom rat liver 
microsomes to achieve maximal activity. The A®-desaturase required cytosohc fi-action acts 
by specifically taking up 18:3(n-6), the reaction product, and preventing product inhibition. 
The A^-desaturase-required cytosolic firaction acts in a similar manner by specifically binding 
20:4(n-6) and preventing inhibition. When the cytosohc firaction is preincubated with 
20:4(n-6), it is not helpful to the reaction, but, when preincubated with 18:3(n-6), the factor 
retains its ability to activate the A^-desaturase reaction. 
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Fifty-fold induction of SCD expression in liver can be achieved by feeding fat-free 
diets and administering insulin injections (Oshino and Sato, 1972). After the metabolic 
modifications are stopped, the enzyme activity quickly returns to normal with a half-life of 2 
hours (Oshino and Sato, 1972). To better imderstand SCD half-life, Ozols (1997) studied the 
degradation of SCD in an attempt to better imderstand the specificity and rapid loss of 
desatiarase activity after metabolic treatments are changed. Desaturase activity was present 
in microsomal, nuclear, and subcellular fractions of hepatocytes from rats alternately fasted 
and refed a low-fat diet. Incubating the fractions at physiological temperature and pH led to 
complete disappearance of activity. The N-terminal sequence of the desaturase isolated from 
microsomes was blocked and had three more amino acid residues than did the desaturases 
found in the nucleus and the subcellular fractions, indicating different processing for the 
desaturase in the latter two locations. Microsomes washed with high-salt buffer retained 
activity longer than did those washed with typical buffers. Ozols speculates that the salt may 
render the enzyme inaccessible to the responsible proteases. A myriad of protease inhibitors 
including leupeptin, pepstatin, N-acetyl-leucyl-leucyl-methional, phenyhnethylsulfonyl 
fluoride, and lactacystin had no effect in helping retain A®-desaturase activity. 
Plant Systems 
Stumpf and James (1963) reported ACP in plants and determined that it had a central 
role in fatty acid biosjmthesis much as in E. coli. Nagai and Bloch (1968) demonstrated that 
chloroplasts from spinach elongate ACP-thioesters provided to the reaction and that there is 
18:l(n-9) production when O2, NAD(P)H, NAD(P)H ferredoxin oxidoreductase, and 
ferredoxin are available. This system described by Nagai and Bloch was the first reported 
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soluble enzyme system for converting 18:0 to 18;l(n-9). Oilseed-producing plants were, and 
continue to be, of great interest vi^ith respect to SACPD activity because many of them such 
as safflower have greater than 75% 18;2(n-6), all of which must originate as 18:0 and be 
converted to 18:l(n-9) by SACPD. 
In 1979, Ohlrogge et al. published further proof that fatty acid synthesis in spinach 
leaf occurs in the chloroplast and is dependent on ACP. Antibodies to spinach ACP inhibited 
greater than 98% of fatty acid synthesis activity in leaf homogenates. By gently separating 
the components of the spinach leaf cells by sucrose gradients and by using 
radioimmunoassay for ACP, all of the ACP was foimd to be associated with the chloroplast 
fraction. This paper provided strong evidence that de novo fatty acid synthesis occurs 
exclusively in the chloroplast and that fatty acids must be transported to the cytosol for 
fiarther modification. 
McKeon and Stumpf (1982) purified and characterized the SACPD from maturing 
seeds of safflower. They were able to purify the enzyme 200-fold and determine that it was a 
dimer with a molecular weight of 68 kDa. The order of substrate preference was 
overwhelmingly stearoyl-ACP followed by stearoyl-CoA and palmitoyl-ACP. When 
comparing stearoyl-CoA to stearoyl-ACP as substrates, the Vmax values are similar (106 
nmoles/min«mg) but the Km values differ greatly (0.38 |iM for stearoyl-ACP and 8.3 |iM for 
stearoyl-CoA). Because of the disparity in Km values, substrate concentration has much control 
over enzyme activity. Below the critical micellar concentration of stearoyl-CoA (2 |j,M), the 
reaction is first order, but, above this concentration, the graph of activity versus substrate 
concentration is sigmoidal and plateaus. Catalase increases activity by protecting the system 
from hydrogen peroxide generated by the aerobic oxidation of feiredoxin and ferredoxin 
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reductase. When the plant and animal desaturases are compared, they have similar Km and Vmax 
for stearoyl-CoA, but for the plant enzyme to work appreciably well on stearoyl-CoA it has to 
be above the critical micellar concentration. 
Once the properties of the soluble plant fatty acid desaturases were elucidated and 
their economic and scientific merits were noted, the cloning of a series of desaturases began. 
Thompson et al. (1991) isolated the cDNA for SACPD from safflower embryos and 
expressed it in E. coli. The enzyme was not active in E. coli, but activity was measured in 
lysate when spinach ferredoxin was added, demonstrating the specific requu-ement for plant 
ferredoxin. Since then, many soluble plant fatty acid desaturases have been cloned. More 
examples of cloned plant enzymes and transgenic applications are presented in the molecular 
biology section of this review. 
Pathways of PUFA synthesis in plants recently was elucidated (Shanklin and 
Somerville, 1991). The first double bond is formed while 18:0 is esterified to ACP as 
described above. Beyond the first double bond, further desatiiration occurs after the fatty 
acid has been incorporated into a lipid such as monogalactosyl diacylglycerol or 
phospholipid. The order of desaturation occurs in the order A9, A12, and A15. 
Reaction Chemistry 
Experiments elucidating the enzymology of both plant and mammalian desaturases 
provided insight to the chemistry of the desaturase reaction. Further insight was provided by 
primary amino acid sequence data and computer modeling of the protein. But, nothing has 
been more useful in determining the exact mechanism of plant enzymes and projecting 
mechanisms for mammalian enzymes than has crystallography of the plant desaturases. The 
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preliminary crystal structure of A®-stearoyl ACP desaturase was the first fatty acid desaturase 
to be solved by X-ray crystallography (Schneider et al., 1992). A more detailed analysis 
followed when Lindqvist et al. (1996) published the 2.4 A crystal structure. 
Despite the variability in sequence of membrane-bomid desaturases from mammals, 
fungi, insects, higher plants, and cyanobacteria, all have three regions of conserved primary 
sequence containing HX(3 or 4)H, HX(2 or 3)HH, and HX(2 or 3)HH (Shanklin et al, 1994). The 
histidine-rich regions in the different desaturases are in similar position relative to 
hydrophobic, membrane-spanning regions of the enzyme. By mutating each histidine residue 
from a rat cDNA for SCD to alanine, one at a time followed by expression in a A®-
desaturase-deficient yeast strain, all eight histidines were found crucial for maintaining active 
enzyme. It is speculated that the eight histidine residues are critical in maintaining the diiron 
center of the enzyme. The diiron center places SCD in a class with alkane hydroxylase and 
xylene monooxygenase as a new class of diiron center-containing enzymes. 
Fox et al. (1993) were the first group to study in detail the catalytic core of castor 
bean SACPD. It was determined that the enzyme contained four atoms of catalytically 
essential iron that was in a diiron-oxo cluster as determined by Mossbauer spectroscopy. The 
catalytic core was similar to other enzymes such as methane monooxygenase hydroxylase 
and ribonucleotide reductase. Furthermore, a set of histidine and carboxylate ligands were 
postulated to hold the diiron-oxo cluster. Physical chemistry properties of the desaturase when 
overexpressed in E. coli were studied by using Mossbauer spectroscopy. The results of this 
work revealed four atoms of iron per homodimer. In the oxidized state, the iron atoms were in 
the diferric (Fe+3) state but, when reduced, they returned to the diferrous state (Fe+2). Addition 
of stearoyl-CoA and O2 caused the iron atoms to return to the diferric state. This catalytically 
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essential diiron-oxo cluster also has been observed in ribonucleotide reductase and methane 
monooxygenase hydroxylase. These three enzymes perform extremely different reactions, but 
all catalyze 02-dependent cleavage of unactivated C-H bonds, probably via reactive high-valent 
iron-oxo intermediates. Interestingly, besides the histidine-rich regions, the only sequence 
commonality between the enzymes is a conserved pair of amino acid sequences -(Asp/Glu)-
Glu-Xaa-Arg-His- separated by about 100 amino acids. 
Ling et al. (1994) studied the formation of the iron-radical cofactor in the R2 subunit 
of rionucleotide reductase, an iron-oxo enzyme in the same family as methane 
monooxygenase and the soluble fatty acid desaturases. By using resonance Raman 
spectroscopy, it was determined that the diferrous cluster in the reduced form of the enzyme 
functions as a tyrosine oxidase by using O2 to oxidize Tyr-122 to a stable radical and form an 
oxo-bridged diferric cluster. In the mechanism proposed, there is a peroxo intermediate that 
undergoes heterolytic 0-0 bond cleavage, resulting in the high valent iron intermediate and 
water. It is proposed that generation of the high valent intermediate is accomplished by the 
negatively charged ligands "pushing" and acid-catalysis "pulling" to accomplish the 0-0 
cleavage. The differences within this family of enzymes for electron abstraction or oxygen 
atom insertion probably lies in sUght structural variation, leading to changes in the 
orientation of the high valent intermediate form of the reactive center. 
The 2.4 A crystal structure of SACPD published by Lindqvist et al. (1996) has 
provided great insight about the positioning of the catalytic diiron cluster, the point of double 
bond insertion, and the lipophilic chaimel that positions the substrate conferring enzyme 
specificity. The 363 amino acid monomer contains 11 a-helices, nine of which form an 
antiparallel helical bundle. The two iron molecules of the diiron catalytic site are bound by 
pairs of amino acid residues glutamate 196/histidine 232 and glutamate 105/histidine 146. 
Electron sparcity, corresponding to a ^i-oxo bridge, and the 4.2 A distance between the irons 
indicate the diferrous form of the enzyme. When the substrate, 18:0, is modeled into the 
deep channel, the A^-carbon is located in the vicinity of the iron ions. The shape of the A®-
desatixrase subunit is 35A X 35A X 50A. Except for a small region of P-hairpin loop, the 
molecule is composed of helical secondary structure. The crystal structure corroborates the 
classic diiron metal cluster proposed by Fox et al. (1993). Because of the 4.2 A distance 
between the irons, the enzyme is probably in the reduced form as a result of X-ray 
photochemical reduction. The authors propose two possible routes for electron transfer from 
the surface to the iron center. One scenario utilizes the axis of a helix bundle containing 
mostly aromatic side chains. The other scenario utilizes a configuration of amino acids 
analogous to those found in R2 of ribonucleotide reductase. With the catalytic site buried 
deep within the enzyme, the expected hydrophobic groove to allow acyl chain entry is found. 
In fact, the channel has a bend at the position of the iron cluster facilitating binding of oleoyl-
ACP with its cis configuration at the double bond. 
Pathways 
In 1960, Klenk and Mohrhauer injected ''^C-labeled fatty acids into rats and proposed 
many of the pathways that are now in biochemistry text books for fatty acid desaturation and 
elongation (Figure 2). The direct desaturation of 22:5(n-3) to 22:6(n-3) by a proposed A''-
desaturase as commonly diagrammed, however, was not or has not been demonstrated. Voss 
et al. (1991) proposed a modification to the previously accepted desaturase/elongase 
pathways by demonstrating in rat liver microsomes that the desaturation of 22:5(n-3) to 
(n-6) Family 
18:2 ^18:3 p 20:3 p 20:4 ^ 22:4 .—^22:5 
A -Desaturase J I^^Elongase^J jT A -Desaturase Elongase A -Desaturase 
(n-3) Family vo 
18:3 p 18:4 ^ 20:4 p 20:5 ^ 22:5 ^22:6 
Figure 2. Biosynthesis of the (11-6) and (n-3) families of polyunsaturated fatty acids. Adapted from Harper's Biochemistry. 
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22:6(n-3) was indirect via an elongation to 24:5(n-3), a A^-desaturation to 24:6(n-3), and p-
oxidation to 22:6(n-3) rather than a direct A'^-desaturation. A parallel scheme was 
demonstrated by Mohammed et al. (1995), showing that the (n-6) acid 22:4 is converted to 
22:5 not via A'^-desaturase, but rather by the elongation, A®-desaturation, and p-oxidation to 
yield 22:5(n-6). Because of the requirement of desaturases, elongases (endoplasmic 
reticulum), and P-oxidation (peroxisomes), there is an increased amount of trafficking 
involved in transporting the fatty acids to different areas within the cell during synthesis. A 
review by Sprecher et al. (1995) discusses alternative pathways for biosynthesis of fatty acids 
in mammals whereby 24-carbon acids are moved from the endoplasmic reticulum to the 
peroxisome for partial P-oxidation and then return to the endoplasmic reticulum for further 
desaturation, bypassing the requirement for direct A'^-desaturation. 
In the alternative path of 22:6(n-3) production proposed by Voss et al. (1991), A®-
desaturase uses 18:3(n-3) as a substrate to produce 18:4(n-3) in what has been considered the 
typical desatiu-ation scheme, and it uses 24:5(n-3) as a substrate to make 24:6(n-3) in the 
newly proposed scheme that bypasses the need for a A'^-desaturase. Henderson et al. (1998) 
examined the conversion of 18:3(n-3) to 24:6(n-3) by using trout microsomes as an enzyme 
source and purified and quantified both labeled and unlabeled intermediates. They 
concluded that A®-desaturase is feedback inhibited the strongest by the 24-carbon 
polyunsaturates in the (n-3) desaturation scheme. It also was found that at equal 
concentrations 24:5(n-3) is the preferred substrate for A^-desatxirase over the traditional 
18:3(n-3). Furthermore, the 18:3(n-3) desaturation is inhibited by the 24-carbon (n-3) acids, 
but the 24:5(n-3) desaturation is not inhibited by the 18-carbon (n-3) acids. 
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The existence of two unique A®-desaturases, one for the traditional and one for the 
alternate pathway was examined by Geiger et al. (1993). In vitro studies utilized rat hepatic 
microsomes. Homo-gamma-linolenic acid did not inhibit A®-desaturation of either substrate, 
but each substrate did inhibit the A^-desaturation of 20:3(n-6) to 20:4(n-6). By incubating 
both the traditional and alternative substrate with microsomes and holding one substrate 
concentration steady and increasing the other, preferential desaturation of 18:3(n-3) was 
noted in this system. All data indicate a single desaturase but, until molecular approaches are 
used, the possibilities of two forms of A®-desaturase exist. On the contrary, Marzo et al. 
(1996) proposed two different A^-desaturases existed in the conversion of 18:3(n-3) to 
22:3(n-6). Two modes of evidence of multiple A^-desaturases are: 1. Trans-9,is a 
potent inhibitor of A®-desaturase and it prevents synthesis of 22:3(n-6) from 18:3(n-3) but not 
from 20:5(n-3) and 2. When Y-79 cells differentiate, traditional A®-desaturase activity is 
greatly increased, but the synthesis of 22:6(n-3) remains constant or decreases. 
The traditional A®-desaturase reaction was deemed rate limiting by Yamazaki et al. 
(1992) when they compared the conversion of 18:3(n-3) and 18:4(n-4) to 20:5(n-3). After 
feeding rats 10% lard or 9% lard supplemented with 1% test fatty acid as an ethyl ester for 
one or 3 weeks, liver and blood fatty acids were identified. Delta-6-desaturase was 
determined to be the rate-limiting step in the desaturase/elongase scheme because rats fed 
18:4(n-3) had 2-fold increases in 20:5(n-3) accumulation in hepatic and blood lipids 
compared with the 18:3(n-3)-fed rats. Also, 18:4(n-3) was not detected in most fractions 
tested, even in rats eating diets containing 1% 18:4(n-3). 
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The effects of dietary fatty acids on metabohc regulation was first noted by Allmann 
and Gibson (1965) when they noticed a 70% depression in hepatic fatty acid synthesis, malic 
enzyme activity, and glucose-6-phosphate dehydrogenase activity 2 days after feeding only 
2% 18:2(n-6) in an otherwise fat-free, high-carbohydrate diet. While dietary fats act by both 
controlling cellular metabohsm by changing fatty acid composition of membranes and 
regulating nuclear events that govern transcription (review by Clarke and Jump, 1996b), the 
rapid suppression of enzyme systems is a transcriptional event (Blake and Clarke, 1990). 
Transcriptional down-regulation occurs within 3 hours after feeding diets containing 5% 
menhaden oil to animals adapted to a high-carbohydrate, fat-free diet (Clarke et al, 1990). 
Clark and Jump (1993a) have demonstrated that depression of lipogenic enzyme expression 
occurs with (n-6) and (n-3) fatty acid intakes at three to four times the amoimt required for 
optimal growth. Transcription returns to normal within 3 hours after removing the oil from 
the diet. While membrane fatty acid composition has been recognized to influence the cell at 
the molecular level by altering such things as hormone signaling (Spector and York, 1985), 
these data emphasize the probability that PUFA is exerting a direct effect on transcription 
rather than acting by changing biophysical properties of membranes. 
Clarke and Jump have focused on hepatic gene expression, but, more recently, 
Tebbey et al. (1994a) and Tebbey and Buttke (1992a) identified PUFA inhibition of 
transcription in Ijmiphoma and adipose cells. By using chimeric promoter/reporter studies, 
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Jump et al. (1993) studied the 4,000 bp sequences upstream of both S14 and pyruvate kinase 
genes. The constructs were responsive to PUFA addition to the culture. Then, by doing 
deletion studies, the regions -220 to -80 and -197 to -96 of S14 and pyruvate kinase genes 
respectively, contained the PUFA-response region, the same region responsible for the 
insulin-carbohydrate induction response. Because of the rapidity of PUFA response, 
scientists have been looking for a nuclear factor that would mediate the PUFA signal. The 
first example of this type of factor came in the cloning of the PPAR that responds to, among 
other things, fatty acids (Gearing et al., 1993). But, as Clarke and Jump (1996a) point out in 
their review, not all genes that respond to PUFA have a PPAR-response element, nor does 
PPAR discriminate between fatty acids as is seen with PUFA, but not 18 :0 for example, 
repression of transcription. 
While examples of fatty acids other than PUFAs acting to modulate desaturation are 
sparse in the literature, there are a few examples. Methyl branched-chain fatty acids 
(MBCFA) inhibit SCD activity by over 50% in rat hver when fed at 50 mg/g diet (Wahle and 
Hare, 1980). Branched-chain fatty acids are found in the adipose tissue of ruminants and 
accumulate as methylmalonyl-CoA, an intermediate in propionate metabolism that is 
incorporated into fatty acids. The inhibition by MBCFA seems specific and not a general 
membrane effect because other membrane-dependent reactions are not affected (0-
hydroxylation) and because MBCFA inhibit in vitro reactions, whereas palmitate does not. 
Periago et al. (1989) fed rats olive oil or com oil with and without supplemental 
medium chain triacylglycerols (MCT) to study the effects on microsomal membrane fatty 
acid composition and desaturase activities. The com oil-fed rats had more saturated fatty 
acids in the microsomal membranes than did olive oil-fed rats. While this cannot be 
explained on the basis of dietary fatty acids directly, it is now understood that the increased 
18:2(n-6) in com oil depressed A'-desaturase activity and that this inhibition led to an 
increased saturated fatty acid content of the membranes. Medium chain triacylglycerols 
depressed A^-desaturase when fed with olive or com oil but only suppressed A®-desaturase 
when fed with com oil. The mechanism for the disparity between A®- and A®-desaturase 
activities when oils are fed in combination with MCT is not known, however it could be an 
indirect effect via the changes in insulin and glucagon status as a result of the dietary MCT. 
Dietary Polyunsaturated Fatty Acids 
The early studies of PUFA regulation of fatty acid desaturases measured enzyme 
activities as a response to dietary fat. Pugh and Kates (1984) studied the activities of hepatic 
fatty acid desaturases and l-acyl-5«-glycero-3-phosphocholine acyltransferase in rats fed 
chow alone or with added com oil or coconut oil. Whereas A®-, A®-, and A^-desaturases were 
increased with com oil and decreased with coconut oil relative to chow-fed rats, there was no 
difference in l-acyl-s«-glycero-3-phosphocholine acyltransferase activity with these dietary 
treatments. The fatty acid composition of hepatic microsomes did not correlate with the in 
vitro determined activity of the desaturases possibly because of dietary fatty acids being 
incorporated directly into membrane lipids. These results differ from those of most 
experiments in that one would expect A®-desaturase to be down-regulated when com oil is 
fed. The A^-desaturase results compare with those of Gomez-Dumm et al. (1983) who 
supplemented fat-free diets with 18;2(n-6), 18;3(n-6), or 20;4(n-6) to study the response of 
A^-desaturase activity. Fat-free diets depressed A^-desaturase activity by about 50% whereas 
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feeding any of the (n-6) acids increased A^-desaturase activity. The increase in A^-desaturase 
is probably because of increased enzjone synthesis, as cycloheximide blocked the 
reactivation. Gamma-linolenic and 20;4(n-6) showed the most potent response with recovery 
of A^-desaturase activity to control values within 48 hours after feeding. 
de Antueno et al. (1993) demonstrated a change in plasma 18:l(n-9) to 18:0 ratio 
when mice were fed 2.5% (n-3)-, (n-6)-, or hydrogenated coconut oil-enriched diets. 
Because the diets had similar ratios of 18:l(n-9) to 18:0 and because liver A^-desaturase 
activity correlated positively with plasma 18:l(n-9) to 18:0 ratios, hepatic A^-desaturase 
activity can be estimated by monitoring plasma fatty acid composition. Estimates of A®-
desaturase activity made by monitoring the ratio of total (n-3) to 18:3(n-3) or total (n-6) to 
18:2(n-6) in plasma indicate that A^- and A®-desatiu:ase activities are correlated positively 
when the different dietary fatty acids were fed to induce changes in lipid metabolism. The 
authors also concluded that absolute PUFA concentrations or PUFA to saturated fatty acid 
ratios were not major factors in determining plasma triacylglycerol concentration or A®-
desaturase activity. However, dietary 20:5(n-3) had a major effect on plasma triacylglycerol 
concentration and A^-desat\irase activity only when fed in combination with 18:3(n-6). This 
study conforms with other studies showing that dietary (n-3) fatty acids are correlated 
inversely with plasma triacylglyceride concentrations and A^-desaturase activity probably via 
an insulin or insulin receptor interruption. 
The (n-6) fatty acid suppressing effect on adipose A^-desaturase was studied by 
Kouba and Mourot (1998) by feeding pigs diets enriched in 18:2(n-6) (4% com oil) or 18:0 
(4% beef tallow) compared with a conventional low-fat swine diet. The 18:2(n-6) 
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enrichment augmented hpogenesis by increasing the activities of acetyl-CoA-carboxylase, 
malic en2yme, and glucose-6-phosphate dehydrogenase. But because of increased PUFA in 
the 18:2(n-6)-enriched diet, A^-desaturase activity was decreased compared with that in pigs 
fed the other two diets. The tissue fatty acid composition reflected the changes in A'-
desaturase activity. 
Essential Fatty Acids 
Lefkowith (1990) studied the rate of development of essential fatty acid deficiency, 
typically a difficult scenario to induce experimentally, when A^-desaturase was induced. The 
author suspected that by increasing A^-desaturase activity he would observe a great increase 
in 20;3(n-9), the halhnark fatty acid that accumulates during fatty acid deficiency. Being 
able to speed the induction of essential fatty acid deficiency would be of great value in the 
time savings it would offer in experimental models. Whereas induction of A®-desaturase by 
alternately fasting and feeding a fat-free diet increased hepatic 20:3(n-3) to 20;4(n-6) ratios 
dramatically, the other samples such as plasma, macrophages, and renal cortex changed only 
slightly or not at all. From this research, it can be noted that essential fatty acid deficiency is 
resisted strongly by the body and that the liver has a pivotal role in maintaining PUFA status 
of the organism. 
Up-regulation of A^- and A^-desaurases in HepG2 cells grown with normal and 
essential fatty acid-deficient (EFAD) media was studied by Melm and Nilsson (1997). When 
''^C-18:2(n-6) was provided in the media, EFAD cells converted six times more radioactivity 
into desaturase and elongase metabolites than did control cells. There was 14 times more 
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labeled 20:4(n-6) in EFAD cells than in controls, indicating the potential for up-regulation of 
both A^- and A^-desaturases and their limited expression in HepG2 cells fed essential fatty 
acids. 
Bond Configuration 
The control of A®-desaturase activity as influenced by the configuration of double 
bonds in 9,12-dienoic fatty acid structures was studied by de Alaniz et al. (1986). Various 
fatty acids were supplied for 24 or 48 hours to rats previously maintained on a fat-free diet. 
The configuration of the bonds proved to be critical as 18:2(9 trans,\2 trans) did not change 
A^-desaturase activity at all compared with the fat-free fed rats. Linoleic acid, 18:3(n-6), and 
18:3A(5t,9c,12c) all suppressed A^-desaturase activity with increasing potency. Presumably, 
A'-desaturase repression is elicited by metabolites of 18;2(n-6) and 18:3(n-6), as 18;l(n-9 
trans) elaidic acid cannot be metabolized ftirther. Because columbinic acid (18:3(5 trans, 9 
trans, 12 cis)) is not a substrate for A®-desaturation and because the space-filling structure is 
similar to 18:2(n-6), the importance of the 9-cis, \2-cis configuration in regulation of A®-
desaturase expression is confirmed. 
Clarke and Jump (1993b) described the physical configurations of PUFAs to act as 
gene regulators. The requirements established so far include two double bonds in an 18-
carbon fatty acid with one bond positioned between carbons 9 and 10 and the other between 
12 and 13. One of the bonds must be in the cis configiuration, but the other can be in the 
trans configuration. 
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Conjugated linoleic acid (CLA) does not fit into the prescribed bond configurations 
for gene regulation, but it does cause a decrease in SCD type one (SCDl) activity in the liver 
of mice (Lee et al., 1998a). When mice were fed a fat-free diet or a diet with 5% com oil, 
CLA addition at 0.5% caused a 45% and 75% decrease in SCDl mRNA, respectively. 
Conjugated linoleic acid at 150 in the media of cultured hepatocytes suppressed SCDl 
expression by 60%. Authors note that it is not the 9 cis, 11 trans isomer but probably the 10 
trans, 12 cis of CLA that is responsible. In initial studies, it was noted that CLA was about 
twice as potent as 20:4(n-6) at down-regulating SCDl expression. 
Polyunsaturated Fatty Acids/Insulin Interaction 
Ntambi et al. (1996) used a mouse liver cell line (H2.35) to study insulin and PUFA 
effects on SCDl expression. Insulin stimulated expression whereas PUFAs down-regulated 
expression. Polyunsaturated fatty acids were able to suppress the insulin induction, with 
20:4(n-6) being the strongest suppressor. Fusions of the 5' regulatory sequence for SCDl 
were made with the chloramphenicol-acyltransferase (CAT) cDNA and expressed in H2.35 
cells. Both insulin and PUFAs were able to modulate expression of CAT, indicating the 
control region for both of these modulators is in the 5' promoter region. 
Polyunsaturated fatty acids decrease mouse liver SCDl activity through an insulin-
independent mechanism as demonstrated by Waters and Ntambi (1996). When diabetic mice 
were provided PUFA plus insulin or PUFA plus fructose, lipogenic gene expression is up-
regulated in the presence of increased carbohydrate or insulin and down-regulated in the 
presence of PUFAs. The regulatory sequences upstream of the Si4 and pyruvate kinase genes 
have been studied, and the regions that are required for PUFA inactivation are the same 
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regions required for insulin/carbohydrate induction (Thompson and Towle, 1990). The 
apparent dual fiinctionality of upstream regulatory sequiences quickly leads to speculation 
about PUFA interfering with the insulin signaling pathways. 
Polyunsaturated Fatty Acids/Cholesterol Interaction 
Garg et al. (1988a,b,c) published a series of articles reporting the regulation of fatty 
acid desaturases after feeding fish oil linseed oil, and beef tallow to rats. The fish oil, and 
linseed oil diets depressed A^-desaturase activity by 90% and 60%, respectively, compared 
with the beef tallow feeding. Interestingly, cholesterol addition stimulated the A®-
desaturation of 16:0, resulting in increased concentrations of 16:l(n-7) and 18:l(n-7). In 
summary, it is evident that A^-desaturase is dependent not only on the fatty acid environment 
but also the cholesterol environment of the membrane. It can be concluded that 
monounsaturated fatty acid (MUFA) synthesis is not regulated by content of MUFAs in the 
diet because dietary MUFA was correlated positively with A^-desaturase activity in this 
study. The authors concluded that increased membrane fluidity caused via feeding PUFAs, 
or less cholesterol, is the primary mechanism for A^-desaturase regulation. Inhibition of A®-
desaturase activity was greater in the fish oil-fed rats than in the linseed oil-fed rats. 
Cholesterol only inhibited A^-desaturase activity when fed with tallow, but, in combination 
with the concentrated (n-3) diets, it had no effect on desaturase activity. This observation 
was one of the first to explain a biochemical reason for the decrease in prostaglandin E2, 
thromboxane, and prostacyclin concentrations after feeding fish oil. Also, small amoimts of 
dietary fish oil block the cholesterol inhibition of A^-desaturase when a diet rich in saturated 
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fat is consumed. Fish oil suppressed A^-desaturase relative to beef tallow whereas linseed oil 
increased A^-desaturase relative to tallow. Cholesterol added to the beef tallow and linseed 
oil-enriched diets casued a decrease in A^-desaturase, but, cholesterol added to the fish oil-
enriched diet did not change A^-desaturase activity. Fatty acid composition of liver 
microsomes were predictable based on the in vitro desaturase activity data. 
Muriana et al. (1992) fed rats diets containing 10% olive oil or fish oil with and 
without 1.0% added cholesterol. Fish oil feeding increased A®-desaturase and decreased A^-
and A®-desaturase activities relative to that of olive oil-fed rats. Adding cholesterol increased 
A®-desaturase with both oils and decreased A^-desaturase activity with both oils. Adding 
cholesterol increased A^-desaturase activity with fish oil and decreased activity with olive oil. 
Patterns in fatty acid composition of liver microsomal membranes matched fatty acid 
desaturase activity data. This report shows the extreme modulation of desaturases with 
dietary modifications in rats. 
Polyunsaturated Fatty Acids and Gene Regulation 
There are many good review articles that have been vmtten in the past few years on 
dietary PUFA and gene regulation. One of the most recent is a review by Sessler and Ntambi 
(1998), that provided a thorough review of the effects of PUFAs on gene expression. 
Whereas PUFAs are important in membrane structure, metaboHsm, and signal transduction, 
it has become clear that PUFAs also have a role in the control of adipogenesis and 
physiologic events that regulate expression of enzymes crucial to energy metabolism. 
Hepatic-specific PUFA regulation was reviewed by Clarke and Jimip (1996a,b). 
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Polyunsaturated fatty acids exert their effect in some cases through eicosanoid production, 
but, in the case of lipogenic enzyme regulation, the effect is independent of eicosanoids. The 
PPAR has been proposed by some to be the PUFA-binding trans acting factor responsible for 
down-regulating lipogenic gene expression (Gearing et al., 1993), but there is evidence to 
support a more direct PUFA effect on gene transcription. SH and pyruvate kinase promoter 
regions do not contain a PPAR-response element (Jump et al., 1995). Transcription trans-
activating assays all give equal response to saturated fatty acids, MUFAs, and PUFAs 
(Gottlicher et al., 1992) 
Clarke and Jump (1993b) also wrote a review on regulation of gene transcription by 
PUFAs. The decrease in hepatic lipogenesis by (n-3) or (n-6) acids seems to be specific to 
liver tissue, as adipose (Clarke et al., 1977) and lung (Clarke et al., 1984) lipogenesis was not 
selectively suppressed by (n-6) or (n-3) fatty acids. When hepatic fatty acid synthesis is 
inhibited, triacylglycerol synthesis and secretion (Phillipson et al., 1985) and A^-desaturase 
(Ntambi, 1992) also are inhibited. The authors of the review speculate that the dramatic 
effect that PUFAs have is not simply to lower serum triacylglycerol concentrations but rather 
to allow synthesis of healthy membranes rich in PUFA rather than 18:l(n-9). 
Monounsaturates would out-compete the PUFAs in phospholipid synthesis if their A®-
desaturase was not down-regulated (Gomez-Dvunm et al., 1983). 
Hepatic SCDl was grouped with fatty acid synthase and S14 in the way that it is 
down-regulated in response to imsaturated fatty acids (Landschulz et al., 1994). Both in mice 
and in cultured hepatocytes, fat-free or 18:l(n-9) feeding did not decrease SCDl mRNA, 
concentrations, but 18:2(n-6), 18:3(n-3), or 20:4(n-6) caused a significant decrease (up to 
90%) in SCDl mRNA with 20:4(n-6) causing the greatest down-regulation. Run-on 
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transcription assays indicate that unsaturated fatty acids control mRNA concentration by 
decreasing the rate of transcription. 
Regulation of SCD type two (SCD2) expression in lymphocytes involves positive and 
negative regulation much like SCDl in liver (Tebbey and Buttke, 1992b). Arachidonic acid 
in particular was shown to regulate SCD2 expression primarily by a decrease in transcription. 
A more detailed investigation of regulation of SCD2 by 20:4(n-6) was provided by Tebbey et 
al. (1994b). When lymphocytes were grown in 25)iM 20:4(n-6), phospholipid 20:4(n-6) 
increased to 18 wt% and SCD2 gene expression was inhibited. When 20:4(n-6) was 
removed from the media, phospholipid 20:4(n-6) decreases to 0.6 wt% in 144 hours, but 
unsaturated fatty acid sjTithesis is fully operational again within 6-12 hours because of an 
increase in SCD2-specific transcription and translation. As unsaturated fatty acid sjTithesis is 
re-established, the 20:4(n-6) content of phoshatidylcholine declines whereas there is no 
change in 20:4(n-6) content of phosphatidylethanolamine and phosphatidylserine. The 
authors suggest a phospholipid intermediate being involved in the signaling pathway 
whereby dietary fatty acids regulate expression of critical biosynthetic genes. 
Dietary trans Fatty Acids 
In 1984, Mahfouz et al. published a study where rats were fed high-oleic safflower 
oil, hydrogenated soy oil, lard, or com oil to determine dietary fat effects on A^-desatiu-ase 
activity. Fatty acid composition of the diets was reflected in the fatty acid composition of the 
hepatic microsomes. The hydrogenated soy oil diet depressed A^-desaturase compared with 
all other diets, but the other diets did not differ from one another with respect to A®-
desaturase activity. This observation indicates that trans fatty acids are stronger inhibitors of 
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A^-desaturase than are saturated fatty acids. Delta-9-desatiu:ase activity was greatest in the 
high-oleic safflower oil-fed rats and different from that in the com oil-fed rats that had the 
least A®-desaturase activity. The lard- and the hydrogenated soy oil-fed rats were 
intermediate in A^-desturase activity and did not differ from the other treatments. Delta-5-
desaturase activity was not changed by any dietary treatments imposed. 
The effects of trans fatty acids on A^-, A®-, and A®-desaturases also were assessed in 
rat liver microsomes from rats fed varying amounts of trans fatty acids (Mahfouz, 1981). 
When 20% of the diet was margarine, A^- and A^-desaturases were significantly inhibited, 
but, when hydrogenated coconut oil was fed, only A^-desaturase was decreased compared 
with that of control rats. This study demonstrates how dietary trans fatty acid could cause 
effects similar to those of essential fatty acid deficiency via fatty acid desaturase inhibition, 
leading to inhibition of eicosanoid formation. 
Svensson (1983) fed hydrogenated peanut oil and hydrogenated marine oils to rats in 
a diet normalized for 18:2(n-6) content to study changes in fatty acid incorporation and fatty 
acid desaturase activity of microsomal membranes. The effects of feeding hydrogenated 
herring oil was more dramatic on inhibiting all three fatty acid desaturases than diets that 
were more enriched in trans fatty acids, probably because of the combination of trans 
isomers and the long-chain highly imsaturated acids in partially hydrogenated fish oil. 
Despite decreasing all three desaturases by nearly 50% and inducing dramatic changes in 
phospholipid fatty acid composition, the authors comment that it is not known if these affects 
are dramatic enough to affect membrane fluidity or eicosanoid production. 
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Natural and hydrogenated peanut and marine oils were fed to rats by Kirstein et al. 
(1983) to delineate the effect of trans isomers and acyl-chain length of MUFAs on A^- and 
A^-desaturase activities. Partial hydrogenation of marine lipids inhibit desaturase activities 
more than peanut oil, again pointing the finger at the higher concentrations of 20:1 and 22:1 
isomers in hydrogenated marine oil 
De Schrijver and Privett (1981) fed trans fatty acids to fatty acid-deficient and 
healthy rats. In all cases, trans fatty acids depressed A^-desaturase activity in vitro and in 
vivo as 18:2(n-6) accumulated when trans fatty acids were fed. The A^-desaturase depression 
was more evident in rats that previously had been maintained on an essential fatty acid-
deficient diet. Delta-9-desaturase activity was not affected by trans fatty acids and, in fact, 
was increased when trans fatty acids were fed in a balanced diet. 
In vitro tissue culture experiments by Rosenthal and Doloresco (1984) used human 
skin fibroblasts to study the effects of different trans isomers of fatty acids on the activity of 
A^-desaturase. The overall goal was to identify potential specific inhibitors of 20:4(n-6) 
synthesis in human cells to decrease inflammatory prostaglandin production. The order of 
potency in inhibiting the A^-desaturase reaction was 18:1(9 trans) > 18:2(9 trans, 12 trans) 
>18:1(9 cis) = 18:2(9 cis, 12 cis) > 18:1(11 trans) . In summary, it was noted that n-9 trans 
fatty acids are potent inhibitors of A^-desaturase, whereas n-7 isomers are not. 
Protein 
When Narce et al. (1992) fed rats a low-protein diet for as little as 2 days, A®-
desaturase activity inhibition was noted. The enzyme activity was further suppressed 14 days 
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after feeding a low-protein diet and then reboiinded to values greater than control rats when 
the rats were refed a protein adequate diet, hiterestingly, the fatty acid composition of the 
liver did not represent the activity of the desaturase because 18:l(n-9) concentrations 
increased in the protein-deficient rats. The only plausible explanation for this discrepancy 
would be a decreased oxidation or altered transport of fatty acids during the protein-deficient 
state to conserve membrane integrity of the liver when A^-desaturase is lacking. The 
decreased ratio of 18:0 to 18:l(n-9) could be explained partially by a decrease in de novo 
synthesis because of the protein-deficient state. 
Narce et al. (1988) also studied the effects of protein malnutrition on A^- and A^-
desaturase activities in growing rats. Oleic acid, 18:2(n-6), and 18:3(n-3) accumulate in total 
liver lipids of protein-deficient rats whereas there is a decrease in 20;3(n-6) and 20:4(n-6) 
when compared with protein-adequate rats, but microsomal phospholipid changes were not 
observed until 52 days of protein malnutrition. Both desaturases decreased by 20-30% of 
their original values after rats were fed a low-protein diet for only 2 days. When the low-
protein diet was fed for 52 days or when the rats were fed a protein balanced diet, desaturase 
activities were greatly restored within 2 days and were back to control values after 13 days of 
refeeding. Liver protein synthesis was impaired because of an increase in fatty liver, an 
indicator of insufficient apoprotein synthesis to support VLDL export fi:om the liver. 
Changes in rat pup fatty acid desaturases as a result of feeding their mothers essential 
fatty acid- or protein-deficient diets were analyzed by De Tomas et al. (1980). Low-protein 
diets when fed to the dams decreased pup A^-, A®-, and A^-desaturase activities by about 60%. 
The low fat diet only changed A^-desaturase; it increased activity by 360%. These results 
36 
explain the reason for increased 20:3(n-9) in essential fatty acid deficiency and the decrease 
in 20:4(n-6) when animals are not receiving an adequate amount of dietary protein. 
Specific dietary proteins seem to differentially affect fatty acid desaturases as 
dramatically as do protein-deficient diets. When highly purified soybean protein or casein 
are fed to rats, the soy protein feeding results in lower microsomal A^-desaturase activity on 
(n-6) fatty acids (Madani et al., 1998). Soy protein only lowered A®-desaturase on (n-3) acids 
when low substrate concentrations (60 nM) were used. The authors suggest this is support 
for two different A®-desaturases as others have proposed. Delta-5-desaturase, however, was 
not affected by type of dietary protein. When the diets contained supplemental cholesterol, 
both desaturase activities were decreased, but A^-desaturase activity decreased more than did 
A®-desaturase. The cholesterol-induced changes often are thought to be associated with 
decreases in membrane fluidity. 
Lindholm et al. (1993) also fed casein and soybean proteins to rats. The casein-fed 
rats had greater A®-desaturase activity than did the soybean protein-fed rats. When 
microsomal fatty acid composition of the two groups of rats was compared, the soybean 
protein-fed rats had greater concentrations of 18:2(n-6) and 20:4(n-6). The increase in 18 
carbon acids can be attributed directly to decreased desaturase activity, whereas the increase 
in 20:4(n-6) only can be explained by a differential use of that particular fatty acid by rats fed 
the two diets. The higher concentration of 20:3(n-9) in the casein-fed rats may occur because 
the increase of A^-desaturase allowed 18:l(n-9) to be more readily utilized as a substrate for 
the A®-desaturase reaction, leading to increased 20:3(n-9) as is observed in essential fatty 
acid-deficient animals. 
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Dietary casein also was shown to enhance the activity of A^-desaturase relative to 
dietary soy protein in rat liver microsomes because of changes in microsomal membrane 
fluidity (Koba et al., 1993). When a variety of protein sources were fed that modulated 
membrane fluidity, a positive correlation (r=0.804; 0.05<P<0.1) was observed between A®-
desaturase activity and fluorescence anisotropy (decreased anisotropy means increased 
fluidity), a measure of membrane fluidity. 
Peluffo et al. (1984) studied the effects of differing amino acid diets on A^-, A®-, and 
A'-desaturase activities. A 45% casein diet decreased A'-desat\irase and increased A^- and 
A®-desaturase activities relative to a typical diet with 5% casein. An amino acid mixture 
equivalent to that found in casein resulted in no differences compared with the 45% casein 
diet. By excluding different amino acids from the simulated casein mixture, it was 
determined that tyrosine and phenylalanine inhibit A^-desaturase, but little change was seen 
in A^- and A^-desaturase activities when amino acid deletions or substitutions in the diet were 
made. When massive doses (20% of dietary calories) of phenylalanine, tyrosine, and 
tryptophan were given, tyrosine inhibited A -desaturase to 33% of control values, 
phenylalanine inhibited to 66% of control values, and tryptophan had no effect. The authors 
speculate that epinephrine formation from phenylalanine and tyrosine could raise cAMP 
concentrations, which inhibit A®-desaturase activity (Gomez-Dumm, 1975). 
Carbohydrate 
The extreme induction of hepatic A^-desaturase noted when rodents are alternately 
fasted and fed a low-fat, high-carbohydrate diet was utilized by Thiede and Strittmatter 
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(1985) to isolate SCD mRNA from in rat liver. By using northern analysis, a 4,900-base 
mRNA increased in concentration 50-fold by the dietary induction protocol. Protein 
synthesis from the recovered mRNA template in a rabbit reticulocj^e lysate system detected 
an immunologically active protein that was only detected at the molecular weight of the 
isolated enzyme, indicating it is not synthesized in a larger pre-enzyme form. 
Ntambi et al. (1992) described the time course of induction of mouse liver SCDl 
mRNA when fasted mice were fed a high-carbohydrate, fat-free diet. Induction of SCDl 
mRNA was 2-fold within 6 hoiu-s of refeeding a fat-free diet and 45-fold within 36 hours of 
refeeding a fat-free diet. Nuclear run-on assays indicated an increase in transcription as a 
result of the dietary change to carbohydrate. The half-life of the mRNA, when the mice were 
switched to a nomial chow diet, was about 4 hours. Also, 5% dietary PUFAs, in the form of 
triacylglycerols, severely decreased the abundance of SCDl mRNA, whereas MUFA or 
saturated fatty acids had little or no effect. The effects observed for SCDl mRNA induction 
with fat-free feeding are much slower than those of other lipogenic genes such as S14 and 
fatty acid synthase, indicating a possible unique induction mechanism for SCDl compared to 
other lipogenic enzymes. 
Vitamins and Minerals 
Fatty acid desaturase systems of zinc-deficient rats fed a "saturated" fat diet (coconut 
oil) or "n-3" diet (linseed oil) were studied by Eder and Kirchgessner (1995). Zinc 
deficiency disturbs the A^-desaturase system more than the other desaturases, causing a 
significant decrease in the rats fed a more saturated diet, but no change was observed in rats 
fed the linseed oil diet. Delta-6-desaturase activity was not changed when 18:2(n-6) was 
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used as a substrate in vitro but was depressed in zinc-deficient rats fed the saturated diet 
when 18:3(n-3) was used as a substrate. This result is interesting, demonstrating how zinc 
deficiency can change the affinity of an enzyme, SCD, for a given substrate. Because the 
rats fed the more saturated diet had ample 18:2(n-6) and the rats fed linseed oil had ample 
18:3(n-3), the net in vivo rate of A^-desatiirase was probably not affected. There were no 
significant differences in A^-desaturase activity. Despite the differences observed, the action 
of zinc on "stabilizing" the membrane is probably not via fatty acid desaturase modulation. 
The similarities between essential fatty acid deficiency and zinc deficiency are not mediated 
by changes in desaturation of 18:2(n-6) or 18:3(n-3). The impairment of prostaglandin 
synthesis in zinc deficiency, however, must be mediated in reaction steps between 20:4(n-6) 
and the prostaglandins. 
Zinc is required for efficient desaturation and elongation of the essential fatty acids in 
rats (Clejan et al., 1982). Cadmium, which is toxic, seems to exert part of its negative effect 
by antagonizing zinc and inhibiting those biological processes that require zinc. Kudo et al. 
(1991) demonstrated that rats fed a fat-fi-ee diet with supplemental zinc were protected 
against cadmium inhibition of SCD activity (35% decrease in activity) whereas zinc-deficient 
animals were not (90% decrease in activity). Fatty acid composition of liver membranes 
were not changed in zinc-replete rats, whereas 18:l(n-9) and 20:3(n-9) decreased in zinc-
deficient rats, supporting the results fi-om in vitro enzyme assays. To imderstand how direct 
the cadmium inhibition of SCD was, studies were conducted in rat hepatocytes in culture that 
had been maintained in an EFAD state (Kudo and Waku, 1996). From this experiment, the 
inhibition seems specific and not mediated by changes in hormonal status (cells cultured in 
serum fi-ee media), as A^-desaturase was inhibited by cadmium and A®-desaturase was 
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slightly elevated. The inhibition, however, cannot be by direct enzyme inhibition, becuase 
cadmium does not inhibit in vitro A^-desaturase activity. 
Low concentrations (30-50 i^M) of coupric ions added to in vitro assays of SCD, 
however, inhibits the conversion of 18:0 to 18;l(n-9) primarily by inhibiting the terminal 
desatiirase (Sreekrishna and Joshi, 1980). While cytochrome bs and its reductase were 
inhibited by about 20%, this inhibition does not account for the >80% inhibition of the 
terminal desaturase. Cupric ion chelators reverse the inhibition. The authors speculate that 
cupric ions are acting as superoxide scavengers, minimizing the availability of the highly 
energetic diiron-oxo form of the desaturase. 
Rao et al. (1983) fed rats iron-deficient diets with (a) no added fat, (b) with 14% com 
oil, or (c) 14% hydrogenated coconut oil and studied SCD activity. Iron depletion 
significantly decreased the activity of SCD in all three dietary treatments firom 1.5- to 2.5-
fold. There was down-regulation of SCDl activity with fat feeding and even more so with 
polyunsaturated fat feeding in rats fed both iron-deficient and iron-adequate diets. The only 
rats that displayed clinical signs of iron deficiency (decreased hemoglobin and hematocrit) 
were the PUFA-fed rats on an iron deficient diet. No known mechanism explains the sparing 
effect of low-fat or saturated fat feeding on iron status. It is interesting to note that SCDl 
activity is an early predictor of marginal iron status even before clinical signs of iron 
deficiency are detected. 
Hepatic microsomes firom rats fed either supplemental P-carotene (0 or 100 mg) or 
supplemental 13-cw-retinoic acid (20 or 100 mg) were assayed for fatty acid desaturase 
activity and microsomal membrane fatty acid composition (Alam et al., 1984). Delta-9-
desaturase activity for the control and the 20 mg/kg 13-cw-retinoic acid groups were the 
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same, whereas the groups fed 100 mg/kg of either p-carotene or 13-c/i-retinoic acid were 
decreased to about 50% of control values. The A^-desaturase activity was not changed by P-
carotene but was increased 70% by 20 mg/kg of dietary 13-cw-retinoic acid and almost 200% 
by 100 mg/kg of dietary 13-cz.s-retinoic acid. The changes of in vitro desaturase activity 
paralleled the increased concentration of unsaturated fatty acids of hepatic microsomes. 
Alam and Alam (1985) measured A®- and A^-desaturase activities in vitamin A-
deficient rats. Deficient rats had increased A^-desaturase activity in vitro which then 
decreased to near control activity when the rats were repleted. Delta-6-desaturase activity 
did not change compared with control values during deficiency or repletion. 
Retinoic acid, when administered to 3T3-L1 preadipocytes along with the 
differentiation cocktail (methylisobutylxanthine, dexamethasone, and insulin) used to 
stimulate lipid accumulation, inhibits transcription of adipocyte lipid-binding protein and 
SCDl (Stone and Bemlohr, 1990). The inhibition was specific for differentiation-dependent 
transcripts, as p-tubulin or glutamine synthase transcription rates were not changed. The 
"window" for retinoic acid being effective is narrow and the effects are persistent, even if 
retinoic acid is removed from the media as the cells are allowed to mature. 
DL-a-Tochpherol addition to microsomal preparations decreased the activity of A®-
desaturase prepared from rat liver, but increased the activity in preparations from rat brain 
(Despret et al., 1992). The maximal increase in activity coixesponded with the minimal 
activity in liver, occurring at a vitamin E enrichment that was 20-fold greater than the 
endogenous vitamin E in the microsomes. This is one experiment that may raise questions 
about humans consuming pharmacological doses of vitamin E. 
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Ethanol 
Chronic ethanol administration decreases SCD activity in rat liver microsomes by 
greater than 80% (Umeki et al., 1984). During ethanol dosing, NADPH-cytochrome c 
reductase, cytochrome bs, and cytochrome P450 respond with an adaptive induction, whereas 
the NADH to NAD ratio of the cell doubles. These data suggest that it is a decrease in the 
terminal desaturase that results in decreased A®-desaturase activity in ethanol-fed rats. 
Similar results were generated by Rao et al. (1984) who fed rats 34% of calories as ethanol or 
dextrins and compared fatty acid synthase and SCD activities in Hver tissue. Both enzyme 
activities were 50% in the alcohol-fed rats compared with those of the control rats. 
When Nakamura et al. (1994) fed 40% of calories as ethanol to Yucatan barrow 
micropigs, hepatic microsomal A^-desaturase activity was inhibited to 40% of the activity 
observed in control pigs, A®-desaturase activity was inhibited to 28% of control, and A®-
desaurase activity increased numerically but not significantly. Because two of these 
desaturases were decreased in activity and the other one was not changed, it is probable that 
the inhibition is specific to the terminal desaturase and not to some supporting proteins 
and/or enzymes common to all three desaturases. The decrease in A^- and A®-desaturase 
activities was most noted by a decrease in the (n-3) series metabolites, but both (n-6) and (n-
3) metabolites were decreased in concentration in the ethanol-fed pigs. 
Angeletti and de Alaniz (1996) determined that ethanol addition to Hep G2 cells in 
culture inhibited logarithmic grov^^h without affecting viability. Concentrations of cellular 
lipid classes did not change except for a slight increase in cholesteryl ester content. 
Evidently, ethanol inhibited fatty acid synthesis because 14:0 and 16:0 decreased in treated 
cells. Indirect evidence that the A^-desaturase was inhibited by ethanol was noted when 16:0 
43 
accumulated as 18:0 and little was converted to 18:l(n-9) in cells treated with ethanol. 
Similarly, A^-desaturase was inhibited because the conversion of 20:3(n-6) to 20:4(n-6) was 
inhibited in ethanol-fed cells. With ethanol supplementation, there was an increase in fatty 
acids, in the form of triacylglycerols, being exported from the cell. Hep G2 cells represent a 
faithfiil model of exposure of hepatocytes to ethanol, but the mechanisms of the noted 
changes are yet to be elucidated. 
Cholesterol 
Increased concentration of membrane cholesterol has been associated with decreased 
membrane fluidity, causing many to speculate about changed membrane protein fxmction as a 
result. Garda and Brenner (1985) modified freshly prepared hepatic microsomes by 
incubating them with cholesterol and phospholipid liposomes. The cholesterol to 
phospholipid ratio in the microsomes ranged from 0.11 up to 0.8 in the modified 
microsomes. With increasing membrane cholesterol, decreases in membrane fluidity were 
measured by using fluorescent membrane probes. With decreased fluidity, NADH-
cj'tochrome c reductase activity was decreased, but NADH-ferricyanide reductase activity 
was not affected. Delta-9-desaturase activity was increased with increased membrane 
cholesterol when 16:0, the assay substrate, was 2 )a.M but not when it was 66 |j.M. Delta-5 
and A^-desaturase activities were increased at either substrate concentration with increased 
cholesterol. These phenomena indicate that there is potentially enzyme regulation at the 
protein level which is controlled by the microenvironment of the enzyme in the membrane 
when A^- and A®-desaturases are concerned, but probably not for A'-desaturase. 
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Contrary to in vitro studies, Garg et al., (1986) found that cholesterol-fed rats have 
enhanced A^-desaturase activity and depressed A^- and A®-desaturase activities no matter if 
the rats are fed chow or chow with added sunflower oil or coconut oil. In fact, the largest 
changes in enzyme activity because of dietary cholesterol were in rats fed no supplemental 
fat. The changes in desaturase activities were supported by more 18:l(n-9) and less 20:4(n-
6) in membranes of rats fed cholesterol. The authors speculate that the changes observed in 
desaturase activities are primarily because of changes in membrane fluidity brought about by 
dietary cholesterol. Osada et al. (1995) also demonstrated suppressed A®-desaturase activity 
in rats fed cholesterol relative to rats fed control diets or oxidized cholesterol, whereas rats 
fed oxidized cholesterol had numerical increases in A®-desaturase activity compared with that 
of control rats. Authors speculate that increased A^-desaturase activity could lead to an 
increase in eicosanoid production when oxidized cholesterol is fed. 
Leikin and Brenner (1987) also fed rats diets containing 1% cholesterol but added 
0.5% chelate and studied hepatic microsomal fluidity, fatty acid composition, and desaturase 
activity. Membrane cholesterol and phosphatidylcholine concentrations both increased, but 
the cholesterol to phosphatidylcholine ratio increased. Saturated fatty acids and 20:4(n-6) 
decreased in the membranes while MUFA concentrations increased. A direct measure of 
fluidity indicated a decreased fluidity of the membrane as would be predicted by increased 
cholesterol content of the membrane. Microsomal A^-desaturase activity increased as early 
as 48 hours after cholesterol feeding and A^- and A®-desaturase activities decreased. The 
desaturases maintained this change over the 21-day feeding period. 
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Landau et al. (1997) demonstrated that in rats fed com oil, with or without added 
cholesterol, the cholesterol-fed animals had less of a decrease in liver SCD message and 
activity in a short time (48 hours). This study weakens the argument of Leikin and Brenner 
(1988) who speculated that the increase in SCD activity in cholesterol-fed animals was 
because the membranes lost fluidity because of increased cholesterol content. In the Landau 
study, the temporal order of events after cholesterol feeding was documented: 1. Licrease in 
SCD message, 2. increase in SCD activity, and 3. increased cholesterol to phospholipid ratio. 
Because of an increase in SCD mRNA but no difference in transcription, it is speculated that 
cholesterol somehow increases message stability. The increased 18:l(n-9) production is 
consistent with an increase in cholesteryl esters because 18:l(n-9) is a preferred substrate for 
acyl-CoA:cholesterol acyl transferase. Part of the need for 18:l(n-9) during cholesterol 
feeding is to esterify the cholesterol and store it as cholesteryl oleate in the liver. 
Hormones 
General Introduction 
A plethora of studies concerning hormone status or hormone administration on fatty 
acid metabolism have accumulated in the literature. Tissue from diabetic animals has less 
SCD activity than does that from non-diabetic animals, but, after insulin treatment of diabetic 
animals, the SCD activities are similar (Faas and Carter, 1980). Thyroxine injections given 
to normal rats causes an increased A®-desaturase activity (Joshi and Aranda, 1979). 
Additional steroid hormones also cause increased SCD activity. Seventeen-p-estradiol 
enhances SCD activity in roosters (Lipiello et al., 1979), and testosterone enhances SCD 
activity in male or female rats (Marra and de Alaniz, 1989). Marra et al. (1988) 
46 
demonstrated that dexamethasone induces SCD in rat liver and in a hepatoma cell line via a 
cytosolic protein yet to be identified. Eleven-deoxycorticosterone, an example of a steroid 
hormone without an 11-OH group, also induces SCD activity via a cytosolic factor (Marra 
and de Alaniz, 1991). A more complete description of these and other hormone related 
studies follow. 
Glucagon 
Gomez-Dumm et al. (1975) speculated that many of the feeding effects observed on 
fatty acid desaturase activity were mediated via insulin and glucagon. To test the effects of 
glucagon on A^-, A®-, and A^-desaturases, they compared fasted mice with refed mice given 
glucagon, dibutyryl adenosine 3'5'-cyclic monophosphate, or theophylline in different 
combinations. There were no differences by the imposed treatments on A^- and A®-
desaturases except that fasted rats had very little enzyme activity compared with refed rats. 
Refeeding stimulated A®-desaturase activity, measured with 18:2(n-6) or 18:3(n-3) as the 
substrate. The activity returned to the "fasted" level when glucagon or dibutyryl adenosine 
3',5'-cyclic monophosphate was given with or without theophylline. With theophyllin alone, 
enzyme activity remained elevated. It was evident that glucagon was exerting an influence 
on A®-desatiirase activity via cyclic adenosine-3'5'-cyclic phosphate (cAMP). The authors 
point out that it is cmcial for cells to have rigorous control over A^-desaturase, the entry point 
of essential fatty acids into the desaturase/elongase system. 
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Adrenocorticotropic Hormone 
Mandon et al. (1987) administered adrenocorticotropic hormone (ACTH) to rats and 
measured A^- and A®-desaturase activities in adrenal gland and liver to elucidate if the 
epinephrine-depressed desaturases results from concomitant ACTH release. Both in vivo and 
in vitro measures of A^- and A^-desaturase activities were depressed because of ACTH 
treatment. But, ACTH viras shown to depress only A^-desaturase activity in isolated 
hepatocytes where no glucocorticoid was present. One explanation could be that the "fast" 
response of ACTH is the result of a direct effect on enzyme activity, whereas the "slow" 
response could be via ACTH-stimulated glucocorticoid release. 
Glucocorticoids 
Glucocorticoids, including dexamethasone, Cortisol, and corticosterone, and 
mineralocorticoids, including deoxycorticosterone and aldosterone as well as the estrogen p-
estradiol and the androgen testosterone, enhanced A^-desaturation of 18:0 in cultured rat 
hepatoma cells (Marra and de Alaniz, 1995). All hormones tested increased 18:0, or its 
metabolites, incorporation into phospholipids, except for deoxycorticosterone having little 
effect and testosterone having a slight inhibition. Unique patterns of labeling from labeled 
stearate within the lipid subclasses were noted for the various hormones, indicating an 
increased, but differential, incorporation of label. This experiment may help explain some of 
the observed physiological changes caused by using these hormones therapeutically or when 
they are not in balance such as in disease states. 
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Marra et al. (1986a) studied the dexamethasone inhibition of A^- and A^-desaturases 
in rat liver. The mode of inhibition was determined to be a soluble product found in the 
cytosolic fraction after membrane preparation. Most likely, the factor is a protein because it 
is trypsin labile. The cytosolic factor inhibits A^- and A®-desaturase activities in vitro when 
added to microsome preparations from non-treated rats. Marra et al. (1986b) previously had 
shovm that synthesis of a glucocorticoid-induced inhibitor of A^- and A^-desaturases could be 
prevented by blocking protein synthesis with cycloheximide. 
Growth Hormone 
Growth hormone administration caused increased A^-desaturase activity, no change in 
A®-desatiirase, and decreased A^-desaturase activity in livers of male rats (Gueraud and Paris, 
1997). Hypophysectomized rats had decreased A^-desaturase, A^-desatiu-ase, and fatty acid 
elongase activities. Growth hormone given to males caused a "feminization" of the fatty acid 
composition of hepatic microsomal membranes. 
Transgenic mice (MGlOl), expressing ovine growth-hormone when fed zinc, had 
increased expression of A^-desaturase activity as measured in vitro and by comparing fatty 
acid composition of hepatic microsomes (Nakamura et al., 1996). In total fatty acids of 
adipose tissue, the products of the A®-desaturase were enriched in treated mice compared 
with control mice, indicating increased expression of A^-desaturase in adipose tissue of mice 
expressing excess growth hormone. Based on the fatty acid composition of phospholipid in 
adipose tissue, the treated mice have less A^-desaturase activity than do control mice. The 
different mechanisms acting in hepatocytes and adipocytes are not known. 
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Mineralocorticoids 
Maixa et al. (1990) observed a decrease in hepatic A®-desaturase activity after 
injecting the mineralocorticoids aldosterone and 11-deoxycoricosterone into rats. A 3-fold 
decrease in specific activity of A^-desaturase as measured in vitro 24 hours after injection 
paralleled a dramatic (2- to 3-fold) decrease in 20:4(n-6) to 18:2(n-6) ratio in plasma as well 
as in liver microsomes. The physical character of the membrane as analyzed by fluorescence 
anisotropy also was changed, with the treated rats having higher anisotropy values (less 
fluidity). 
Sex Hormones 
Stearoyl CoA desaturase-1 mRNA is more than 4 times greater in female 7-week-old 
ICR mice than in littermate males (Lee et al., 1996). This message difference resulted in a 2-
fold increase in 16:l(n-7) and a nearly 2-fold increase in 18:l(n-9) concentration in liver. 
The authors propose gender-specific hormonal differences as an explanation of their resuhs. 
Medeiros et al. (1995) conducted correlation analysis on data from lean and obese women to 
identify insulin or estrogen as the primary regulator of desaturase activity. The obese women 
had increased insulin, but similar fasting glucose, compared with lean women. Estrogen 
decreased with age but was not affected by body mass index. Insulin was correlated 
positively with the ratio 20;4(n-6) to 18:3(n-6) in serum, an indicator of A^-desaturase 
activity, and with the ratio 20:4(n-6) to 18:2(n-6) in serum, an indicator of overall (n-6) 
pathway activity. The only variable studied that correlated with estrogen was age, 
demonstrating that insulin is a stronger regulator of desaturase activity compared with 
estrogen. 
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Thorling and Hansen (1995) studied fatty acid composition of omental adipose tissue 
in male, female, castrated, and castrated-estrogen-treated rats. Mature female rats had more 
18:l(n-9) in omental adipose than did male rats. Castrated males were intermediate to intact 
males and females but had nearly equal concentrations of 18:l(n-9) to females when given 
injections of estrogen. According to this study, it can be sunmiarized that androgens and 
estrogens affect the accumulation of 18:l(n-9) in adipose tissue, possibly by decreasing and 
increasing SCD activity, respectively. 
TriiodothyroDine 
van Doormaal et al. (1986) assayed fatty acid composition of blood lipid 
compartments in hypothyroid men in an attempt to understand A^-desaturase activity in 
relation to thyroid status. Triiodothyronine supplementation of athyreotic patients with later 
withdrawal caused increases in plasma cholesterol, phospholipid, and triacylglycerol 
concentrations. The relative amount of 18:2(n-6) increased in all blood lipid compartments 
tested, whereas amoimt of 20:3(n-6) decreased, hi plasma, all other (n-6) fatty acids, 22:6(n-
3), 20:3(n-9), 16:0,18:0 and total saturated fatty acids decreased, whereas MUFAs increased 
in the erythrocytes. The amount of 20:3(n-9) rose in erythrocytes, and the 20:3(n-9) to 
20:4(n-6) ratio rose in polymorphonuclear leukocytes. This study indicates the crucial 
control of thyroid hormones over lipid metabolism, particularly A®-desaturase, leading to 
potential disturbances in eicosanoid synthesis. 
Ves Losada and Peluffo (1989) injected male rats with saturating doses of L-
triiodothyronine (1000 |ag T3 per 100 g body weight) daily for 5 days. Hepatic microsomes 
were assayed for A^-desaturase activity at eight time points throughout the period. 
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Desaturase activity was doubled in treated animals and was decreased to control activity 
when cycloheximide was injected, indicating a high rate of turnover of the enzyme. 
Surprisingly, hepatic membrane fatty acid composition of treated and control rats did not 
differ at the end of 5 days. In a separate publication, Ves Losada and Peluffo (1993) reported 
the changes in A^- and A®-desaturase response. There was about a 25% reduction in both 
desaturases when 1000 |ig T3 per lOOg body weight was injected daily for 5 days. When half 
the dose was administered, only A®-desaturase activity was decreased. There were no 
changes in desaturase activity before the 5"^ day of the study independent of the dose. 
Changes in microsomal membrane fatty acid composition did not correspond to the changes 
observed when in vitro desaturase enzyme activity was measured, indicating that other 
mechanisms are acting to modify fatty acid composition of the membranes. 
Insulin 
One of the first studies to relate insulin to SCD was that of Prasad and Joshi (1979). 
They noted a 3.7-fold decrease in A®-desaturase in liver-of rats with stroptozotocin-induced 
diabetes. While insulin administration resulted in a 7-fold increase in A^-desaturase activity 
in diabetic rats, fioictose resulted in a 20-fold increase and glucose had no effect in diabetic 
rats. Because of the strong finctose effect, the authors speculated that insulin did not act 
alone to stimulate A'-desaturase, but some intermediates of carbohydrate metabolism 
increase the activity of the terminal desaturase. This paper was also one of the first to 
demonstrate that carbohydrate metabolism had a significant effect on A^-desaturase activity. 
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A study by Kawashima et al. (1985) compared the role of SCD on fatty acid 
composition of the microsomal membrane phospholipids. Rats had differing relative SCD 
activity in liver microsomes depending on how they were treated (starved < diabetic < 
control < fed clofibric acid < diabetic given insulin < refed after starvation). It was noted 
that, despite the divergent concentrations of 18:l(n-9) and 18:2(n-6) in the C-2 position of 
phosphatidylcholine, the sum of the two acids in the C-2 position was constant, indicating a 
direct competition for that position. There was a linear and direct association between the 
free 18:l(n-9) concentration of the microsomes and the 18:l(n-9) concentration in the C-2 
position of phospholipids. The rats fed clofibric acid, however, had an increased amount of 
18:l(n-9) at C-2 relative to the free 18:l(n-9) available on the microsome, indicating a 
preference shown by the acyltransferases required for phospholipid synthesis. 
Streptozotocin, along with various concentrations of four different streptozotocin 
antagonists, was administered to rats to generate divergent concenfrations of circulating 
insulin, triiodothyronine, and thyroxine (Nishida et al., 1988). When A®-desaturase activity 
was plotted versus concentrations of all three hormones, sigmoidal curves with a positive 
slope were the result. Insulin gave a sigmoidal curve that had a more gradual slope, 
indicating that it regulates A^-desaturase activity over a broader concentration range, whereas 
thyroid hormones acted more drastically to regulate A®-desaturase over a much narrower 
concentration range. 
Boustani et al. (1989) dosed diabetic and normal confrol humans with deuterium 
labeled 20:3(n-6) as a method to measure insulin-dependent A^-desaturase activity. 
Deuterium labeled 20;4(n-6) appeared in plasma phospholipids about 12 hours after dosing 
and maximized between 48 and 72 hours after dosing. Labeled 20:4(n-6) was at the 
detection limit in plasma triacylglycerols and not detectable in platelets. Arachidonic acid 
appearance in plasma phospholipids was about 50% in diabetic patients compared with 
controls. Insulin administered to the diabetic patients elevated 20:4(n-6) in plasma to the 
same concentration as in control patients, indicating the increased A^-desaturase activity 
occurred via insulin. 
Mimouni et al. (1992) studied the effects of insulin on A®-desaturase by using Bio-
Breeding rats that spontaneously develop diabetes. Hepatic microsomes were prepared from 
control rats and diabetic rats 3,17, or 48 hours after their last insulin injection. In vitro A®-
desaturase activity assays indicated that the diabetic rats had 92,64, and 50 percent of the A®-
desaturase activity at 3, 17, and 48 hours, respectivley, after their last insulin injection 
compared with that of control rats. The changes observed in vitro were not correlated with 
the fatty acid composition of liver membranes, but this result was not surprising considering 
the short time period involved. 
Dosage and pattern of insulin administration was studied in the spontaneously 
diabetic Bio-Breeding rat as related to desaturase activities (Mimouni and Poisson, 1992). 
Delta-9-, A®-, and A^-desaturase activities were similar to those of the control rats when 
insulin was administered at the proper dosage of 101.U. twice a day. When the rats were 
held in a state of hyperglycemia by administering 1-half the dosage of insulin. A®-, A®-, and 
A^-desatiirase activities decreased to 25%, 42%, and 49% of control values, respectively. 
One dose of 101.U. insulin 17 hours before collecting microsomes (normoglycemia) resulted 
in all three desaturases being at about 65% of control values. Again, microsomal fatty acid 
compositions did not reflect all the changes in desaturase activity because of the short time 
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between changes in insulin status and sample collection and because of the multifactorial 
nature of fatty acid composition of animals. 
Over a longer period of time, Shin et al. (1995) showed that insulin treatment of 
streptozotocin-induced diabetic rats restored the fatty acid composition of microsomal 
membranes. The disrupted fatty acid composition of membranes as a result of decreased A®-
desatxirase activity associated with hypoinsulinemia was restored faster in the microsomal 
membrane than in the erythrocyte membranes upon insulin administration. The restoration 
of membrane fatty acid composition occurred because of insulin-induced A®-desaturase 
activity, which was 68% and 119% of control rats before and after insulin therapy. This 
study also indicates that fatty acid composition of erythrocytes is not a good indicator of 
rapid changes in fatty acid metabolism. 
Waters and Ntambi (1994) demonstrated that both insulin and fructose stimulate 
SCDl gene expression in liver of diabetic mice. Fructose feeding to fasted diabetic mice 
caused a 23-fold increase in SCDl niRNA in a 24-hoiu' period whereas insulin caused a 22-
fold increase during the same time period. Together, they resulted in a 45-fold increase in 
SCDl mRNA concentration and a 10-fold increase in transcription 24 hours after 
administration. This experiment shows that posttranscriptional events occur when the mice 
are fed fructose that helps maintain SCDl mRNA concentrations. One possible way the 
authors speculate that fructose could be acting is when insulin concentrations are decreased 
glucokinase is depressed but fiuctokinase and triosekinase are unaffected. Therefore, 
fructose itself or one of its metabolites could be acting to enhance SCDl transcription. The 
up-regulation observed with insulin could be counteracted with cAMP derivatives, indicating 
that expression of SCDl during fasting is inhibited by glucagon-stimulated cAMP. 
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Cycloheximide use also demonstrates the need for protein synthesis before the insuhn effect 
can be observed. 
Dang et al. (1989) fed normal and streptozotocin-injected diabetic rats different fatty 
acids to delineate changes in A^-desaturase activity. As it has been noted, saturated fat 
feeding will increase the activity of A'-desaturase relative to feeding unsaturated fatty acids. 
In vitro A^-desaturase activity decreased, however, with feeding of sattirated diets, did not 
change with unsatiu-ated fat feeding, and decreased with fish oil feeding. The diabetic rats 
had an inherently depressed A^-desaturase activity, which was not suppressed further by 
saturated fat or fish oil feeding. Feeding unsaturated fats enriched in (n-6) fatty acids did 
help restore activity but not to the same activity of control rats. Insulin dosing has been 
shown to correct A®- and A^-desaturase activities in diabetic animals, but it did not correct A^-
desaturase activity on the basis of in vitro enzyme assays or fatty acid composition of hepatic 
microsomes. An interesting observation was increased 22:6(n-3) in hepatic microsomes of 
diabetic rats fed fish oil, whereas 20:5(n-3) and 22:5(n-3) decreased despite being 
concentrated in the diet. The authors speculate that increased 22:6(n-3) and decreased 
20:5(n-3) and 22:5(n-3) indicates a possible up-regulation of A'^-desaturase activity in livers 
of fish oil-fed diabetic rats. 
The relationship between healthy insulin balance and fatty acid composition of 
membranes has been recognized increasingly as important (Storlien et al., 1997). The 
endogenous desaturase systems are very important in converting the average Western diet for 
humans that contains 80 double bonds per 100 fatty acids to skeletal muscle fatty acids that 
contain 180 double bond per 100 fatty acids. An index of A^-desaturase activity, as measured 
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by the ratio of 20:4(n-6) to 20:3(n-6), has shown a correlation between decreased A^-
desaturase activity and insulin resistance (Borkman et al, 1993). When there is limited A^-
desaturase activity and there is an increase in dietary (n-6) fatty acids in an attempt to eat a 
"heart-healthy" diet, the membrane fatty acids can change dramatically. Under these 
conditions, competition for desaturation of the dietary fatty acid goes to the (n-6) acids that 
primarily end in 20:4(n-6) in the desaturation/elongation pathway, whereas the (n-3) fatty 
acids would have proceeded to pentaenoic and hexaenoic acids. 
Differentiation 
3T3-L1 Differentiation 
The differentiation process of 3T3-L1 mouse preadipocytes maturing into lipid-laden 
adipocytes has been one of the pillars for studying both the enzymology and molecular 
biology associated with lipid metabolism. Kasuri and Joshi (1982) studied hormonal 
regulation of SCD and lipogenesis during the differentiation of 3T3-L1 preadipocytes into 
adipocytes. During differentiation, the rate of lipid desaturation increased 5.9-fold and the 
rate of fatty acid synthesis increased 255-fold. Stearoyl-CoA desaturase, fatty acid 
synthetase, and malic en2yme activities also could be induced in fully differentiated cells by 
100-, 63-, and 50-fold, respectively, by providing insulin. Despite the dependence of SCD 
on NADH-cytochrome bs reductase and cytochrome bs itself, the most regulated and limiting 
factor during and after differentiation proved to be the terminal desaturase. Biotin deficiency 
definitely slowed the synthesis of saturated fatty acids, but decreased biotin or saturated fatty 
acids did not decrease the ability of cells to desaturate exogenously attained fatty acids. 
While insulin-stimulated differentiation is slower than stimulation with dexamethasone, 1-
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methyl-3-isobutylxanthine, and insulin, addition of insulin antibodies efficiently inhibits 
differentiation. 
The molecular biological approach of studying SCD began in 1986 when Thiede et al. 
isolated a cDNA from rat that coded for SCD. In 1988, Ntambi et al. isolated and 
characterized the cDNA and gene responsible for production of SCD from 3T3-L1 cells. The 
open reading frame codes for a protein with 92% homology to the cloned rat liver SCD. The 
message for SCD contains an unusually long 3' untranslated region (UTR)(3.5 kb) and a 
large 5' UTR. While the gene is expressed constitutively in murine adipose tissue, it is 
increased in the liver when mice are starved and refed a high-carbohydrate diet. The isolated 
gene is 15 kb and includes six exons and five introns. The promoter region contained 
homologous sequences to putative fat-specific transcriptional element (FSE2), cAMP, and 
glucocorticoid regulatory elements. To confirm differentiation-induced expression, the 
promoter region was fused to the CAT gene and CAT expression was measured in 3T3-L1 
cells only after differentiation protocols were initiated. 
Kaestner et al. (1989) identified two different genes encoding SCD from mouse 3T3-
L1 cells. They have been designated SCDl, which is exclusively expressed in the liver, and 
SCD2, which is expressed exclusively in spleen, heart, and brain. Adipose, lung, and kidney 
tissues express both forms to varying extents. Stearoyl-CoA desaturase-l and SCD2 have 
greater than 87% sequence identity. The genes for the two desaturases have similar 
intron/exon junctions and similar regulatory regions in the promoter. Whereas SCD2 lacks 
the TATA box in the 5' region compared to SCDl, it does have a 140-bp sequence in the 
promoter that shares 77% identity with the SCDl promoter. Stearoyl-CoA desaturase-2 has 
two CCAAT boxes, a GC-rich region similar to proven Spl transcription factor binding 
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regions, consensus sequence for the glucocorticoid regulatory element, and CCAAT 
box/enhancer binding protein sequence. The promoter regions were immediately noted as 
being rich in known and putative regulatory sequences, and this cell line continues today to 
be a useful tool for examination of gene regulation related to lipid metabolism. In 1995, 
Ntambi summarized the research on SCDl and SCD2 expression during differentiation of 
adipocj^es and as regulated by dietary factors. 
The counter regulation of SCDl and acyl-CoA synthetase (ACS) by insulin and 
tumor necrosis factor-a (TNF-a) in 3T3-L1 was studied by Weiner et al. (1991). Insulin 
stimulates a 4-fold increase in rate of transcription of these two lipogenic genes, but TNF-a 
causes greater than 75% decrease in mRNA expression for both ACS and SCDl. Other 
lipogenic genes such as malic enzyme and lipoprotein lipase are not regulated 
transcriptionally by either of these two factors. 
Casimir and Ntambi (1996) evaluated the effects of cAMP on SCDl expression in 
3T3-L1 preadipocytes as they differentiated into lipid-laden adipocytes. The induction 
protocol for differentiating preadipocytes into mature adipocytes includes a cocktail of 
methylisobutylxanthine, dexamethasone, and insulin. It was determined that 
methylisobutylxanthine was the only compound responsible for SCDl induction, presumably 
via its ability to generate cAMP by inhibition of cAMP phosphodiesterase. Cell-permeable 
cAMP analogs resulted in similar results. By conducting deletion analysis of chimeric 
SCDl-promoter/reporter gene constructs, it was shown that the cAMP response requires the 
-253 to +30 region and that constructs from -253 to -76 and -76 to +30 both respond to 
cAMP, indicating multiple response elements. Both regions contain an AP-2 response 
element. The rapid (minutes) response observed with genes that are induced via the 
cAMP/AP-2 mechanism does not occur with the cAMP-induced expression of SCDl. 
Therefore, the obvious induction of SCDl by cAMP is not direct. 
Sassier et al. (1996) provided 20:4(n-6) to 3T3-L1 cells in culture and observed 
decreased SCDl activity and mRNA concentrations without changing the rate of 
transcription. The half-life of SCD message in the presence of 20:4(n-6) dropped to 8.5 
hours from 25.1 hours in control cells. Blocking the conversion of 20:4(n-6) to eicosanoids 
did not change the result, indicating that 20:4(n-6) is the responsible compound. As had been 
demonstrated in the past, saturated fatty acids or MUFAs did not change SCDl mRNA or 
enzyme concentrations, but 18:2(n-6) and 18:3(n-3) behaved similarly to 20:4(n-6). The 
60% decrease in enzyme activity caused by feeding cells 20;4(n-6) could be accounted for by 
the 80% decrease in SCDl mRNA concentration because of loss of message stability and no 
changes in transcription as is observed in the liver. The authors speculate that the long 3' tail 
of SCDl message may play a role in controlling the half-life of the mRNA. 
Development 
One of the first papers describing SCD activity during phases of development was by 
Wilson et al. (1976). They studied the expression of SCD in newly hatched chicks through 6 
days of age. At hatch, hepatic microsomes were lacking in SCD activity (0.05 
nmol/min«mg), but, by 6 days of age, the activity had increased 100-fold (4-5 
mnol/min*mg). Supporting enzymes, proteins, and cofactors were assayed and did not 
change significantly through this time. When partially purified desaturase was added to 
microsomes from newly hatched chicks, a fully functional desaturase system was observed. 
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indicating that induction of the terminal desaturase occurs during the first days of a chick's 
life. 
In the mammal, the placenta provides a barrier to protect the developing fetus firom 
the mothers immune system but at the same time prevents some nutrients firom entering into 
the fetal blood supply. Descomps and Rodriguez (1995) studied the disparity of 20:4(n-6) 
and 22:6(n-3) being 2-fold greater in fetal plasma compared with that in maternal plasma, 
whereas just the opposite is true for their precursors 18:2(n-6) and 18:3(n-3). The disparity 
between maternal and fetal blood fatty acid composition raises questions about which fatty 
acids should be included in prepared infant formulas. Supplementation of formulas for 
premature infants with 4.95% of total energy as 18:2(n-6) and 0.77% as 18:3(n-3) resulted in 
blood fatty acid profiles that were more similar to infants fed breast milk than that in infants 
fed typical formula. Based on in vitro assays of A^- and A®-desaturase activities, it is crucial 
to maintain the 6.4 to 1 molar ratio of 18:2(n-6) to 18:3(n-3) to prevent substrate inhibition. 
The authors concluded that human fetal liver has the ability to desaturate fatty acids and that 
18:2(n-6) and 18:3(n-3) supplementation, when provided in the correct ratio, should fulfill 
the infants essential fatty acid requirement. 
Genes critical to myelin formation in the developing mouse brain were studied by 
Garbay et al. (1997). Myelin is 70-85% lipid and quadruples in mass firom 2 weeks of age to 
6 months of age, whereas the brain weight only increases by 50% during this time. Oleic 
acid, the product of SCD2, comprises up to 40% of myelin fatty acids. Maximal myelination 
occurs at day 20 after birth in rats and mice. Ceramide galactosyltransferase, a critical 
enzyme in myelin formation, had maximal expression at about day 18 in this study. 
Messenger RNA concentrations for acetyl-CoA carboxylase and fatty acid synthase are 
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maximal 5 days after birth and decline to 20% of maximal concentration at day 20. 
Expression of SCD2 is different from that of other genes during active myelination because it 
remains near maximal from birth to about day 10 and then gradually declines to about 60% 
of maximal at day 40. This study confirms that regulation must occur at the transcriptional 
level for enzymes crucial to myelination. 
de la Presa-Owens et al. (1998) compared tissue fatty acid composition and 
desaturase activities after addition of 20:4(n-6) or 22:6(n-3) in dietary triacylglycerols in 
formula fed to pigs. The underlying concern is the use of plant lipids in infant formulas that 
contain the essential fatty acids 18:2(n-6) and 18;3(n-3) but little 20;4(n-6) and 22;6(n-3) as 
found in human breast milk. During rapid post-natal development, there is concern about the 
ability of infants to desaturate and elongate dietaiy fatty acids for use in critical growth such 
as that of neural and organ tissues. The authors found that the dietary fatty acids were 
enriched in plasma and tissue depots except for brain, which remained resistant to change 
despite dietary fatty acid supplementation. 
Peroxisome Proliferators 
Kawashima and Kozuka (1982) noted 4-fold increases in SCD activity in rat liver 
after feeding clofibric acid. The increase in activity was determined to be because of the 
terminal desaturase and not the activity of NADH-cytochrome bs reductase or the availability 
of cytochrome bs. Similar inductions of enzyme activity were noted in clofibrate-fed rats 
that had been afflicted with hormone anomalies or given hormone injections, creating or 
nfiimicking diabetes, hyperthyroidism, or hypothyroidism. Therefore, the mechanism of 
clofibrate action is probably not via changes m insulin or thyroid status and probably is not 
62 
hormonally associated. Changes in SCD activity were reflected by increased concentrations 
of 18:l(n-9) in livers and even more markedly in the isolated hepatic microsomes of treated 
rats. 
In a study conducted later, Kawashima et al. (1986) fed two different peroxisome 
proliferators, clofibric acid or tiadenol, to rats, mice, and guinea pigs to study changes in 
microsomal lipid composition and the enzyme systems responsible for any observed changes. 
Rats and mice responded similarly in that I8:l(n-9), via SCD, increased in 
phosphatidylcholine of hepatic microsomes, whereas guinea pigs did not respond. 
Supporting enzymes such as palmitoyl-CoA elongase, 1-acylgIycerophosphate 
acyltransferase, and 1-acylgIycerophosphocholine acyltransferase also increased after feeding 
peroxisome proliferators, indicating orchestrated changes in lipid metabolism, not just 
modulation of SCD, by peroxisome proliferators. 
Kawashima et al. (1989) fed clofibric acid, tiadenol, and perfluoro-octanoic acid to 
male and female mice. All three compoimds increased A®-desaturase activity in liver except 
perfluoro-octanoic acid did not cause a response in female mice, making perfluorinated 
carboxylic acids the only known peroxisome proliferator that is affected by gonadal 
hormones. The changes were measured by in vitro assays and confirmed by comparing 
phospholipid fatty acid composition of microsomal membranes. Fatty acid composition data 
agreed well with enzyme assay data collected by in vitro assays. 
Diczfalusy et at. (1995) imposed clofibrate treatments on mice and quantijSed both 
SCDl and SCD2 mRNA in several tissues along with SCDl activity in the liver. As 
expected, SCDl was expressed in liver and brown adipose tissue, whereas SCD2 was 
expressed in brown adipose tissue and brain. Diurnal variation of hepatic SCDl existed, and 
63 
expression was found to be greatest during the feeding period. Clofibrate increased hepatic 
mRNA and in vitro activity of SCDl by around 2-fold and 1.5-foId, respectively. The tissue 
with the highest concentration of message for both SCDl and SCD2 was brown adipose 
tissue, which was down-regulated by feeding a fat-free diet. This observation has no current 
explanation and warrants further investigation 
It has been noted that clofibric acid increases selectively the proportion of 18:l(n-9) 
in the C-2 position of phospholipids, but 18.i(n-9) is usually distributed equally between C-1 
and C-2 positions. The two primary enzymes required to accommodate this change are SCD 
and 1-acylglycerophosphocholine acyltransferase. Three peroxisome proliferators (4-
chlorophenoxyisobutyric acid [clofibric acid], 2,2'-(decamethylenediothio)-di-ethanol 
[tiadenol], and perfluoro-octanoic acid) at various dosages were fed to rats to induce SCD 
and 1-acylglycerophosphocholine acyltransferase. This experiment was an attempt to 
understand which of the two enzymes was most responsible for the large increase in 18:1 (n-
9) in the C-2 position of phosphatidylcholine (Mizuguchi et al., 1996). Multiple regression 
analysis revealed correlations between the concentration of both enzymes and 18:l(n-9) 
enrichment at the C-2 position of phosphatidylcholine, but SCD was by far more strongly 
correlated and therefore most responsible. 
The increase of SCDl mRNA after feeding peroxisome prohferators to mice was 
shown to be at the level of transcription by using nuclear run-on assays in nuclei from mice 
fed clofibrate (Miller and Ntambi, 1996). Deletion analysis of the SCDl/CAT construct 
identified AGGTCA at position -664 in the promoter for SCDl as a cis-linked response 
element for the PPAR. These data put SCDl expression in a class of its own because it is a 
lipogenic gene that is down-regulated by PUFAs, but peroxisome proliferators also induce its 
64 
expression. The blood lipid-lowering effects of peroxisome proliferators acts via increasing 
hepatic clearance of triacylglycerols (Reddy and Lalwai, 1983). This results in an increase in 
enzymes required for P-oxidation and phospholipid synthesis and a decrease in enzymes 
associated with fatty acid synthesis. In contrast, A^-, A®-, A®-desaturase and elongase 
activities are increased by peroxisome proliferators. It is thought that the desaturases are 
increased because of the great need for membrane phospholipid sj^ithesis and the great 
increase in P-oxidation; therefore, the endogenous desaturase system must be up-regulated to 
help support phospholipid synthesis. 
Perfluoro-decanoic acid is another known peroxisome proliferator that produces 
confusing results with respect to SCD. Yamamoto and Kawashima (1997) fed rats 0.005% 
perfluoro-decanoic acid (w/w) for 7 days. In this scenario, perfluoro-decanoic acid acted as a 
typical peroxisome proliferator because it up-regulated SCD. In vitro, however, perfluoro-
decanoic acid acts as an inhibitor of the terminal desaturase by interfering with the electron 
transport system required to support desaturase activity. The doses given to the rats were 
probably enough to activate the transcriptional machinery of the cell but not enough to inhibit 
the terminal desaturase in vivo. 
Thiazolidinediones (TZDs), developed for the treatment of non-insulin-dependent 
diabetes, activate PPAR-y, but result in down-regulation of SCD 1 expression in fully 
differentiated 3T3-L1 cells (Kurebayashi et al., 1997). Stearoyl-CoA desaturase-1 mRNA 
was identified by using differential display techniques as being down-regulated with TZD 
treatment. The fatty acid composition of the TZD-treated cells shows a significant increase 
in saturated fatty acids and a decrease in MUFAs. Kliewer et al. (1997) has documented an 
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increase in insulin secretion from rat pancreas perfused with saturated fatty acids as a 
possible explanation of the mode of action for TZDs. 
Inhibitors 
Inhibitors of fatty acid desaturases in animals could be important in treating disease, 
producing food products of specific fatty acid composition, or learning about metabolic 
pathways in vivo. It has been demonstrated that dietaiy cyclopropene fatty acids, such as 
sterculate, cause a decreased in MUFAs and an increase in the corresponding saturated acids 
in tissue lipids. Pande and Mead (1970) published an experiment where sterculate seemed to 
inhibit desaturases in vivo because of some undetermined mechanism, but in in vitro 
experiments the inhibition was simply a detergent effect of sterculate and not competitive 
inhibition or interaction of desaturase sulfhydryl groups with the cyclopropene ring. 
Raju and Reiser (1972) confirmed that sterculate was a specific and potent inhibitor 
of SCD and was not acting as a nonspecific detergent. To arrive at this conclusion, sterculate 
was shown to inhibit the SCD reaction much more potently than did 18:l(n-9) and its 
potency was not decreased when more microsomal protein was added to the reaction, which 
would have diluted out a detergent effect. The mode of inhibition was suspected to be via 
binding of sterculate to sulfhydryl groups of the protein, but the sequence of SCD was not 
known at the time to confirm this as a possibility. Sterculic acid also has been shown by 
Zoeller and Wood (1985) to inhibit SCD in the Morris hepatoma 7288C cell line. Sterculic 
acid at 20-30 laM inhibited production of monoenoic fatty acids via de novo synthesis by 
90% and decreased 18:l(n-9) content of the cell by 50%. 
Sterculic acid was used to inhibit implanted tumor growth in rats (Khoo et al., 1991). 
When administered subcutaneously for 4 weeks prior to and 4 weeks after tumor 
implantation, the tumor volume was decreased by more than 3-fold. Oleic acid content of 
liver, plasma, erythrocytes, and tumor tissue was decreased in the treated rats compared with 
the control rats. It is highly likely that the changes observed in tumor fatty acid composition 
were the reasons for the decrease in tumor growth-rate, whereas the rate of newly implanted 
tumors taking hold and becoming established was not changed with sterculic acid treatment. 
On the basis of the increased ratio of 18:2(n-6) to 20;4(n-6), it is suggested that sterculic acid 
is also a A^-desaturase inhibitor. Brain fatty acid composition was not affected however. 
The mechanism of sterculic acid inhibiting tumor growth has not been identified, but the 
most probable mode is speculated to be the decreased fluidity of cell membranes, which 
could confer differences in surface protein activity of crucial receptors. 
It was noted that sesame seed oil inhibited mycelial 20:3(n-6) conversion to 20:4(n-6) 
(Shimizu et al., 1991). Fractions of sesame seed oil, separated by high-performance liquid 
chromtography (HPLC), were assessed for their ability to inhibit in vitro A^-desaturase 
reactions. The active compoimd, as identified by mass spectrometry, 'H NMR, optical 
rotation, and melting point, was (+)-sesamin. When kinetic inhibition studies were 
conducted on fungal and mammalian (rat) A^-desaturases, (+)-sesaniin was foimd to be a 
potent and specific non-competitive inhibitor of A^-desaturase. This was the first identified 
natural inhibitor of the A^-desaturase enzyme. 
Eritadenine, a hypocholesterolemic factor of the mushroom Lentinus edodes, is 
another natural fatty acid desaturase inhibitor. It inhibits A®-desaturase activity in rat liver 
67 
microsomes. The phosphatidylcholine to phosphatidylethanolamine ratio in eritadenine-fed 
rats decreases in a dose-dependent manner (Sugiyama et al., 1997). In vitro manipulation of 
the phospholipid composition of liver microsomes by phospholipase C indicates that A^-
desaturase activity can be modified by phospholipid composition (Leikin and Shinitzy, 
1995). 
Obukowicz et al. (1998) identified and examined a compound named CP-24879 as a 
potential and A^-desaturase inhibitor. The hypothesis was that inhibition of A^- and A®-
desaturases could result in an anti-inflammatory response. When mouse mastocytoma cells 
ABMC-7 were cultured with the compound, there was a dose-dependent decrease in (a) 
desaturase activity, (b) 20:4(n-6) production, and (c) leukotriene C4 production. When 
maximally tolerated doses of CP-24879 were given to mice, the combined A^- and A®-
desaturase activities were inhibited 80% and 20:4(n-6) was depleted by 50% leading to a 
predicted decrease in ensuing eicosanoid production. Chronic use of a drug such as this 
would probably not work well because of the disease states known to exist when defective 
A®-destuarase activities are present, such as diabetic neuropathy and chronic inflammation 
disease, but short-term drug therapy may prove useful. 
Membrane Fluidity 
Fatty acid composition of liver microsomes were modified by feeding rats choline-
free diets for up to 21 days (Leikin and Brenner, 1992). As phosphatidylcholine 
concentration decreased in the membranes, phosphatidylserine and cholesterol increased, 
resulting in a decrease in membrane fluidity as measured by fluorescence anisotropy. Along 
with the decrease in fluidity was a decrease in A^-desaturase activity and a concomitant 
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decrease in 20;4(n-6) content of the membranes. This study along with the study of Garda 
and Brenner (1985), where cholesterol added to microsomal membranes in vitro increased 
A^-desaturase activity, demonstrate that trying to correlate desaturase activity directly with 
membrane fluidity may not be accurate. A more detailed look at phospholipid ratios, 
cholesterol content, and fatty acid composition of the membrane make predicting desaturase 
activities difficult. 
When considering the effects of dietary fatty acids, it is useful to know the minimal 
response time of the criteria being measured in trying to define possible mechanisms. 
Dietary fatty acids affected rat hepatic membrane composition and desaturase activities as 
quickly as 6 days after initiating a diet with 10% fat from coconut oil, olive oil, or simflower 
oil (Giron and Su^ez, 1996). Delta-9-desaturase activity was significantly different in all 
three groups at day 6 with simflower oil-fed rats having the least A^-desaturase activity and 
olive oil-fed rats having the greatest. Delta-6-desaturase was significantly increased at day 6 
in the olive oil- and sunflower oil-fed animals relative to the coconut oil fed animals. 
Foucher et al. (1997) compared membrane fluidity, desaturase activities, and 
membrane fatty acid composition in normal and spontaneously hypertensive rats (SHR). 
Based on electron spin resonance of 10-nitroxide 18:0, the microsomal membranes of SHR 
were more fluid than those firom control rats. When fatty acid composition and desaturase 
activity assays were compared, the decrease in A^-desaturase of the SHR paralleled the 
decrease in 20:4(n-6). The decrease in A®-desaturase observed in vitro for the SHR, 
however, was not consistent with a significant increase in 18: l(n-9) in the SHR. The authors 
suggest that the increase in membrane fluidity of SHR may result in a viscotropic regulation 
of fatty acid desaturases and explain the decrease in A®- and A^-desaturase activities. They 
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also suggest that the PUFA biosynthesis impairment is related to change in the 
microenvironment of the desaturases. 
Environmental Temperatures 
Kasai and Nozawa (1980) tested the theory that has been presented for A^-desaturase 
activity regulation based on changes in membrane fluidity. They simmiarized that decreasing 
the temperature of starved tetrahymena (no detectable A^-desaturase) quickly induces the 
desaturase capabilities of these organisms as measured by in vivo conversion and in vitro 
assays. 
Brain lipids in hibernating hamsters are enriched in MUFAs (Goldman, 1975). 
Goldman (1978) identified that MUFAs in brain tissue must come firom exogenous sources, 
as SCD was not increased in brain tissue of hibernating hamsters. Liver tissue, however, had 
an 8-fold increase in desaturase activity when hibemating versus warm-adapted hamsters 
were compared. The liver could supply the brain with MUFAs via lipoprotein transport. 
Gonzalez et al. (1983) studied fatty acid desaturase activity in rats during the 
transition from warm adaptation (32° C) to cold adaptation (15° C). In female rats, A®-
desaturase and fatty acid synthetase were decreased in liver microsomes 24 hours after cold 
exposure, whereas A^- and A®-desaturases were increased. The changes in fatty acid 
desaturase activity were evident by the increase in 20:4(n-6) and the decrease in 18:l(n-9) in 
membrane phospholipids. Desaturase activities in male rats subjected to the same conditions 
did not change, indicating a possible link between cold adaptation and gender in rats. To 
study gender-specific hormone effects, Gonzalez et al. (1986) studied the effects of 
temperature change on hepatic A®-desaturase in intact and ovariectomized female rats. The 
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intact rats had an increased A®-desaturase system when switched to 15° C after having been 
acclimated to a 32° C environment. The increase was documented by in vitro enzyme assays 
and increases in microsomal 20:4(n-6). The ovariectomized rats treated to the same 
temperature protocol had increased membrane 20:4(n-6), but no change in desaturase activity 
was measured in vitro. Estradiol concentration in plasma of intact rats was higher in the 
warm acclimated rats compared with when the rats were switched to the cold environment. 
To test if ovaric sex hormones were depressing A^-desaturase, 17-P estradiol was injected 
into intact and ovariectomized female rats maintained at 15° C and 30° C. In all cases, A®-
desaturase decreased, indicating that estradiol is a depressor of A®-desaturase activity. 
Ves Losada and Peluffo (1987a) studied the effects of a cold environment on hepatic 
microsomal A®- and A®-desaturase activities in male rats. There was no change in A^-
desaturase activity as measured in vitro or by analyzing microsomal membrane fatty acid 
composition. Unlike in fish, where Tiku et al. (1996) observed an up-regulation of A®-
desaturase in hepatocytes, there was a decrease in A®-desaturase activity in mice maintained 
at 5° C compared to that in those kept at 24° C. When rats were pair-fed, it was determined 
that the down-regulation of A^-desaturase was based on restricted energy available for 
lipogenesis and not a direct effect of the colder environmental temperature. 
In a similar study, Ves Losada and Peluffo (1987b) measured A^- and A®-desaturase 
activities in liver of male rats before and after a decrease in environmental temperature. 
When shifted from an adapted temperature of 24° C to a 12° C environment, there was no 
difference in A^- or A®-desaturase activities unless the rats were first fed a hyperglycidic diet 
(carbohydrate enrichment in place of protein). The depression of A^- and A^-desaturases as a 
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result of the hyperglycidic diet was compensated for by the increase in activities of both 
enzymes when the environmental temperature was decreased to 12° C. Therefore, it can be 
said that cold evokes an increase in A^- and A®-desaturases in male rats only when these 
enzymes are first suppressed by dietary means. 
Modes of temperature induction of unsaturated acid formation have been studied in 
many species. Guerzoni et al. (1997) have proposed a novel mechanism of MUFA formation 
in Saccharomyces cerevisiae under superoptimal thermal stress. They and other groups have 
demonstrated an increase in saturated fatty acids in yeast as the temperature is increased from 
10° C to 37° C. However, their question was; why is there an increase in MUFAs as the 
temperature continues to increase into the superoptimal range (42° C)? Thermotolerant yeast 
have 3-fold lower thiobarbituric acid reactive substances (TBARs) than do common strains 
when grown at 42° C. Their conclusion was that in a thermotolerant strain of yeast, the use 
of oxygen for the desaturation reaction is a way to decrease the damaging oxidative products 
that increase in the membrane as the temperature approaches the superoptimal range. 
Disease 
Aging 
Aging is a mysterious and long-studied process. One of the dociraiented science-based 
processes related to aging is a dramatic drop in A®-desaturase activity. Dietary 18:3(n-6) 
bypasses the need for A®-desaturase activity in the (n-6) pathway and restores production of 
20:3(n-6) and prostaglandin El. Unfortunately, foods rich in 18:3(n-6) such as human milk, 
evening primrose oil, and borage oil are not common dietary components. The most likely 
problems to arise when prostaglandin El concentrations in tissue membranes drop are a 
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decrease in activated T-cells, increases in blood pressure, increased risk of malignancy, and a 
drop in cAMP concentration in various tissues (Horrobin, 1981), which are all conditions 
often correlated with aging. 
Bordoni et al. (1988) correlated A^-desaturase activity and microsomal membrane 
fatty acid composition by using aging rats. There were no differences between suckling and 
weanling rats, but from weaning until senescence there was a linear decrease in hepatic A®-
desaturase activity and a predicted decrease in the 20:4(n-6) to I8:2(n-6) weight ratio of 
microsomal membranes. Hrlia et al. (1990) studied the substrate-dependent kinetics of A®-
desaturase in aging rats. When 18:2(n-6) was used as a substrate, the Km increased linearly 
with age and there was no change in Vmax until 25 months of age. With 18:3(n-3) as a 
substrate, however, there was no change in Km but Vmax increased with aging. 
The expression patterns of A®-desaturase activity in mouse brain and liver during 
normal development differ greatly (Bourre et al., 1990). From day 2 before birth until 21 
days after birth, the activity of brain A®-desaturase activity declines about 10-fold and then 
maintains stable activity until 17 months of age when this study ended. Hepatic A^-
desatxurase, however, increased from day 2 before birth until day 7 after birth, declined 
rapidly until day 13, and then declined gradually until 4 months when the slope of decline 
increased imtil 17 months. Overall, there was a 40% decrease in hepatic A®-desaturase 
activity between 4 and 17 months. The activity of hepatic A^-desaturase was 10-to 20-fold 
greater after weaning compared with values obtained at the end of the study. 
Maniongui et al. (1993) compared the activities of A^- and A®-desatiirases with aging 
in rat liver microsomes. Delta-6-desaturase activity with 18:3(n-3) as a substrate increased 
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from 1.5 to 3 months of age and then decreased linearly to 24 months of age only to return to 
the original value observed at 1.5 months. With 18:2(n-6) as a substrate, A®-desaturase 
activity increased up to 6 months and then remained constant imtil 24 months of age. Delta-5 
desaturase activity decreased from 1.5 months of age to 3 months of age and then increased 
until 24 months of age vi^hen it regained the same activity as it had at 1.5 months of age. The 
age-related changes in desaturase activity were reflected in the observed fatty acid 
composition of microsomal phospholipid fatty acids. Arachidonic acid increased in both red 
cell membranes and microsomal phospholipids throughout the aging study, whereas total (n-
3) acids did not vary with aging. 
Jimenez et al. (1993) were the first to document A®-desaturase activity in heart 
microsomes prepared from rats. The age-related decrease observed by most investigators in 
hepatic A^-desaturase also occurs in heart tissue but to a lesser extent. Despite measurable 
decreases in A^-desaturase activity with aging in heart tissue, microsomal fatty acid 
composition did not change. 
Essential fatty acid status has been implicated with many disease-related processes 
such as coronary heart disease (Wood et al., 1987), diabetes meUitus (Horrobin, 1993), and 
rheumatoid arthritis (Belch and Maple, 1992). To better understand the activity of A®-
desaturase activity related to aging in humans, Bolton-Smith et al. (1997) compared the fatty 
acid composition of adipose biopsies from over 4,000 men and women. When adjustments 
were made for dietary fats, body mass index, and smoking, the ratio of 18;2(n-6) to 18;3(n-6) 
increased with age in both men and women, indicating a decreased activity of A®-desaturase 
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enzyme with aging. Increasing dietary 18:3(n-6) intake with age is suggested but not yet 
accepted as a strategy to overcome the age-associated decHne in A^-desaturase activity. 
Aging as related to 18:2(n-6) modification and incorporation into lipids was studied 
in human skin fibroblasts at various passages ranging from 3 to 30 (Raederstorff et al., 1994). 
While total uptake of 18:2(n-6) into cells did not differ in passage three compared to passage 
30, the composition of the metabolized 18:2(n-6) did change. The ratio of 20:4(n-6) to 
18:2(n-6) which reflects the combined A^- and A®-desaturase capacities of the cells, and the 
20:3(n-6) to 18:2(n-6) ratio as a measure of A®-desaturase capacity decreased 66% and 58%, 
respectively, from passage three to passage 30. When the 20:4(n-6) to 20:3(n-6) ratio of the 
passaged cells was compared, the A^-desaturase activity decreased 14% from passage three to 
30. Thus, during in vitro aging, the rate limiting A^-desaturase displays the greatest loss of 
activity compared with A^-desaturase. 
The kinetics of A®-desaturase related to aging in rats was studied by Hreha et al. 
(1990). There was little effect on kinetic parameters of A®-desaturase when young rats were 
fed 18:3(n-6), but when old rats were fed 18:3(n-6) the Vmax forboth 18:2(n-6)and 18:3(n-3) 
were increased, and Km values did not change. In fact, the Vmax in old rats fed 18:3(n-6) was 
greater than that in young, pair-fed control rats. It seems probable that feeding small 
amounts of 18:3(n-6) containing evening primrose oil can restore A®-desaturase activity 
normally lost during aging. Going one step further, presumably the increased availability of 
de novo synthesized pentaenoic and hexaenoic acids would maintain proper membrane 
fluidity during aging. 
75 
Biagi et al. (1991) also studied the effects of dietary 18:3(n-6) on hepatic microsomal 
A®-desaturase activity in aged rats. Old rats were fed diets containing 50% of dietary lipid 
from evening primrose oil or from soybean oil, which provided about 6% 18:3(n-6) to those 
rats fed evening primrose oil. In the yoimg rat, there was no change in A®-desaturase activity 
as measured by using 18:2(n-6) or 18:3(n-3) as the assay substrate. In the old animals, 
however, 18:3(n-6) feeding enhanced A®-desaturase activity 36% and 79% with 18:2(n-6) 
and 18:3(n-3), respectively, as substrates. Even with 18:3(n-6) feeding, the A®-desaturase 
activity observed in old rats with 18:2(n-6) as the substrate was about 50% of the rate 
observed in young rats. When 18:3(n-3) was used as a substrate, however, the old rats fed 
18;3(n-6) had more than 150% of A®-desaturase activity compared with young rats. 
Dinh et al. (1993) studied the effects of aging and 18;3(n-3) deficiency on A®-
desaturase activity in rats. As others have shown, A^-desaturase activity decreases with age 
but the rate and pattern in which it decreases was demonstrated to be diet-dependent. 
Comparable with other studies, the A^-desatxirase rate was stable until about 6 months of age, 
decreased 30% from 6 to 12 months of age, and then remained stable until 24 months of age. 
The A^-desaturase activity in the fatty acid-deficient rats did not decrease throughout the 
study. It was interesting to note that refeeding essential fatty acids to depleted rats resulted in 
decreased total liver PUFA in young rats but increased liver PUFA in older rats. Fish oil 
refeeding resulted in a more rapid and complete recovery than simply feeding 18:3(n-3) to 
the older rats, but either refeeding regime was acceptable for younger rats that possess 
maximal A^- and A®-desaturase systems. 
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Recovery of full A^-desaturase activity after being suppressed by dietary fish oil was 
not as rapid or complete in old rats (24 months old) compared with recovery of young rats (9 
months old) (Dihn et al., 1995). Young rats had regained enzyme activity similar to that of 
control rats after 3 days of feeding a low (n-3) diet, with a slight additional increase at 7 days. 
The old rats, however, regained only about 65% of control activity after being fed a low (n-3) 
diet for 7 days. The liver phospholipid fatty acid composition had not fully recovered to its 
original composition 7 days after switching back to a low (n-3) diet but had changed 
considerably because of increased A®-desaturase activity. The brain phospholipids, however, 
remained resistant to change during this time period. 
Cancer 
Hepatic tumors have been linked to long-term peroxisome proliferator administration 
in rats and mice (Reddy and Lalwai, 1983). The association of enhanced SCD activity with 
peroxisome proliferators and increased 18:l(n-9) synthesis in some types of tumors, which 
increases membrane fluidity, have led to speculation about the possible carcinogenic nature 
of peroxisome proliferators. A contradiction to this theme was examined by Zoeller et al. 
(1984). They analyzed the SCD system in the Morris hepatoma cell line 7288C in culture 
and in 7288CTC maintained in host rats. These cells had extremely decreased SCD activity 
compared with normal liver tissue (4% and 8% respectively). The reason for the observed 
decrease in terminal desaturase activity may be because of decreased concentrations of 
cytochrome bs (2% compared with control liver) and cj^ochrome bs reductase (15% 
compared with control liver) or a decrease in the terminal desaturase enzyme itself 
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It has been postulated that SCD is expressed at high concentrations in malignant 
tissues (Li et al., 1994). To test this hypothesis, a segment of the human SCD cDNA was 
made from mRNA harvested from healthy adipose tissue by using a primer corresponding to 
the sequence for rat SCD. Increased SCD mRNA was found in colonic and esophageal 
carcinomas and in hepatocellular adenoma, but no trend was seen in hepatocellular 
carcinoma, demonstrating the differences in metabolism of different tumor tissues. An 
example of SCD expression being associated with tumor tissue was detected by differential 
display. Genes that are expressed differentially in a chemically induced rat mammary 
carcinogenesis model were identified by Lu et al. (1997). Seven cDNA fragments were 
identified and sequenced from the differential display, one of which was 81% homologous to 
mouse SCD2. The genes identified may represent molecular markers that are helpful in 
identifying mammary cancer and in aiding in its treatment or prevention. 
Fermor et al. (1992) studied the cytotoxicity of fatty acids on normal and mahgnant 
cells in hopes of being able to inhibit A^-desaturase activity in cancer cells and increase 18:0 
concentrations to inhibit cancerous growth. Both 18:0 and 18:l(n-9) inhibited colony 
forming abilities of five cell lines tested in culture, but 2- to 3-fold more 18:l(n-9) was 
needed for a similar response when compared with 18:0. Inhibition of A®-desaturase by 
using sterculic acid modulated the IS-carbon fatty acid composition by increasing 18:0 by 
more than 2-fold and decreasing 18:l(n-9) by about 2.5-fold. The changes that were 
observed were not enough to modify cell viability; ftirthermore, cytotoxic effects of 18:0 or 
18:l(n-9) were no different for cancer cell lines or non-neoplastic cell lines. 
de Bravo et al. (1996) studied the effects of lovastatin on fatty acid desaturase 
activities in a human lung mucoepidermoid carcinoma grown in the legs of nude mice. 
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Despite nearly a 50% decrease in hepatic cholesterol concentration, there was not a 
significant decrease in tumor cholesterol. Phospholipid content of lovastatin-treated mice 
liver decreased but did not change in the tumor tissue, but the phospholipid to cholesterol 
weight ratio was significantly increased in both tissue of treatment mice. Tumor A®- and A^-
desaturase activities increased in treated mice, but A^-desaturase activity did not change. The 
fatty acid composition of tumor tissue, however, did not reflect the changes in desaturase 
activity as measured in vitro. Despite the failure of lovastatin to decrease fatty acid 
desaturase in tumor tissue, there is still potential of modulating the fatty acid metabolism of 
tumor cells, via changes in fatty acid or eicosanoid synthesis to change the rate of growth or 
even cause cell arrest. 
It has been demonstrated that malignant cells can be growth inhibited in vitro by 
18:2(n-6) and 18:3(n-6). Some types of malignant cells, however, lose A®-desaturase 
activity, thus requiring 18:3(n-6) as an essential fatty acid (Gardiner and Duncan, 1991). In 
this study, BL6 melanoma cells, which have no A®-desaturase activity, attained more mass 
when grown in mice fed 18:3(n-6) than in mice fed 18:2(n-6), indicating a possible negative 
effect of consuming 18:3(n-6) with respect to some forms of tumor development. 
Diabetes 
Diabetes meUitus alters fatty acid metabolism, possibly giving rise to many of the 
secondary disease states observed in diabetic patients. To better understand lipid metabolism 
in diabetic rats, A^- and A^-desaturase activities were measured in kidneys and livers of 
control and streptozotocin-induced diabetic rats (Clark and Queener, 1985). The liver 
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enzyme results were consistent with what was expected in that the A^-desaturase activity in 
diabetic rats was decreased severely relative to that of control rats, with no change in A^-
desaturase activity between treatment groups. In kidney tissue, however, there was an 
increase in A®-desaturase activity in diabetic rats with no change in A®-desaturase activity. 
Further, it was determined that, with added fatty acyl-CoA synthetase, A^-desaturase activity 
in renal plasma membranes from control rats increased to be equal to the activity measured in 
diabetic rats. Direct measure of fatty acyl Co-A synthetase activity also indicated increased 
activity in diabetic rat kidney. The authors concluded that the two desaturases are regulated 
differently in different tissues and that the two tissues are affected differently by the 
induction of diabetes, hi some tissues such as kidney, the rate of fatty acid activation may be 
limiting. 
The hypothesis that available fatty acid precursors for thromboxane synthesis were 
different in platelets of human diabetics and non-diabetics was tested to explain the increased 
incidence of microangiopathy in diabetics (Jones et al., 1986). Platelet fatty acid 
composition was measured in normal, insulin-dependent diabetics, and non-insulin-
dependent diabetics. There was an inverse correlation between 18:2(n-6) and 20:4(n-6) in 
healthy men, but no such relationship existed in diabetic patients. The authors propose that 
the increased thromboxane synthesis and impaired A^- and A^-desaturases in diabetics deplete 
the 20:4(n-6) supply from platelets. However, more details of exactly which catabolic steps 
are inhibited must be obtained before knowing which fatty acids to supplement in attempting 
to correct this metabolic anomoly. 
Bassi et al. (1996) induced ketosis in insulin-dependent diabetic humans and 
measured fatty acid composition of serum phospholipids as an indicator of fatty acid 
desaturase activity. Initial fatty acid profiles between diabetic and control patients were not 
different. However, after a period of ketosis, where glucose, ketones, and fi-ee fatty acid 
concentrations were elevated and insulin was decreased, 20:4(n-6) and all (n-6) acids as a 
group were decreased. There was a significant inverse correlation between plasma glucose 
and plasma 20:4(n-6) concentrations. The change firom the baseline ratio of 20:4(n-6) to 
20;3(n-6), an indicator of A^-desaturase activity, was significantly and inversely correlated 
with hemoglobin Aic concentrations. Both short-term increased utilization of 20;4(n-6) and 
changes in desaturase activities could explain the differences in 20:4(n-6) concentrations. 
The difference noted in the 20:4(n-6) to 20:3(n-6) ratio before and after ketosis and the 
correlation of that change with hemoglobin Aic would indicate long-term metabolic control. 
Obesity 
The regulation of hepatic SCDl in ob/ob mice fed differing amounts of energy and 
types of fatty acids was studied (Enser and Roberts, 1982). The ob/ob mice had a 6.5-fold 
increase in hepatic SCDl activity compared with lean controls when both were allowed ad 
libitum feed intake. This difference can be explained simply by increased caloric intake by 
the ob/ob mice because when the ob/ob mice were pair-fed to match the feed intake of the 
lean controls, their SCDl activity decreased and became more under the regulation of the 
type of fat consumed. Not all the difference can be explained by intake, however, because, 
during a 72-hour starvation, SCDl activity decreased 99% in lean controls but only 
decreased 89% in the ob/ob mice. The authors conclude that because of increased de novo 
fatty acid synthesis in ob/ob mice, the 18:2(n-6) that is normally available to regulate SCDl 
expression is diluted out by the endogenous saturated fatty acids. This contradicts the 
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conclusions of Jeffcoat et al. (1979) who proposed that inhibition of fatty acid synthesis 
occurred through an initial decrease in A'-desaturase activity, leading to a decrease in fatty 
acid synthesis de novo. 
Blond et al. (1989) measured hepatic microsomal A^- and A^-desaturase activities in 
obese Zucker rats (fa/fa) at 6, 9, and 12 weeks of age. In general, obese rats had similar A^-
desaturase activity and lesser A^-desaturase activities compared with control rats. The A^-
desaturase activity increased 47% in the lean rats during the study compared with only a 10% 
increase for the obese rats. This change could be accounted for by a increase in Km of the 
desaturase in the obese rats at 12 weeks compared with that of the control rats. The in vitro 
measures predicted the tissue fatty acid composition with the 20:4(n-6) to 20:3(n-6) ratio 
being 5-times greater in lean control rats with little difference noted in the 20:4(n-6) to 
18;2(n-6) ratio. These results demonstrate the differences between obese animal models, 
where obese mice (ob/ob) have increased A^- and A^-desaturase activities and more 20:4(n-6) 
in hepatic membranes than do lean control mice. 
Phiimey et al. (1993) wanted to correct the abnormally decreased concentration of 
phospholipid 20:4(n-6) in obese Zucker rats by feeding 18:3(n-6). One proposed problem 
noted in obese humans and rats is a great decrease in 20:4(n-6), which causes speculation 
about inadequate desaturase systems. Dietary 18:3(n-6) normalized 20:4(n-6) in 
phospholipids of obese rats, caused a decrease in food intake, and resulted in a decreased 
amount of body fat. The other (n-6) metabolites of 18:2(n-6) were similar to those of control 
rats, indicating a sufficient desaturase system but an altered metabolism of 20:4(n-6) in the 
obese rats. In fact, they found a greater amount of cholesteryl arachidonate in the serum and 
hepatic tissue of obese rats than in the lean control rats. They caution direct extrapolation of 
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these data in utilizing supplemental 18:3(n-6) as a human diet compound because of the risk 
associated with elevated 20:4(n-6) in tissues. 
A review by Pan et al. (1994) described the effects of types of dietary fats and their 
effect on membrane phospholipids as they relate to obesity. Increased A^-desaturase activity 
has been associated with obesity in several animal studies (chickens, Legrand and Hermier, 
1992; rats, Wahle and Radchffe, 1977; pigs, Kouba et al., 1997; humans, unpublished data 
noted in Pan et al. 1994). Not as many data are available for A^- and A^-desaturase activities 
related to obesity. Indirect evidence provided by Nakamura et al. (1994) indicates, in cases 
of insulin resistance, such as in chronic alcoholism, a decrease in A^- and A®-desaturase 
expression. Borkman et al. (1993) concluded that the strongest single correlate of insulin 
action was that of A^-desaturase activity as monitored by tissue ratios of 20:4(n-6) to 20:3(n-
6). The authors propose that decreased unsaturation because of lesser expression of fatty 
acid desaturases would lead to less fatty acid oxidation, and therefore more triacylglycerol 
storage. 
Jones et al. (1996) determined stearoyl-CoA expression in adipose tissue, a major site 
of SCD expression and lipid metabolism, in lean and obese Zucker rats fed control (12% com 
oil) or PUFA-enriched (48% com oil) diets. The pattern of increased desatiirase expression 
in obese animals and a repression of expression with increased dietary PUFA in both lean 
and obese rats mimics data observed for hepatic SCD expression in other studies with rodents 
and other animal species. It is not known if the same control mechanisms are acting in 
adipocjAtes as compared with hepatocytes. It was noted by Shillabeer et al. (1990) that, 
because of the delay in deliver of dietary fatty acid to the adipose tissue compared with 
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delivery time to the liver, there will be a delayed response time in SCD expression in 
adipocytes compared with hepatocytes when dietary lipids are fed. 
Fatty acid composition of several blood lipids were analyzed in 22 obese and 25 
aged-matched control children averaging 13.7 years of age (Decsi et al., 1996). By 
comparing pre- and post-A^-desaturase metabolites, the obese children had more A®-
desaturase activity than did the aged-matched controls. Plasma glucose concentrations were 
related inversely to 20:4(n-6) in phospholipid and sterol esters and to the 20;4(n-6) to 20;3(n-
6) ratio in phospholipid and sterol esters. A logical conclusion is that increased 
concentrations of longer chain (n-6) metabolites of 18:2(n-6) is probably a result of increased 
A^-desaturase activity via elevated fasting insulin in obese children. 
Hypertension 
Correlations between hypertension and membrane fatty acid composition have been 
noted for some time (Watanabe et al., 1989). Narce and Poisson (1995) used a spontaneously 
hypertensive rat model to study the effects of hypertension and aging with respect to A^- and 
A^-desaturase activities because increased dietary supply of 18;2(n-6), a prostaglandin 
precursor, can attenuate blood pressure. In this study, the ratio of 18;2(n-6) to 20:4(n-6) in 
total liver lipids increased in the hypertensive rats with aging (7 weeks of age to 13 weeks of 
age) but not in the control rats. Delta-5 and A®-desaturase activities were measured from 
liver microsome preparations, and, as predicted from the fatty acid composition both A^- and 
A®-desaturase activities were decreased in hypertensive rats. At 13 weeks of age, both 
desaturases in hypertensive rats were less than that measured in controls. In later studies by 
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Narce et al. (1995) where rats were allowed to age further, A®-desaturase activity of the 
hypertensive and normal rats equalize and approach the activity observed in control rats at 1 
month of age. The initiation of hypertension in this rat model may be via change in 
eicosanoid balance during the growth phase of the rats, the time when hypertension is 
manifested. 
de Catalfo and de Gomez Dumm (1996) found a decrease in hepatic A^- and A®-
desaturases and long-chain fatty acyl-CoA synthetase activities in spontaneously 
hypertensive rats compared with controls. In testis, the thioesterification and A^-desaturase 
activities also were inhibited in hypertensive rats. Membrane fatty acid composition revealed 
the changes measured by in vitro enzyme activity. These authors also proposed that 
increases in eicosanoid availability via increases in desaturase activities could explain the 
differences between spontaneously hypertensive and normal rats. 
Dietary supplemental fatty acids that bypass A^- and A®-desaturases have been 
demonstrated to attenuate pressor and tachycardic response in stressed normotensive and 
hypertensive rats (Mills et al., 1985). Isolation stress in spontaneously hypertensive and 
Wistar Kyoto (control) rats caused a decrease in A^- and A^-desaturase activities in liver 
microsomes (Mills et al., 1994). In the same paper, an experiment utilizing essential fatty 
acid-deficient Sprague-Dawley rats injected with epinephrine and gavaged with 18:2(n-6) 
showed decreased 20:4(n-6) in plasma lipids while 18:2(n-6) was increased. This 
observation indicates a dose response of epinephrine on inhibition of desaturases that are 
required to sjoithesize 20:4(n-6) fi-om 18:2(n-6) in rats. 
Russo et al. (1997) compared fatty acid composition of plasma and erythrocyte 
membranes and zinc status of hypertensive and control patients to understand the association 
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of fatty acid desaturase activity and hypertension. Greater zinc concentrations and ratios of 
fatty acids in plasma that are indicative of greater desaturase activity were observed in 
hypertensive compared with control patients. The increased desaturase activity will provide 
more eicosanoid precursors, which could explain the association between fatty acid 
desaturase activity and hypertension. The direct association between hypertension and 
desaturase activities remains to be seen, but this study provides good evidence for a strong 
correlation despite contradictions to hypertensive rodent models. 
General Disease 
Stearoyl-CoA desaturase has been associated with all three studies discussed in this 
section of the review. Kaput et al. (1994) have been studying genes that are regulated by 
great amounts of dietary fat in an attempt to understand disease processes associated with 
increased dietary fat intake. Two genes identified by using this method, originally 
designated Lfin-1 and Lfitn-2, have been identified as an FiFo-ATPase-like gene and SCD, 
respectively. Lfin-1 has a restriction-length polymorphism (RFLP) on chromosome 8 of 
mice associated with atherosclerosis. This general approach of subtractive hybridization and 
+/- screening (EUiott et al., 1993) has the potential of imlocking genes expressed during 
dietarily induced disease states and then predicting the risk of diet-related diseases in 
individuals. 
Paisley et al. (1996) fed BALB/cHnn mice diets containing 3,10, or 20% com oil for 
2 weeks and then studied hepatic A®-desaturase expression following food depravation and 
refeeding. This effort is part of the scientific movement to understand gene expression in 
normal and disease states as a way of predicting health status. As would be expected, the 
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mice fed more com oil had less SCD mRNA. In the same study it also was noted that 
starvation greatly elevated the SCDl expression whereas refeeding suppressed activity. 
Differential disease induction by dietary fat in two strains of mice was studied (Park 
et al., 1997). One strain, C57BL/6J, is highly susceptible to atherosclerosis, diabetes, and 
disorders of lipid metabolism while BALB/cByJ mice served as the healthy controls. Both 
types of mice were fed diets containing either 4% or 20% coconut or com oil for 4 months. 
The BALB/cByJ mice grew faster on all four diets. Analysis of the SCD promoters of both 
strains revealed no difference in DNA sequnences, but northern analysis revealed SCDl 
expression was greater in C57BL/6 mice than in BALB/c mice. While the BALB/c mice 
responded to increased com oil or coconut oil by dovm-regulating SCDl expression, the 
C57BL/6 mice responded nicely by down-regulating SCDl expression with an increase in 
com oil but had high rates of expression with either 4% or 20% coconut oil diets. These data 
will be used in future research to study the heritability of certain diseases luiked to abnormal 
lipid metabolism. 
Gamma-Linolenic Acid Supplementation 
In 1993, Horrobin wrote a review on the role of A®-desaturase in health and disease. 
In this article, he addressed the idea of 18:3(n-6) supplementation of diets to overcome 
shortfalls in the A®-desaturation of 18:2(n-6). Desaturation and elongation of 18:2(n-6) is 
cmcial because 18:2(n-6) has little value metabolically other than supplying energy. The 
products of 18:2(n-6) desaturation, however, have increasing biological potency as the 
molecule becomes longer and less saturated. The longer chain acids are precxu-sors to the 
eicosanoids, which regulate many aspects of physiology such as reproduction and inmiune 
mediation. Topics of medical interest associated with dietary supplemental 18:3(n-6) include 
inclusion of post-A^-desatirase metabolites in infant formula and supplementation of 18;3(n-
6) to bypass A^-desaturase in treating the symptoms of atopic eczema and diabetes. 
Karlstad et al. (1993) studied the effect of 18:3(n-6) addition to parenteral feeding of 
control and injured rats. By supplying increasing amounts of 18:3(n-6) to injured rats, they 
observed a favorable reduction in the ratio of thromboxane B2 to 6-keto-prostaglandin F|a. 
These results were achieved when the A®-desaturation of 18:2(n-6) was bypassed with 
additional dietary 18:3(n-6) that increased 20:3(n-6), the precursor to prostaglandin Ei, an 
anti-inflammatory prostaglandin. This treatment also attenuated 20:4(n-6)-derived 
prostaglandins. Arachidonic acid concentration in plasma did not increase with increased 
amounts of 18:3(n-6). Ganuna-linolenic acid conversion to 20:3(n-6) actually decreases the 
amoimt of 20:4(n-6) formed because, as 20:3(n-6) is being converted to the one series 
prostaglandins, there is competition for cyclooxygenase conversion of 20;4(n-6) to the 
inflammatory prostaglandins. 
Heart 
Possible new predictive risk factors for coronary heart disease (CHD) have been 
observed in a health survey study by Ohrvall et al. (1996). Two-thousand-three-hundred and 
twenty-two 50-year-old men were studied, and it was discovered that participants with lower 
proportions of 14:0,16:0,16:l(n-7), and 20:3(n-6) in plasma cholesteryl esters were at less 
risk for CHD than those with higher amounts of 18:2(n-6) cholesteryl ester. Middle aged 
men who develop CHD have a low 20:4(n-6) to 20:3(n-6) ratio of plasma cholesteryl ester, 
indicating a possible decrease in A^-desaturase activity in individuals at risk. 
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Liver 
Both A^- and A®-desaturase specific activities increased in liver of rats 3 to 7 days 
after 65% hepatectomy (Carreau et al., 1981). The activity of both enzymes increased to 
match total desaturation capacity of the intact livers in sham-operated control rats. On the 
other hand, liver cirrhosis in humans, regardless of the origin, caused a 50% decrease in A^-
desaturase activity compared with control livers (Biagi et al., 1990). Despite the large 
change in enzyme activity, fatty acid composition of the liver microsomal membranes was 
not different. This response is a good demonstration of the ability of organs to maintain 
membrane integrity even in the advent of dire circumstances. 
Neurology 
Carreau et al. (1979) measured A^-desaturase activity in brain microsomes from 
normal mice and mice with genetic defects causing neurological abnormalities. Up until this 
study, the existence of A^-desaturase activity in brain tissue was controversial. This 
experiment demonstrated A®-desaturase activity in neural tissue and that the desaturase was 
not as active in the diseased mice during myelination, a period of rapid brain growth and 
membrane synthesis. 
DeWille and Farmer (1992) detected decreased expression of genes known to be 
critical for neuronal myelination in mice of the quaking phenotype. Neural mRNA for the 
major myelin proteins, proteolipid protein, and myelin basic protein, along with SCD, LDL-
receptor, and ApoE, were all greatly decreased in 23-day- old mice with the quaking 
phenotype compared with control mice. Not only is MUFA synthesis down-regulated during 
a critical time of brain growth, but critical proteins that become part of the neural tissue and 
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proteins such as the LDL-receptor and ApoE that help sequester and transport lipids are 
suppressed as well. 
DeWille and Farmer (1993) compared brain SCD2 mRNA to hepatic SCDl mRNA in 
rat pups nursed by mothers fed a control (5% com oil) or an EFAD diet (5% coconut oil). 
The com oil diet was formulated to just meet the essential fatty acid requirements of the 
nursing pups. There was a 2-fold decrease in brain SCD2 mRNA when dams were fed an 
EFAD diet, whereas SCDl mRNA in liver increased 29-foId. While modulation of hepatic 
expression by diet has been demonstrated frequently, this experiment is the first noted 
example of dietary lipids controlling a gene encoding a lipogenic enzyme in brain. The 
coding sequences for SCDl and SCD2 are similar, but the promoter for each is quite 
different, containing only a few regions of homology. Both SCDl and SCD2 promoters 
contain C/EBP consensus binding sites. C/EBP-a, P, and 6 are expressed in Uver, whereas 
the 8 form is the only major C/EBP expressed in brain. Expression of any of the C/EBPs, 
however, did not change in either tissue with either diet, giving rise to the question of post-
translational modification of C/EBPs for modulation of activity. 
Cultured fibroblasts from skin-punch biopsies from schizophrenic patients, bipolar 
patients, and normal controls were grown in culture and analyzed for phospholipid fatty acid 
composition. Fatty acid composition of controls and bipolar patients did not differ, but those 
with schizophrenia had lesser amounts of 22:6(n-3) as well as less total (n-3) fatty acids. 
Arachidonic acid did not differ across groups, indicating a deficiency in A'^-desaturase 
activity among schizophrenic patients (Mahadik et al., 1996a). In a later study by Mahadik et 
al. (1996b), fibroblasts grown from skin-punch biopsies were provided 18:2(n-6) and 18:3(n-
3) separately in culture. Uptake and incorporation of these two acids into phospholipids were 
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not different between patients and controls. Their conversion to longer chain-unsaturates, 
however, indicated a defect in A^-desaturase in schizophrenic patients. 
Fatty acid composition analysis of pathologically proven Alzheimer's diseased brains 
and age-matched controls were obtained for study (Nakada et al., 1990). In the diseased 
brains, 18:2(n-6) was elevated from 6- to 25-fold in the various phospholipid classes 
compared with those of controls. At the same time, 20:4(n-6) and 22:4(n-6), metabolites 
from 18;2(n-6), were imchanged to 12-fold less in the various phospholipid classes of 
diseased patients. In the (n-3) series, 22:6(n-3) was unchanged to 3-fold less in the diseased 
brains. These findings link the pathology of Alzheimer's disease with defective fatty acid 
desaturase systems. 
Toxins 
Carreau et al. (1980) quantified A^- and A®-desaturase activities in rat hver after 
carbon tetrachloride poisoning to learn about desaturase activity recovery during liver 
regeneration. Delta-9-desaturase activity decreased to a low of 24% of control and recovered 
to 94% of control after 14 days of recovery. Delta-6-desaturase responded more rapidly to 
the toxin and did not recover as fully. Delta-6 desaturase activity already had decreased 30% 
at 3 hours, attained a minimum of 37% of control activity at 12 hours, and rebounded to 72% 
activity at 14 days. The supporting proteins, NADH-ferricyanide reductase, and NADH-
cytochrome c reductase activities were not as severely depressed as that of the terminal 
desaturases. 
Borlakoglu et al. (1991) noted a great increase in 20:4(n-6) in hepatic microsomal 
membranes of rats and pigeons dosed with Aroclor, a polychlorinated biphenyl. Along with 
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the significant increase in cytochrome P450 concentration and increases in activities of 
associated enzymes was an increase in A^-desaturase activity (40-fold in pigeons and 10-fold 
in rats), leading the authors to question if A^-desaturase is actually a P45o-dependent 
monooxygenase. When cytochrome P450 is extrapolated to zero, it is coincident with zero 
desaturase activity. 
Desaturases in Other Tissues 
Fatty acid desaturases usually are associated with liver, adipse, and neural tissues. 
Other tissues that have been studied with respect to fatty acid desaturation include mammary, 
intestinal, kidney, fetal, and lens tissues. This section surveys the various tissues not covered 
in other sections of the review. 
ICinsella (1972) assayed SCD activity in bovine mammary microsomes and 
established that the cofactor requirements are the same as those for hepatic SCD, but little or 
no SCD activity can be detected in tissues obtained from non-lactating cows. Desaturation of 
18:0 was proposed as a limiting factor in milk triacylglycerol synthesis in vivo and the theory 
was tested in vitro. The affinity of the transacylases for activated 18:0 or 18:l(n-9) differed, 
with glyceride acyl transferase preferring 18:l(n-9) and phosphatidyl acyl transferase 
preferring 18:0. When SCD was inhibited or stimulated in vitro, the rate of triacylglycerol 
synthesis was inhibited or stimulated in a parallel fashion. This in vitro response is 
suggestive that any factor that affects the activity of SCD such as availability of activated 
precursor, NADH concentration, or concentration of SCD would limit milk triacylglycerol 
synthesis. 
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Delta-9-desaturase from lactating rat mammary gland and liver was studied by 
Calabro et al. (1982). They found that mammary tissue had 1.25- to 25-fold less terminal 
desaturase activity than did liver tissue. When purified A^-desaturase was added to 
mammary microsomes, there was a 55-fold stimulation of desaturase activity. Cytochrome 
bj addition had no effect on activity, but when both cytochrome bs and A'-desaturase were 
added, there was a 200-fold increase in activity. These results suggest that the majority of 
monounsaturated lipids incorporated into milk lipids in rats are probably dietary or hepatic in 
origin. 
Bandyopadhyay et al. (1995) has documented a 4-fold increase in specific activity of 
A^-desaturase in intact mammary fat pads of pregnant mice compared with lactating mice. 
This change is a good example of how mammary adipose tissue behaves differently during 
pregnancy and lactation as it is not dedicated to sequestration and accumulation of dietary 
lipids but rather to production of stimulatory type molecules needed to initiate and support 
lactation, such as eicosanoids. 
Intestinal cell membrane integrity is of utmost importance in maintaining absorptive 
capabilities. It is well documented that membrane fatty acid composition can greatly affect 
membrane fluidity and therefore greatly change its physiochemical character. Garg et al. 
(1988) studied A®- and A^-desaturase activities in microsomes prepared from rat jejunum, 
ileum, and liver. Delta-9-desaturase specific activity was about 50% in jejunum and ileum 
compared with liver, whereas A®-desaturase activity was about 50% in the jejunum and 25% 
in the ileum compared with liver. While it is possible for the enterocytes to obtain much of 
the fatty acid required for membrane growth from recovery of bile-derived phospholipid fatty 
acids, the enterocytes are also capable of de novo synthesis of PUFAs. 
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Keelan et al. (1997) studied fatty acid desaturases in portions of the jejunal villus 
from rats fed PUFA- or saturated fatty acid-enriched diets. Previously, they had noted 
changes in phospholipid fatty acid composition in the upper versus the lower segments of the 
villi. To determine if these changes were the result of differential desaturase expression, the 
villi were isolated in four fractions from distal to proximal regions for analysis. Delta-5-
desaturase activity was greatest in the upper fractions compared with the lower fractions and 
was decreased when dietary saturated fatty acids were fed compared with PUFAs. Delta-6-
or A®-desaturase activities did not change because of dietary manipulation or with location 
within the villus. Despite the change in A^-desaturase activity, there were no differences in 
fatty acid composition that reflected this change. 
Delta-5-desaturase activity was confirmed in rat kidney microsomes by Irazii et al. 
(1993). The enzyme has characteristics similar to those described for hepatic A^-desaturase. 
The concentration of A^-desaturase is over 10-times greater in liver compared with kidney 
tissue. Kidney A^-desaturase also differed from hepatic A^-desaturase in that it is not further 
activated by addition of cytosolic preparations from liver or kidney cells. Activity of A^-
desaturase in kidney cells indicates that this organ is capable, at least in part, of satisfying its 
own eicosanoid needs. 
Salviati et al. (1979) noted that NADH-cytochrome c reductase activity of 
sarcoplasmic reticulum fragments, a measure of NADH-cytochrome bs reductase-
cytochrome bs, was much greater in slow (red) muscles than in fast (white) muscles. They 
also note an inverse relationship between Ca^'^-transport and elecfron transport activity of 
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different membranes. Their data support that decreased A^-desaturase activity is restricted 
because of terminal desaturase enzyme in slow muscles. 
Unesterified fatty acids, the major source of plasma lipid supply for the developing 
fetus, in the plasma of ewes is much more satiarated than are the fatty acids found in total 
lipids of the placenta and fetal plasma (Shand and Noble, 1979). These differences correlate 
with an active desaturase system in the placentae of ewes. Placental A^-desaturase activity 
was found to be 4-fold greater than that of newborn lamb liver, double that of 8-day-old lamb 
liver and 30% higher than adult liver, whereas placental A®-desaturase was 47-, 8-, and 12-
times greater in placentae than in newborn liver, 8-day-old liver, and adult liver. It is now 
clear that the placenta not only acts as a barrier, allowing appropriate nutrients to pass into 
the developing fetus, but also as a processor of fatty acids, modifying highly saturated 
maternal blood, lipids into longer chain, more unsaturated acids for the developing fetus. 
This conclusion directly contradicts the functions of the himian placenta where no A^- or A®-
desaturase activities were found, but rather an impressive but declining activity of these two 
enzjTnes in fetal liver from 18- to 22-weeks of gestation was observed (Chambaz et al., 
1985). In humans, the differential fatty acid composition of the fetus and the mother must be 
explained by preferential uptake of fatty acids across the placenta and/or active fetal 
elongation and desaturation of fatty acids. Poisson et al. (1993) evaluated human new bora 
liver for A^- and A®-desaturase activities and determined that both desaturases were present 
but they were less concentrated than that found in adult liver. Also, there was substrate 
inhibition by the (n-6) fatty acids but not by the (n-3) fatty acids. 
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'"'C-Stearic acid, when incubated with rabbit lens tissue in culture, is P-oxidized, the 
label is transferred into 12-, 14-, and 16-carbon fatty acids as well as into cholesterol, it is A^-
desaturated, and it is elongated (Albers-Jackson and Bunch, 1982). The resulting acids also 
were incorporated into triacylglycerols and phospholipids. These results demonstrate that 
lens has appreciable metabolic and catabolic ability and is not completely reliant upon the 
aqueous hiimor as a supplier for all fatty acid precursors and metabolites. 
Molecular Biology 
Animal Systems 
Thiede et al. (1986) isolated the cDNA for rat liver SCD by inducing the expression 
with alternate periods of fasting and feeding a high-carbohydrate diet, performing primer-
extension of cDNA, and analyzing overlapping fragments. The resulting 4,689 bp cDNA 
sequence includes a 1,074 bp open reading frame coding for a 358 amino acid enzjrme of 
molecular weight 41,400 daltons. The large region of 3' untranslated region has been 
identified as coming from one axon by Southern blot analysis. Comparison of cyanogen 
bromide sequence analysis of the purified enzyme and total amino acid analysis confirmed 
the cDNA as being that for SCD. The protein is comprised of 62% hydrophobic amino acids. 
Strittmatter et al. (1988) expressed rat liver SCD in E. coli. One construct contained 
the sequence for amino acid residues 3-358 and the other for residues 27-358. Both proteins 
were associated almost exclusively with membrane fractions of cell homogenates. 
Posttranslational iron addition to the apoprotein can be achieved in vitro or by adding iron 
during induction of the cDNA. Both proteins expressed activity when appropriate cofactors 
were added in an assay system. Both expression constructs provided equal activity. 
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indicating that the region that was deleted in the second construct was not crucial to proper 
membrane insertion, iron sequestration, or catalysis. The deleted region is unique in that it 
contains an unusually high content of hydroxylated residues 
Promoters 
A rat genomic library was screened to determine the gene structure of SCDl and 
SCD2 (Miharra, 1990). The upstream regulatory regions differ greatly between the two 
forms. Stearoyl-CoA desaturase-one is organized with six exons and five introns spanning 
about 15 kb and coding for an mJRNA with an open reading frame of 1074 bp. The 5'-
flanking region of SCDl contains sequences that are homologous to the FSE2, a negative 
regulatory element of gene expression during differentiation. The tissue distribution of 
SCDl and SCD2 mRNAs differs greatly. Stearoyl-CoA desatiirase-l is in adipose tissue and 
can be induced in liver, whereas SCD2 is in brain, kidney, and testis. 
Ntambi (1995) reviewed the differential expression of SCDl and SCD2 and noted 
that the two forms probably arose from a single gene because the coding regions are 
conserved (87% amino acid identity) and the 5'-promoter region contains similar elements. 
In the promoter region, the two genes share a 146 bp sequence that is 77% identical and 
contains two CCAAT boxes. 
The CCAAT/enhancer binding protein (C/EBP) is central in activating transcription 
of several genes during preadipocyte differentiation including SCD. Several lines of 
evidence that implicate C/EBP as determined by Christy (1989) include: 1. C/EBP binds to 
SCDl, GLUT4, and aP2 promoters, 2. C/EBP is expressed just prior to SCDl, GLUT4, and 
aP2, 3. Cotransfection of C/EBP with reporter genes linked to the promoters of the genes 
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mentioned above result in increased amounts of reporter product, and 4. Mutations in the 
C/EBP binding sites in the promoter regions result in a decreased amount of trans activation. 
Swick and Lane (1992) identified a transcriptional repressor that binds to the 
promoter region of SCD2 and is only expressed before preadipocytes are allowed to 
differentiate into adipocytes. They termed the binding site PRE (preadipocyte repressor 
element). The PRE was located -435 to -410 relative to the SCD2 start codon. By using 
Southwestem blotting, the PRE binding protein was found to be present in preadipocytes and 
HeLa cells but not present or active in adipocytes. When the PRE was inserted upstream of 
the SV40 enhancer/promoter, the reporter gene was expressed in a pattern similar to that for 
SCD2 in preadipocytes, adipocytes, and HeLa cells. 
Sterol-regulatory element binding protein-1 a (SREBP-la) is a membrane-bound 
protein associated with the nuclear envelope. Upon sterol-depletion-dependent proteolysis, 
SREBP-la is cleaved, creating a soluble NHa-terminal domain that enters the nucleus and 
activates transcription of several cholesterol and fatty acid biosynthetic genes. Shimano et al. 
(1996) overexpressed the soluble NHi-terminal fi:agment of SREBP-1 in transgenic mice. 
While serum lipids did not change, hepatic lipid synthesis was greatly up-regulated, resulting 
in liver enlargement as triacylglycerols and cholesterol accumulated. One of the lipogeneic 
genes activated was SCD. 
The promoter for SCDl contains several cw-DNA elements that mediate responses to 
PUFAs (Waters et al., 1997), thyroid hormone, (Waters et al., 1997), cAMP analogs (Casimir 
et al., 1996), and PPAR (Miller et al., 1996). The transcription factor C/EBPa is known to 
bind to the SCDl promoter between -60 and -80 (Christy et al., 1989). Region -253 - +30 
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contains cw-DNA elements that respond to the AP-2-mediated cAMP induction of SCDl 
(Casimir et al., 1996). 
The PUFA response region of SCDl was localized by using a chimeric 5'-flanking 
region fiised to a reporter gene (Waters et al, 1997a). When the entire 4.3 kb SCDl putative 
promoter was used, 18:3(n-3) repressed transcription by 60% and 20:4(n-6) and 20:5(n-3) by 
75%, but no change was observed with 18:0 addition. Progressively smaller SCDl chimeric 
constructs revealed a 237-bp sequence that was responsible for PUFA regulation in the 
proximal promoter. Mobility shift analysis identified a 60-bp sequence that boimd proteins 
from nuclear extracts from 3T3-L1, Hep G2, and mouse liver cells. The 60-bp sequence, 
which is also present in the SCD2 proximal promoter, confers PUFA responsiveness to 
reporter constructs. This observation indicates that SCDl (liver) and SCD2 (adipose) may 
share common transcription regulatory mechanisms. 
Stearoyl-CoA desaturase has been used as a model for studying the pattems of 
lipogenic gene expression. The way SCDl is down-regulated and up-regulated by PUFA and 
insulin, respectively, is similar to the way other lipogenic genes respond (Ntambi, 1992). An 
example of SCDl not responding along with the other lipogenic genes is the up-regulation of 
hepatic SCDl by retinol pahnitate, with no change in fatty acid synthase expression (Miller 
et al., 1997). Other examples of SCDl not responding as a lipogenic gene include thyroid 
hormone repression (Waters et al., impublished data) and peroxisome proliferator induction 
(Miller and Ntambi, 1996). Because thyroid hormone represses retinol-elevated SCDl 
expression and because peroxisome proliferator-elevated SCDl mRNA are unaffected by 
administration of thyroid hormone, SCDl regulation evidently is under control of 
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heterodimerization with the retinoid X receptor and the peroxisome proliferator regulation 
occurs through a different mechanism (Miller et al., 1997). 
Singh and Ntambi (1998) report the necessity of nuclear factor 1 (NFl) for SCDl 
expression during preadipocyte differentiation. Region -114 to -86 is essential for 
transcriptional activation of SCDl during differentiation and contains the sequence TGGCA, 
a known NFl binding site. By using chimeric promoter/reporter constructs, it was 
determined that the NFl binding site was necessary for differentiation-induced expression of 
SCDl by both NFl and cAMP-response. Gel-shift assays confirm that mutated forms of the 
NFl binding sequence do not associate with NFl. Also discovered was an additional protein 
in the NFl family that is present only after preadipocyte differentiation that is specific for 
NFl sequence as based on competition assays. The authors believe that this protein is 
modified during differentiation because cycloheximide does not inhibit binding to the DNA 
during addition of the differentiation mix. Evidently, NFl interacts with other regulatory 
elements during differentiation to induce changes in SCDl expression. 
Genetics 
Birds 
Avian lipid metabolism is markedly different fi'om that in mammalian systems 
because of the anatomical site of de novo lipid synthesis. In birds, the liver is the 
predominant tissue of de novo fatty acid synthesis and adipocytes are primarily utilized for 
storing triacylglycerol. In the pig, however, adipocytes are primary sites of both synthesis 
and storage. Other animal species synthesize fatty acids in both liver and adipose to varying 
degrees. 
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Joshi et al. (1977) determined that hepatic microsomes from 20-day-old chicken 
embryos or 1-day-old chicks contained ample cytochrome bs and cytochrome bs reductase to 
support A®-desatiirase activity, but no detectable terminal A®-desaturase. Therefore, purified 
desaturase could be added to microsomal preparations from young chicks and a functionally 
complete desaturase system w^ould be available for study. This in vitro system demonstrated 
the lack of A®-desaturase in embryonic chicks and also provided an inexpensive source of 
supporting enzymes and proteins to assay A'-desaturase for other experiments. Legrand et al. 
(1994) studied primary chicken hepatocytes in culture and determined that they respond to 
insulin and PUFAs the same as do rodent hepatocytes. The authors noted a 30-hour delay in 
maximal SCD activity vi^hen hepatocytes were isolated from fasted chickens. This 
methodology should be foundational to fiirther studies of hormone or metabolite regulation 
of SCD or of other genes expressed in chicken hepatocytes. Recently, SCDl from chicken 
has been cloned, and Fillon et al. (1997) have reported that chicken SCDl has been mapped 
to chromosome 6 (R-band 6ql4). 
Because fatty liver is sometimes a problem in laying hens, resulting in fatty liver 
hemorrhagic syndrome and even death, mechanisms to maintain triacylglycerol flux from the 
liver in the form of VLDL particles are important to understand. Hermier et al. (1996) used 
estrogenized young male chickens to study the relationship between fatty acid desatuxation, 
hepatic lipid storage, and VLDL secretion. Hepatic SCD was 2-fold higher in estrogenized 
chickens than in control chickens. Stearoyl-CoA desaturase induction was noted by 
increased MUFA concentration in VLDL, liver, and liver microsomes. The MUFA content 
of VLDL fatty acids was 55% whereas the MUFA content of liver fatty acids was 50%. This 
disparity in MUFA concentration indicates the preferential export of monoenes and provides 
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the opportunity to protect the liver from triacylglycerol accumulation and resultant steatosis. 
This protection theory was supported when Legrand et al. (1997) inhibited A®-desaturase 
activity in cultured chicken hepatocytes and were able to decrease triacylglycerol secretion 
rates by greater than 4-fold. The authors had noted the increased 18:l(n-9) content in 
secreted triacylglycerols (VLDL) compared with intracellular triacylglycerols. When 18: l(n-
9) was added to the cultures that had inhibited A®-desaturase activity, there was an increase in 
triacylglycerol secretion rate, but it did not return to the rate of the control cells. In summary, 
the authors suggest that this could be the mechanism linking increased A^-desaturase activity 
with excessive over-fattening in chickens. 
Ruminants 
Whereas the highly reductive environment in the rumen almost completely saturates 
dietary PUFA prior to absorption in the ruminants (Ashes et al., 1997), the fatty acid 
composition of ruminant animals can vary considerably. Ch'ang et al. (1980) determined the 
genetic effects of sire on five fatty acids in sheep and determined that the weight percentage 
of 16:0 and the ratio of palmitoleic to 16:0 were highly heritable (0.40 and 0.38, 
respectively). From this study, it is feasible to consider a genetic approach to altering 
physical-chemical properties of fatty acids in animal products by selecting for desired 
desaturase activities. 
Chang et al. (1992) fed high 18:l(n-9) sunflower seed to steers to learn about lipid 
metabolizing enzymes such as SCD and fatty acid elongase. The steers fed increased 
concentrations of 18:l(n-9) had elevated plasma 18:l(n-9), and 18:l(n-9), 18:0, and myristate 
were elevated in adipose tissue, probably as a function of the increased lipid in the diet. 
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While fatty acid elongase was not modulated by diet in tissues sampled, SCD was increased 
in skeletal muscle, with numerical increases in adipose, liver, and small intestine. There was 
a 30% decrease in liver 18:0 in cattle fed the high 18:l(n-9) sunflower seed, despite having a 
3-fold increase in duodenal 18:0 available for absorption. The authors suggest an adaptive 
response of the steers, allowing them to up-regulate SCD when excess 18:0 is present. 
American Wagyu cattle, the North American counterpart of Japanese Black cattle, 
have increased concentrations of MUFAs in their tissues compared to other beef cattle 
breeds. Wilson et al. (1993) noted the identification of an RFLP in the SCD gene in DNA 
firom purebred Japanese Black Cattle. Cameron et al. (1994) proposed that the increased 
18:l(n-9) in Wagyu cattle when compared with Black Angus cattle was because of increased 
SCD expression or activity. However, there were no differences in mRNA quantity or 
enzyme activity in mature cattle of both breeds. The authors concluded that the differences 
must occur at earlier stages of development. 
Page et al. (1997) fed whole cottonseed to steers in an attempt to depress SCD 
activity in adipose or liver tissue. The authors believed this could occur because of 
cyclopropene fatty acids present in whole cottonseed. The steers fed whole cottonseed 
attained a greater body weight and had greater subcutaneous adipose tissue and marbling 
because of greater dietary fat intake. Of the biochemical parameters measured, the only 
difference noted was a suppression in lipogenesis in steers fed whole cottonseed probably 
because they were fed greater amounts of dietary fat. Delta-9-desaturase activity and adipose 
cellularity were not changed. Again, the reductive nature of the rumen converted dietary 
PUFAs into mostly saturated fatty acids before they were absorbed. This occurrence makes 
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the PUFA regulation of SCD in adipose tissue much different in ruminants than in 
nonruminants. 
Ovine SCD is the only example of a cloned SCD from ruminants. An adipose tissue 
cDNA library was screened to obtain the clone by using a 1.2 kb rat SCDl probe. The 
resultant sequence was 90% homologous with mouse, rat, and human sequences (Ward et al., 
1997). By restriction analysis and by screening a genomic library, it was verified that there is 
only one unique SCD gene in sheep, which is unlike that in the mouse where both SCDl and 
SCD2 have been mapped to adjacent sites on mouse chromosome 19 (Tabor et al., 1998). 
Rodents 
de Antueno et al. (1994) compared the A^- and A®-desaturase activities of four strains 
of laboratory rats and compared microsomal membrane fatty acid composition to the enzyme 
activities. There was over a 2-fold difference in enzyme activities when the strains with the 
greatest and least activities were compared. Despite great differences in activity, these two 
desaturases were tightly correlated between strains. The greatest activity was observed for 
the BB-Wistar control rats, with the CR Wistar and Long-Evans strains being intermediate, 
and Sprague-Dawley rats having the least activity. The authors emphasize that no significant 
correlations were found between either A^- or A^-desaturase activities as determined by in 
vitro assay and the fatty acid substrates or products as part of the microsomal fatty acid 
composition. 
Ulmaim et al. (1994) measured incorporation of 18:2(n-6), 18:3(n-3), and 20:3(n-6), 
and their metabolites into hepatic microsomal phospholipids of rats fed diets enriched in (n-
3) fatty acids (5% fish oil) or (n-6) fatty acids (19% borage oil). Obese Zucker rats, their 
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lean littennates, and Wistar control rats were used. The majority of the labeled acids were 
found in the triacylglycerols of obese rats but in phospholipids of lean rats. All phenotypes 
incorporated more 18;3(n-3) and its metabolites when fed the fish oil diet. The fish oil diet 
favors the (n-3) fatty acid biosynthesis and incorporation into liver microsomal lipids classes 
as the (n-6) fatty acids are synthesized and incorporated at a lesser rate. This study 
demonstrates dietary and genotype effects on several aspects of fatty acid metabolism. 
Hughes and York (1985) noted an increase in A^-desaturase and A^-desaturases in 
liver of young genetically obese (ob\ob) mice. The onset of increased desaturase activity 
does not occur until weaning. Restricting food intake or giving insulin does not restore the 
two desaturases to control desaturase activity. Cold acclimation and triiodothyronine, 
however, decrease A^-desaturase activity to be equvalent to activity observed in control mice. 
Pigs 
Activity of SCD in adipose and liver tissues fi-cm growing Large White and Meishan 
pigs was studied (Kouba et al, 1997). Both breeds had more SCD activity in adipose tissue 
than in liver when expressed on a protein basis, but, because of the 10-fold greater 
concentration of microsomal proteins in liver, when expressed on a tissue weight basis, the 
liver had more activity. However, the adipose tissue weight is greater than the liver weight, 
making liver desaturase a minor component of overall fatty acid desaturation in the pig. The 
specific activity of SCD in adipose was much greater in Large White than in Meishan pigs, 
and the 18:l(n-9) content of Large White adipose was slightly lower. Hepatic 18:l(n-9) 
content was higher in Meishan pigs, which had an increased hepatic SCD activity compared 
with Large White pigs. This observation holds true to other studies that have demonstrated 
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rats (Wahle and Radcliffe, 1977) and chickens (Kouba et al., 1993) with higher body fat, like 
the Meishan pig, have increased hepatic SCD activity. But, there was a lack of correlation in 
adipose SCD activity with 18:l(n-9) content of adipose tissue much as in the study 
comparing Black Angus and American Wagyu cattle (Cameron et al., 1994). Some of the 
differences in adiposity of strains of animals within the same species may arise from 
increased A®-desaturase activity providing more 18:l(n-9), which has been demonstrated to 
aid in assembly and secretion of lipid-rich VLDL for delivery to tissues, adipose depots in 
particular (Legrand and Hermier, 1992). 
Plant Systems 
Most plants lack desaturases that act on 18:0 other than SACPD. That fact makes this 
enzyme pivotal in determining the overall amount of fatty acid desaturation in plants. To 
date, this enzyme, which has been cloned from several species of plants, is the only identified 
soluble fatty acid desaturase. When Shanklin and Somerville (1991) cloned the Ricinus 
communis (castor) and Cucumis sativus (cucumber) SACPDs, they noted 88% amino acid 
identity between the two enzymes. On the other hand, these soluble desatiirases are not 
genetically similar to the membrane-bound mammalian homologue of SCD. This 
observation provides strong evidence that the plant and mammalian genes evolved 
separately. 
Expression of cloned plant desaturases in yeast or E. coli has provided enough 
enzjone to conduct enzymatic and crystallographic studies. Both castor and cucximber 
cDNAs were expressed in yeast and immimoreactive protein was synthesized that had 
desaturase activity in an in vitro assay (Shanklin and Somerville, 1991). Gibson (1993) 
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verified that pabnitoyl-ACP was an alternate substrate for stearoyl-ACP A®-desaturase. 
Recombinant enzyme expressed in E. coli was used to demonstrate that despite its catalytic 
effect on desaturation, stearoyl-ACP A®-desaturase has a 100-fold greater specificity factor 
(Vmax/Km) for stearoyl-ACP when compared with palmitoyl-ACP. The majority of the 
difference was because of the difference in Vmax-
The soluble enzymes that utilize saturated fatty acids bound to ACP as their substrate 
that have been identified to date include the A^-SACPDs mentioned above, A'^-palmitoyl-
ACP desaturase of Coriandrum sativum (Cahoon et al., 1992), A^-palmitoyl-ACP desaturase 
of Thunbergia alata (Cahoon et al., 1994), A^-myristoyl-ACP desaturase of Pelargonium 
xhortorum (Schultz et al., 1996), and A^-SACPD isolated fi-om milkweed seed. The 
milkweed seed desaturase has a 10-fold greater specificity for palmitoyl-ACP and a 30-fold 
greater specificity for myristoyl-ACP than other known A^-desaturases, giving rise to the 
unique fatty acid composition of milkweed tissue (Cahoon et al., 1997b). This set of 
enzymes has been shown to have >70% homology, with most of the divergence occurring at 
the ends of the primary structure. The crystal structure of A^-stearoyl-ACP firom R. 
amminus (Lindqvist et al., 1996) has been very valuable in understanding fatty acid chain 
length specificity and reaction center mechanisms. 
Modifying plants to make fatty acids for special industrial or nutritional applications 
has been attempted with limited success through traditional plant breeding efforts. More 
recently, transgenic approaches, as described over 8 years ago by Somerville and Browse 
(1991), have been employed to shuttle desirable characteristics of oil production firom one 
plant to another plant that is easier to grow or that produces more triacylglycerol. Cahoon et 
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al. (1997a) have redesigned ACP desaturases to leam about the chain-length and positional 
specificities of this class of soluble desaturases in plants. In one experiment, A®-palmitoyl-
ACP desaturase was mutated by replacing key amino acids from A^-stearoyl ACP desaturase, 
creating a new series of enzymes capable of desaturating substrates with different number of 
carbon atoms or at different positions in the acyl chain. With this sort of flexibility, a broad 
spectrum of lipid products can be envisioned. 
Stearoyl-ACP desaturases that have been cloned from plants include safflower 
(Thompson et al., 1991), cucumber and caster (Shanklin and Somerville, 1991), potato 
(Taylor et al., 1992), spinach (Nishida et al., 1992), Brassica napus (Slocombe et al., 1992), 
Brassica rapa (Knutzon et al., 1992), jojoba (Sato et al., 1992), sesame (Yukawa et al., 
1996), and rice (Akagi et al., 1995). 
Cahoon et al. (1992) identified a protein from Coriandrum sativum (coriander) by 
using the antibody for A^-SACPD from avocado in an attempt to define the enzyme 
responsible for petroselinic acid (18:l(n-12)) production in coriander. The antibody reacted 
with 39- and 36-kDa proteins. Only the 36-kDa protein was in tissues that synthesize 18:l(n-
12). The cDNA, isolated by using an expression library, was expressed in tobacco and 
conferred the ability to produce 18:l(n-12) to the transgenic tobacco callus. 
Expression of antisense SACPD message in Brassica napus (canola) resulted in 
dramatic increases (25-fold) in 18:0 concentration in modified plants (Knutzon et al., 1992). 
Seeds from plants that had the greatest inhibition of SACPD also had a decreased oil content 
and poor germination. One hypothesis that has been proposed is that, as pools of stearoyl-
ACP accumulate, available ACP concentrations drop low enough that fatty acid synthesis is 
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no longer supported maximally. Seeds that had intermediate activities of SACPD had 
somewhat normal lipid content and germination rates. 
A cDNA isolated jfrom rose petals was found to be homologous to acyl-lipid 
desaturase from cyanobacteria and acyl-CoA desatiirase from mammals (Fukuchi-Mizutani 
et al., 1995). This is the first known example of sequence homology between desaturases 
from plants and animals. The putative rose A®-desaturase lacks a leader sequence associated 
with entry into the chloroplast. The gene is only expressed in matiu-e petals and not in the 
typical chloroplast-rich tissue, such as leaves. Brown et al. (1991) demonstrated an increased 
cataboUsm of PUFA relative to saturated fatty acids in aging carnation petals. This positive 
correlation between senescence and increased PUFA catabolism had led to the speculation 
that the senescence-induced desaturase may render fatty acids more susceptible to 
catabolism. 
Coexpression of thaliana ferredoxin along with palmitoyl-ACP A^-desaturase in E. 
coli results in twice as much 16:l(n-10) as do cells not expressing the exogenous desaturase 
(Cahoon et al., 1996). Coexpression of exogenous ferredoxin reductase from maize had little 
effect on desaturase activity, suggesting that E. coli are able to maintain a reduced plant 
ferredoxin or that other substrates such as NADPH of the desaturase elecfron fransport reaction 
are more limiting. 
Yukawa et al. (1996) isolated and studied the expression of two unique SACPDs from 
sesame. The two genes are expressed differentially in leaf and seed tissue, with one 
expressing at low levels in leaves and young seeds and the other being \mique to seed oil 
modification. Not only are these gene products usefiil in the study of plant oil synthesis and 
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accumulation, but the promoters may be useful in genetic modification of plants when 
controlled expression of a transgene is desired. 
Cahoon et al. (1996) were able to detect 3.2 and 1.4 mol% of 16:l(n-10) and 18:l(n-
10) , respectively, when they expressed A®-palmitoyl-ACP desaturase from Thunbergia alata 
in E. coli. Both acids were increased by 2-fold when ferredoxin from Arabidopsis thaliana 
was coexpressed. Cahoon et al. (1998) have also isolated a cDNA for fatty acyl-ACP 
desatiirase from cat's claw seed {Doxantha unguis-cati) by probing with the known A^-
S ACPD from castor bean. Interest in this species arose when it was noted that up to 80% of 
the fatty acids in the seed are 16:l(n-7) or 18:l(n-7) . The predominant cDNA was very 
similar to the form from castor bean, but, when expressed in E. coli, the enzyme preferred 
pahnitoyl-ACP as a substrate, explaining the unusually large amount of 16:l(n-7) in cat's 
claw seed. The authors speculate that the substrate preferences between the two desaturases 
can be explained by a leucine to tryptophan difference at amino acid position 118. This 
bulky group decreases the depth of the substrate pocket. When the similar mutation was 
made in A®-SACPD, the specificity for the palmitoyl-ACP substrate was increased to 115% 
relative to the stearoyl-ACP substrate. Crystallographic data also predict the change in 
substrate specificity for the A®-SACPD mutant. Learning about natural and engineered 
differences in desaturases will allow very specific engineering of plants to produce specific 
oils for industrial, nutritional, or pharmaceutical applications. 
Yeast Systems 
Yeast have proven to be a good model for studying fatty acid desaturases from plants 
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or animals. Bossie and Martin (1989) conducted experiments that proved that OLEl, the 
Saccharomyces cerevisieae equivalent of mammalian SCDl, was transcriptionally regulated 
by supplemented fatty acids in the media. When 18:l(n-9) or 16:l(n-7) were supplemented 
to the media, the supplemented acid increased in membrane fatty acids, but, because of 
suppressed A®-desaturase activity, the complementary fatty acid decreased. Supplemented 
18:2(n-6) was incorporated into membrane lipids at nearly 50% of the fatty acids, whereas 
16;l(n-7) became barely detectable and 18;l(n-9) was decreased by 75%. Northern blotting 
shows a greater than 80% decrease in mRNA concentration within 60 minutes when yeast are 
supplemented with 18:2(n-6) or a mix of 18:1 (n-9) and 16:1 (n-7). The authors suggest the 
possibility of a soluble factor such as a fatty acid binding protein that may mediate 
transcriptional control by fatty acids. 
The Saccharomyces cerevisiae mutant OLEl is defective in lipid metabolism and 
requires unsatxirated fatty acids for growth. The defective yeast protein in its active state is 
57.4 kDa and has an internal region of identity (36%) and similarity (60%) to the rat liver 
SCD enzyme. When Stukey et al. (1990) expressed the rat SCD in yeast driven by the 
promoter region and N-terminal 27 codons of OLEl, the yeast no longer required unsaturated 
fatty acids for growth and had similar lipid composition to wild-type control yeast. 
Mitchell and Martin (1995) studied the cytochrome bs-like domain linked to the 
carboxy terminus of the A^-desaturase in Saccharomyces cerevisiea. They noted that 
disruption of the cytochrome bs gene in yeast resulted in viable cells that did not require 
added sterols or unsaturated fatty acids for growth. When the C-terminal end of the A^-
desaturase gene was disrupted in cells that were producing the diffiisable cytochrome bs, the 
cells became unsaturated fatty acid auxotrophs. When the rat SCD was expressed in 
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cytochrome bs disrupted and OLEl-disrupted yeast, it became obvious that the mammalian 
form of the enzyme requires cytochrome bs, but yeast A'-desaturase enzyme has cytochrome 
bs activity. 
The effects of fatty acids on OLEl mRNA stability in yeast as a possible control 
mechanism involved in fatty acid metabolism was studied by Gonzalez and Martin (1996). 
OLEl codes for a membrane-bound protein located on the endoplasmic reticulum that is 
responsible for A®-desatiiration of palmitoyl- and stearoyl-CoA to paknitoleoyl- and oleoyl-
CoA. Two independent control systems regulate expression of active enzyme by fatty acid-
mediated control of transcription and mRNA stability. Unsaturated fatty acids decrease the 
message half-life from 10 to less than 2.5 minutes in yeast. Unlike saturated fatty acid 
activation of transcription, saturated fatty acids have no effect on message half-life. By 
constructing chimeric constructs of the GALl promoter region and the OLEl 5'-UTR and 
promoter, it was demonstrated that the region of mRNA required for changes in stability 
related to unsaturated fatty acids is the 5'-UTR of OLEl. Cycloheximide slows nucleolj^ic 
degradation of OLEl mRNA and blocks the unsaturated fatty acid decrease in half-life. 
Disruption of the XRNl gene, a 5' to 3' exonuclease, increases the half-life of OLEl mRNA 
but does not protect OLEl mRNA from imsaturated fatty acid destabilization. It is 
speculated that the two sensing mechanisms that respond from the same stimuli might 
regulate different pools of fatty acids within the cell. 
Messters and Eggink (1996) isolated and characterized a A®-desaturase from 
Cryptococcus curvatus CSB 570, a yeast strain that accumulates up to 60% of its dry weight 
as triacylglycerol. Cloning of the A®-desaturase from this species is the first step in utilizing 
this strain of yeast commercially for tailor-made oil production. The newly cloned gene has 
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62% and 72% homology with the rat and Saccharomyces cerevisiae genes, respectively. 
Oleic acid decreased mRNA concentration for the A^-desaturase by 90%, but 18:l(n-12) did 
not affect the mRNA concentration. 
The promoter region of Saccharomyces cerevisieae OLEl was examined by Choi et 
al. (1996). A 111-bp, fatty acid-regulated region was found at nucleotide -580. In yeast, this 
region was critical for the 1.6-fold increase in expression when cells are fed saturated fatty 
acids and the 60-fold decrease in transcription when unsaturated fatty acids are fed. This 
region, when inserted into the CYCl promoter, confers fatty acid responsiveness to CYCl 
transcription. Two other genes, fatty acid-activation (FAA)-1 and FAA-4 were found to be 
required for the unsaturated fatty acid repression of transcription. With one of the FAA 
genes present, there was an intermediate amount of unsaturated fatty acid responsiveness, 
but, with both FAA genes deleted, there was no unsaturated fatty acid responsiveness. When 
the fatty acyl-CoA binding protein gene was missing, transcription increased 5-fold but 
unsaturated fatty acid repression was not affected. 
Gyorfy et al. (1997) expressed the A^-desaturase gene of Saccharomyces cerevisiea 
under the control of other fungal promoters {H. capsulatum) and conferred yeast A®-
desatuarse activity in a mouse fibroblast cell line. By using this system, active yeast A®-
desaturase was expressed in mammalian cells and the MUFA composition of membranes was 
increased. 
Insect Systems 
Nutritionally essential fatty acids for animals always have been considered to be 
18:2(n-6) and 18:3(n-3). Borgeson et al. (1990) have proposed a A'^-oleoyl-CoA desaturase 
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in the American cockroach as demonstrated by efficient conversion of oleoyl-CoA to 18:2(n-
6) with little conversion of 18:l(n-9) that is esterified to a phospholipid molecule. To date, 
this is the only known example of a dietarily essential fatty acid in mammalian diets being 
synthesized anywhere but in a plants, cyanobacteria, or fungi. Axenic conditions were used 
to rear house crickets and the American cockroach to eliminate the chance of detecting 
microbial desaturase activity and to verify that both species had oleoyl desaturase activity 
(Borgeson et al., 1991). This unique desaturase activity remains controversial, and no 
specific enzyme or DNA sequence has been identified. 
An SCD has been cloned from the salivary gland of the arthropod Amblyomma 
americanum (a species of tick) (Luo et al., 1997). The salivary gland of ticks can increase by 
about 25-fold in size and protein content during feeding. The mass of 18:l(n-9) increases 
more than 10-fold during this same time period, indicating the possible crucial role of fatty 
acid desaturation in supporting this phase of the tick's life cycle. It has also been speculated 
that SCD is critical in the overwintering process. Now that a clone is available, it will be 
easier to study this process in more detail. 
Wicker-Thomas et al. (1997) identified and sequenced a cDNA fi-om Drosophila 
melanogaster that codes for a protein with homology (up to 40% identical) to mammalian 
and yeast A^-desaturases. The 383 amino acid protein has two histidine cluster motifs 
(HXXHH) and two hydrophobic regions. Two forms of the gene have been identified by 
using the polymerase-chain reaction. One form has three introns, and the other has no 
introns. Drosophila melanogaster is known for having specific hydrocarbon sex 
pheromones, all with n-7 double bonds but with varying degrees of unsaturation. This gene 
may be responsible for synthesis of such pheromones as females at different ages express 
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different concentrations of the mRNA for this newly described gene. Subspecies of 
Drosophila melanogaster produce different arrays of pheromones; therefore, it would be of 
great interest to learn about the potential differences in the putative desaturase gene. The 
association of SCD stability and reproductive cycles in the house fly were noted by Wang 
and Reitz (1983). The half-Hfe of SCD was 9.35 hours in 4-day-old females but only 3.38 
hours in 1-day-old females. Evidentely, the half-life increased with age and its expression 
moved from the integument to the inner body tissue as the female approached ovarian 
development, indicating a possible increased need for desaturase activity for reproduction. 
Fish Systems 
Hazel (1984) summarized the lipid altering events that occur when fish are forced to 
adapt to cold environments. The changes include increased rate of fatty acid desaturation, 
increased incorporation of fatty acids into phospholipids during fatty acid synthesis, and 
changes in phospholipid metabolism with the increased rates of desaturation. Wodtke and 
Cossins (1991) studied cold- induced changes in membr^e fluorescence polarization and A®-
desaturase activity in carp hver. Upon cooling from 30° C to 10° C, the A®-desaturase 
activity was increased to a first maximum 3 days after the onset of cooling with a decline in 
activity back to basal activity with a second and larger maximum at day 10 of cold 
adaptation, followed by a steep decline to basal levels. Activities in rough and smooth 
endoplasmic reticulum were assayed separately and had similar responses. The fluorescent 
polarization, however, increased to about day 3 and then maintained a steady state for the 
next 7 days. 
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Tiku et al. (1996) also studied the induction of A®-desaturase in carp liver when the 
fish were switched to a cold environment. The switch to cold caused a 10-fold increase in 
both specific activity of the A^-desaturase protein in microsomal membranes and of the 
mRNA concentration in the cells. These changes took 48-60 hours to occur, but, before this 
time, there was a modest increase in the specific activity of the A®-desaturase in the hepatic 
microsomes, probably because of some activation mechanism of latent A®-desaturase. The 
authors speculated that the mechanism of activation could be myristylation, phosphorylation, 
or N-glycosylation on the basis of the known sequence of the protein. 
Assays 
Original methods of assaying desaturase activity utilized '''C-labeled 18:0 or 16:0 as a 
CoA- or ACP- ester depending on whether one was working with mammalian or plant 
desaturases. The reaction mixture that contained the appropriate cofactors and buffers was 
saponified and derivatized after incubation, and 18:0 and 18:l(n-9) or 16:0 and 16:l(n-7) 
derivatives were separated. Modes of separation included arginated thin-layer 
chromatography, radio-HPLC, or radio-gas chromatography. Activity of the enzyme 
preparations then could be determined on the basis of rate of substrate conversion and 
amount of membrane protein used in the reaction. These methods all relied on multiple 
analytic steps, many of which are very cumbersome. Thus, the chance for introducing error 
was great and sample numbers had to be increased to accommodate a "sloppy" assay system. 
The use of 9,10-[^H]-l8:0 to quantify the activity of SACPD or SCD in vitro by 
measuring the appearance of simplified the analytical methods greatly (Talamo and 
Bloch, 1969). Both CoA and ACP-fatty acid thioesters are precipitable by acid after the 
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reaction has been completed. The precipitate can be collected on a Millipore filter, and the 
tritiated water extract is counted in a liquid scintillation counter. This method circumvents 
the need to saponify and separate saturated fatty acids and MUFAs by thin-layer 
chromatography or other means. 
Ivanetich et al. (1996) developed an improved assay system for A®-desaturase 
activity. The unique ideas that were crucial to the difference from previous systems included 
separation of reactant and product molecules in the free acid form on an HPLC system. This 
circumvented the error involved with differential derivatization efficiencies and the use of 
thin-layer chromatographic plates, The other major change was to account for the free 
18:2(n-6) that is associated with the microsomal preparations. By accounting for the 
microsomal 18:2(n-6), the Km and Vmax changed from 1.5 (iM and 0.063 nmol/min to 10.7 
|4.M and 0.08 nmol/min. 
A simultaneous measure of A^-, A®-, and A®-desaturases has been validated by Su and 
Brenna (1998) for conducting assays without the use of labeled fatty acids. They compared 
the results obtained by using stable isotopes followed by gas chromatography/mass 
spectrometry, and results obtained by using nonlabeled fatty acids and traditional gas 
chromatography with flame ionization detection. When various tissues with varying 
concentrations of the three different desaturases were measured, drastic differences by tissue 
were noted, but both the stable isotope and the non-labeled methods gave the same results. 
This technique will allow for the study of reactions where labeled substrates are not readily 
available or where isotope use is not desirable. It is cautioned that this method should be 
used with systems that are predictable because detection limits might restrict noticing loss of 
substrate to other unanticipated reactions. 
117 
Thia fatty acids can be useful in the study of lipid metabolism because their chemical 
character is similar to typical fatty acids, but their metabolic fate can be unique, depending 
on the position of the sulfiir atom in the alkyl chain. Skrede et al. (1997) have prepared an 
extensive review of thia fatty acids and their metabolic effects. Thia fatty acids can be 
activated to CoA esters, partially p-oxidized, and partially co-oxidized, resulting in short 
sulfoxy dicarboxylic acids. Some isomers can be desatvirated and incorporated in 
phospholipids, often times causing changes in (n-3) to (n-6) ratios. Three-thia fatty acids 
induce PPAR-a and the retinoid-X receptor-a, inhibit cholesterol and malonyl-CoA 
sjoithesis, and activate the enzymes of P-oxidation, leading to a hypolipidemic effect. Four-
thia fatty acids can inhibit p-oxidation, leading to fatty liver, and 9-thia 18:0 is a strong 
inhibitor of A'-desaturase. Apart from research uses, the thia fatty acids hold the greatest 
hope of being hypolipidemic agents used in place of the fibrates, which have more negative 
side-effects. 
Fr0yland et al. (1997) utihzed three-thia fatty acids, known mitochondrial and 
peroxisome proliferators, to better understand factors affecting fatty acid composition and 
lipoprotein metabolism. C12-S-Acetic acid and C14-S-acetic acid were the most 
hypolipidemic, decreasing plasma triacylglycerols by 50%. At the same time, A®-desaturase 
gene expression was increased resulting in a greater concentration of hepatic 18:l(n-9). 
Oxidation of 20:5(n-3) increased, probably because of increased peroxisomal enzymes and 
decreased plasma VLDL and PUFAs (20:5(n-3)), leading to a less oxidatively atherogenic 
lipoprotein profile. 
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Miscellaneous Related Information 
Broido et al. (1991) studied the expression of Lemma gibba light harvesting complex 
Hb AB30 or AB19 in COS-7 cells to understand cellular targeting of chloroplast-destined 
proteins in an animal cell. The cDNAs were expressed under the control of an SV40 
promoter but were not processed and accumulated in structures resembling inclusion bodies 
within the COS-7 cells. 
After 18.5 days of space flight on the Soviet Cosmos 936 biosatellite and after 25 
days of recovery after flight, 28 hepatic enzymes were assayed in rats (Abraham et al., 1983). 
Five enzymes decreased in activity including glycogen phosphorylase, 6-phosphogluconate 
dehydrogenase, aconitate hydratase, a-glycerolphosphate acyltransferase, and diglycerol 
acyltransferase because of space flight. Two enzymes including palmitoyl-CoA desaturase 
and lactate dehydrogenase increased during flight. Both liver glycogen and the ratio of 16:0 
to 16:l(n-7) increased, supporting the in vitro assays for glycogen phosphorylase and 
palmitoyl-CoA desaturase. All seven enzymes that changed because of flight had returned to 
normal after the 25-day recovery period. This study reinforces the concern of long-term 
weightlessness on humans in space stations. 
Albert and Coniglio (1977) presented evidence for what they considered A®-
desaturase activity in rat testes. By injecting radioactive 20:2A"'''' and sampling tissue for 
radioactive fatty acid composition 8 hours later, they found 51.5% of the label as the original 
compound. The metabolite with the most radioactivity was 20:3(n-6) which contained 29.5% 
of the counts. Ozonolysis of the 20:3(n-6) acids resulted in about 85% as the 5-carbon 
aldehydo ester (indicating 20:3A^'"'"') and 15% as the 8-carbon aldehydo ester (indicating 
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20:3A®'"'''*). Microsomes from testes resulted in similar in vitro results, whereas hepatic 
microsomes did not exhibit A^-desaturase activity 
Cadena et al. (1997) cloned a member of the membrane lipid desatiirase (MLD) 
family by using the yeast two-hybrid system with a fragment of the epidermal growth factor 
receptor as the binding protein. When expressed, the MLD has three consensus motifs, 
HX3H, HX2HH, and HX2HHXFP that fit the character of other fatty acid desaturases. The 
conserved histidine residues are proposed by Shanklin et al. (1994) to be crucial in binding 
the catalytic iron. Expression of this membrane-bound protein is quite ubiquitous, occurring 
in all 16 of the human tissues tested. Other than the three conserved histidine regions, the 
protein does not share homology with other known fatty acid desaturase genes. 
Overexpression of MLD specifically inhibits epidermal growth factor receptor expression. 
The authors speculate that is possible that MLD expression could coordinate fatty acid 
metabohsm with regulation of the epidermal groAvth factor receptor. 
It has been accepted that cats do not have the ability to perform A^-desatiuration, as 
they became "essential fatty acid deficient" and had low levels of 20:4(n-6) when fed 
safflower oil as their fat source (Rivers et al., 1975). Pawlosky et al. (1994) utihzed sensitive 
gas chromatography-mass spectrometry methods to identify A^-desaturation products in cats 
fed 9:1 hydrogenated coconut oilxom oil. After a 6-month feeding period, deuterium 
labeled 18;3(n-3) and 18;2(n-6) were given orally and tissues were collected for analysis. 
Labeled 18:3(n-6), 22:4(n-6), and 22:5(n-3) were found in the plasma, indicating hepatic A^-
and A^-desaturase activities, whereas 22:6(n-3), 24:5(n-3), 24:6(n-3), 22:5(n-6), 24:4(n-6), 
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and 24:5(n-6) were found only in brain, indicating that neural tissue is unique in its ability to 
perform A''-desaturation. 
Lee et al. (1998b) have identified and cloned a cDNA from Crepis alpina encoding 
an enzyme capable of forming acetylenic (triple) bonds in fatty acids. Formation of 
crepenynic acid (9-octadecen-12-ynoic acid) from 18;2(n-6) was detected. Up to 25% of the 
total fatty acids were determined to be crepenynic acid in transgenic Arabidopsis expressing 
the newly cloned acetylenase. The primary sequence of the acetylenase indicates that it is 
likely to be a non-heme diiron protein such as the fatty acid desaturases, hydroxylases, and 
epoxigenases found in plants, animals, fungi, and bacteria. Because these enzymes all 
contain histidine-rich motifs, and are capable of stabilizing a diiron center where oxidation of 
the substrate occurs, they are classified together. The economic potential of transferring 
unique fatty acid processing capabilities to easy-to-grow oil crops axe great and the reality of 
this scenario is fast approaching. 
Pugh and Kates (1979) demonstrated a flmctional phospholipid desaturase in rat liver 
by using a purification scheme for SCD published by Strittmatter et al. (1974). These 
en2yme preparations had a 7-fold increase in activity compared with crude microsomes. The 
enzyme converted 2-eicosatrienoyl-lecithin to 2-arachidonoyl-lecithin without a lag period 
and in a linear fashion with added protein or increased time. They minimize the possibility 
that phospholipase A2 could release free fatty acids that then would be activated by a 
thiokinase to their CoA derivative, which then could be desaturated by the traditional fatty 
acid CoA desaturase and re-esterified to the lecithin. They argue that there was no release of 
free fatty acid and that ATP or CoA, required compontents in reacylation, were not necessary 
in the reaction mixture. 
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Schenck et al. (1996) have proposed A®-desaturase activity in mouse liver. By dosing 
mice with 20:3(n-3) with deuterium at 3,3,4,4,8,8,9,9 carbon positions, 4.4% of the 
deuteriimi products proceeded through a A®-desaturase pathway. The majority of the 
deuterated products (35.3%) were retroconverted to 18:3(n-3)-d6 and then elongated and 
desaturated via typical A^- and A^-desaturases and elongases. Greater than 22% remained as 
the original deuterated fatty acid, and 28.9% were typical elongation and desaturation 
products of the original deuterated fatty acid. To detect A^-desaturase activity, the mice were 
fed marginally EFAD-diets. The deuterium label may cause an isotope effect by inhibiting 
the A^-desaturase and increasing the chance of A^-desaturation. 
Schultz et al. (1996) identified the gene for a imique fatty acid desaturase, A'-
myristoyl-ACP desatiu'ase. The (n-5) product is a necessary precursor to 16:l(n-5) and 
18:l(n-5) which ultimately are needed for anacardic acid synthesis, a secondary compound 
derived fi-om fatty acids. Anacardic acid often is associated with pest resistance in plants. 
The gene was cloned firom pest-resistant geraniums {Pelargonium xhortorum) and was not 
found to be expressed in pest-susceptible geraniums. 
Spychalla et al. (1997) searched the Caenorhabditis elegans DNA database to 
compare known sequences firom Arabidopsis. Several putative desatxirases were identified 
on the basis of sequence homology. One of the genes identified,had greater than 30% 
homology with FAD2 (A^^-desaturase) and FAD3 (n-3 desaturase). The unique nature offat-
1 was discovered when it was expressed in A. thaliana and caused a 90% increase in root 
lipid 18:3(n-3), as well as converting 20;3(n-6) to 20:4(n-3) and 20:4(n-6) to 20:5(n-3). 
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Thus, the fatl gene is the first example of an animal glycerolipid desaturase, capable of 
converting (n-6) acids to (n-3) acids, previously only identified in plants and cyanobacteria. 
Ves Losada and Breimer (1995) have demonstrated A^-desaturase activity in rat liver 
nuclei, the first timemammalian fatty acid desaturase activity has been documented in 
membranes other than endoplasmic reticulum. The nuclear enzyme had a pH optimum of 7.6 
and required the yet-to-be identified cytosolic factor that microsomal A^-desatiirase requires 
for full activity. Long-chain fatty acyl-CoA synthetase activity also was found in nuclear 
membranes. While the nuclear membrane is linked directly to the endoplasmic reticulum, it 
is not with great surprise that other endoplasmic reticulum proteins such as cytochrome bj 
and cytochrome P450 are also found in nuclei at low specific activities. It is speculated, 
however, that minor changes in fatty acid composition of nuclear membranes could exert 
large changes in cell metabolism by changing passage of mRNA or nucleoside triphosphates 
through the nuclear membrane. 
Tebbey and Buttke (1992a) demonstrated that p-lymphoc5d:es fi-om BALB/c (normal) 
and MRL/lpr (autoimmune strain) mice express SCD2, as opposed to SCDl, which is 
expressed in liver exclusively. BALB/c T cells do not express either form of SCD, but 
BALB/c thymocytes and MRL/lpr T cells express SCD2, demonstrating a developmental 
dovm-regulation of SCD2, which also is known to occur in the presence of 20:4(n-6). SCDl 
was not detected in any lymphoid cells. 
Summary 
Genetic, dietary, environmental, hormonal, pharmaceutical, and other unknown 
factors control the actions of fatty acid desaturases. The complexity of desaturase control is 
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deserving for such a vital system. The maintenance of all biological processes, in some way 
depends on the integrity of membrane structure, which, is in part determined by the 
availability of an optimal ratio of fatty acids. Other crucial molecules such as prostaglandins 
and leukotrienes also originate from the fatty acid desaturase system. To obtain a better 
overview of the myriad of controlling factors of the fatty acid desaturase systems examined 
in this review, the following tables help summarize the data in the literature. Tables 1, 2, 3, 
and 4 compile the agents used and the effects observed on A^-desaturase in vivo, A®-
desaturase in vitro, A^-desaturase, and A^-desaturase, respectively. Figures 3 and 4 condense 
the observation^in the literature into a summary of inhibitors and activators of the A®-
desaturase system and the A^- and A^-desatiu-ase systems, respectively. 
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Table 1. Summary of A^-desaturase in vivo modulators. 
Agent Effect Reference 
P-Carotene or 13-c/5-retinoic acid 
fed to rats 
Decreases activity with above 
normal doses 
Alam etal., 1984 
(n-3) Fatty acids fed to mice Decrease SCD activity via insulin 
or insulin receptor interuption in 
liver 
de Antueno et al., 1993 
11-Deoxycorticosterone 
injections given to rats 
Increases acitivity Mana and de Alaniz, 1991 
17-P-Estradiol injections given to 
roosters 
Increases activity Lipiello et al., 1979 
4% Com oil fed to pigs Decreases SCD activity in 
adipose tissue 
Kouba andMourot, 1998 
9-cis,l2'Cis Configuration 
PUFAs fed to rats 
Maximal inhibition in liver 
compared with isomers having 
trans bonds 
de Alaniz et al., 1986 
Androgen injections given to rats Decreases activity Thorling and Hansen, 1995 
Branched-chain fatty acids fed to 
rats 
Decreases hepatic SCD activity in 
liver 
Wahle and Hare, 1980 
Cadmium fed to rats Inhibits activity by antagonizing 
zinc 
Kudo etal., 1991 
Casein fed to rats Decreases activity when 45% vs 
5% is fed 
Peluffo et al., 1984 
Cholesterol fed to rats Increases SCD activity Garg et al., 1988a; Muriana et al., 
1992; Garg et al., 1986;Leikin 
and Brenner, 1987; Landau et al., 
1997; 
Clofibric acid fed to mice Increases activity Kawashima et al., 1986 
Clofibric acid fed to mice Incerases transcription Miller and Ntambi, 1996 
Clofibric acid fed to rats Increases activity Kawashima and Kozuka, 1982; 
Kawashima et al., 1986; 
Kawashima et al., 1985; 
Cold environment for fish Increases activity Tiku et al., 1996 
Cold enviromnent for male rats Decreases activity (no difference 
when pair-fed) 
Ves Losada and Peluffo, 1987 
Cold environments for femle rats Decreases activity Gonzalez et al., 1983 
Cold temperature treatment of 
tetrahymena 
Increases activity Kasai and Nozawa, 1980 
Conjucated linoleic acid fed to 
mice 
Decreases SCD activity in liver Lee etal, 1998 
Com oil/coconut oil fed to rats Increases/decreases activity in 
liver 
Pugh and Kates, 1984 
Dexamethasone injections given 
to rats 
Increases activity Marraetal., 1988 
Diabetic rats Decreases activity Kawashima et al., 1985; Mimouni 
et al., 1992; Prasad and Joshi, 
1979; Clark and Queener, 1985 
Estrogen injections given to rats Increases activity Thorling and Hansen, 1995 
Ethanol fed to rats Decreases activity Umeki et al., 1984; Rao et al., 
1984 
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Table 1. (continued) 
Agent Effect Reference 
Fasting and refeeding high 
carbohydrate diet to rats 
Increases activity Thiede and Strittmatter, 1985 
Fish oil fed to rats Increases SCD activity relative to 
olive oil 
Muriana et al., 1992 
Fish oil or lindseed oil fed to rats Decreases SCD activity Garg et al., 1988a 
Fructose fed to diabetic mice Increases SCD activity Waters and Ntambi, 1996 
Fructose fed to streptozotocin 
treated rats 
Increases activity Prasad and Joshi, 1979 
Glucagon injections given to 
mice 
Decreases expression Waters and Ntambi, 1994 
Growth hormone injections given 
to rats 
Decreases activity Gueraud and Paris, 1997 
Hot environments for yeast Increases activity Guerzoini et al., 1997 
Hybernation of hamsters Increases brain MUFA via liver 
not brain SCD 
Goldman, 1978 
Hyperglycemic and diabetic rats Decreases activity Mimouni and Poisson, 1992 
Insulin administration and fat-
free feeding of rats 
50-fold increase in specific 
activity in liver 
OSMQO and Sato, 1972 
Insulin injections given to 
diabetic mice 
Increases expression Waters and Ntabmi, 1994 
Insuliu injections given to 
diabetic rats 
Increases activity Faas and Carter, 1980; 
Kawashima et al., 1985; Nishida 
et al., 1988; Mimouni et al., 1992; 
Prasad and Joshi, 1979 
Iron deficient diet fed to rats Decreases activity Rao etal., 1983 
Low protein diet fed to rats Decreases activity Narce etal., 1992 
Low protein/essential fatty acid 
deficient diets fed to nursing rat 
dams 
Decreases (60%)/iQcreases 
(360%) activity in pups 
De Tomas et al., 1980 
Margarine fed to rats Decreases activity relative to 
hydrogenated coconut oil 
Mahfouz et al., 1981 
Medium-chain triacylglycerols 
fed with com or olive oils to rats 
Decreases SCD activity in liver Periago etal., 1989 
ob/ob Mice Increase in activity because of 
increased caloric intake 
Enser and Roberts, 1982 
Obese Zucker rats Increases activity Jones etal., 1996 
Partially hydrogenated marine 
oils fed to rats 
Decrease hepatic activity 
compared with hydrogenated 
peanut oil 
Svensson, 1983 
Perfluoro-octanoic acid fed to 
mice 
Increases acitivity in males but 
not females 
Kawashima et al., 1989 
Refeeding after starvation Increases activity Kawashima et al., 1985 
Retinol palmitate fed to mice Increases expression Miller etal., 1997 
Starvation of rats Decreases activity Kawashima et al., 1985 
Testosterone injections given to 
male or female rats 
Increases activity Marra and de Alaniz, 1989 
Thyroxine injections given to rats Incresaes activity Joshi and Aranda, 1979; Nishida 
et al., 1988 
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Table 1. (continued) 
Agent Effect Reference 
Triiodotbyronine injections given 
to rats 
Increases activity Yes Losada and Peluffo, 1989; 
Nishida et al., 1988 
Vitamin A deficient diets fed to 
rats 
Increase in activity Alam and Alam, 1985 
Zinc deficient diets fed to rats Decreases activity Eder and Kirchgessner, 1995 
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Table 2. Summary of A®-desaturase in vitro modulators. 
Agent Effect Reference 
p-Estradiol given to rat 
hepatocytes in culture 
Increases activity Marra and de Alaniz, 1995 
12 kDa Rat liver cytosolic protein 
in in vitro reaction 
Increase activity by preferentially 
binding 18:1 vs 18:0 
Catala, 1986 
26.5 kDa Rat liver cytosolic 
protein in in vitro reaction 
Increase activity by organizing 
multienzyme complex 
Jones and Gaylor, 1979 
Aldosterone given to rat 
hepatocytes in culture 
Increases activity Marra and de Alaniz, 1995 
Arachidonic acid given to 3T3-L1 
cells in culture 
Decreases activity and mRNA Sessler et al., 1996 
Bovine serum albumin and rat 
liver cytoplasm in in vitro 
reaction 
Increase activity by protection 
from thioesterases 
Jeffcoat et al., 1977 
Cholesterol added to hepatic 
microsomes in vitro 
Increases activity Garda and Brenner, 1985 
Corticosterone given to rat 
hepatocytes in culture 
Increases activity Marra and de Alaniz, 1995 
Cortisone given to rat hepatocytes 
in culture 
Increases activity Marra and de Alaniz, 1995 
Cu"" ions in in vitro reactions Decrease activity Sreekrishna and Joshi, 1980 
Deoxy corticosterone given to rat 
hepatocytes in culture 
Increases activity Marra and de Alaniz, 1995 
Dexamethasone given to rat 
hepatocytes in culture 
Increases activity Marra and de Alaniz, 1995 
Differentiation of 3T3-L1 cells in 
culture 
6-Fold increase in activity Kasuri and Joshi, 1982 
Ethanol given to HepG2 cells in 
culture 
Decreases activity Angeletti and de Alaniz, 1996 
Insulin given to differentiated 
3T3-L1 cells in culture 
100-Fold increase in activity Kasuri and Joshi, 1982 
Insulin/PUFA given to H2.35 
cells in culture 
Increases/decreases activity but 
PUFA over rides insulin 
Ntambi et al., 1996 
Methylisobutylxanthine given to 
3T3-L1 cells in culture 
Increases expression Casimir and Ntambi, 1996 
Retinoic acid given to 3T3-L1 
cells in culture 
Decreases activity Stone and Bemlohr, 1990 
Testosterone given to rat 
hepatocytes in culture 
Increases activity Marra and de Alaniz, 1995 
Thiazolidinediones given to 3T3-
L1 cells in culture 
Decreases expression Kurebayashi et al., 1997 
TNF-a given to 3T3-L1 cells in 
culture 
Decreases expression Weineretal., 1991 
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Table 3. Summary of A®-desaturase modulators. 
Agent Effect Reference 
11-Deoxycorticosterone 
injections given to rats 
Decreases activity Marra and de Alaniz, 1990 
13-cw-Retinoic acid fed to rats Increases activity Alam et al., 1984 
18:2(9 trans,12 trans) Given to 
human Jurkat-T cells in culture 
Inhibits 18:3(n-3) conversion to 




injection given to rats 
Decreases activity Mandon et al., 1987 
Aging in humans Decreases activity based on fatty 
acid composition 
Raederstorff et al., 1994 
Aging in mice Decrease in liver activity Bourreetal., 1990 
Aging in rats Decreases activity Bordoni et al., 1988 
Aging in rats Increases activity on 18:2(n-6) Maniongui et al., 1993 
Aging in rats Decreases activity in heart 
microsomes 
Jimenez et al., 1993 
Aldosterone injections given to 
rats 
Decreases activity Marra and de Alaniz, 1990 
Casein fed to rats Increases activity when 45% vs 
5% is fed 
Peluffo etal., 1984 
Cholesterol added to hepatic 
microsomes in vitro 
Increases activity Garda and Brenner, 1985 
Cholesterol fed to rats Decreases activity when fed with 
tallow 
Garg et al., 1988c 
Cholesterol fed to rats Decreases activity Garg et al., 1986; Osada et al., 
1995; Leikin and Breimer, 1987; 
Muriana et al., 1992 
Cholesterol fed to rats with soy or 
casein protein 
Decreases activity Lindholm et al., 1993 
Cold environment for femle rats Increases activity Gonzalez et al., 1983 
Com oil/coconut oil fed to rats Increases/decreases activity in 
liver 
Pugh and Kates, 1984 
CP-24979 Fed to mice Decreases activity Obukowicz et al. 1998 
Dexamethasone injections given 
to rats 
Decreases activity Marra et al., 1986a 
DL-a-Tocopherol added in 20-
fold excess to microsomes in 
vitro 
Decreases activity from liver 
microsomes, increases activity 
from brain microsomes 
Despret et al., 1992 
Epinephrine injections given to 
rats 
Decreases activity Mills etal., 1995 
Eritadenine added to microsomes 
in in vitro assays 
Decreases activity Sugiyama et al., 1997 
Essential fatty acid deficient 
media given to HepG2 cells in 
culture 
Increases activity MelinandNilsson, 1997 
Ethanol fed to Yucatan barrow 
micropigs 
Decreases activity Nakamura et al., 1994 
Fish oil fed to rats Decreases activity compared with 
olive oil 
Muriana et al., 1992 
129 
Tables, (continued) 
Agent Effect Reference 
Fish oil fed to rats Deccreased activity Dihn etal., 1995 
Fish oil or linseed oil fed to rats Decreases activity compared with 
tallow 
Garg et al., 1988c 
Gamma-linolenic acid fed to aged 
rats 
Increases activity especially of 
(n-3) metabolites 
Biagi et al., 1991 
Glucagon injections given to rats Decreases activity Gomez-Dumm et al., 1975 
Growth hormone expression in 
transgenic mice 
Increases activity in liver and 
adipose 
Nakamura et al., 1996 
Hyperglycemic and diabetic rats Decreases activity Mimouni and Poisson, 1992 
Large doses of tyrosine or 
phenylalanine fed to rats 
Decrease activity via increased 
epinephrine and cAMP 
Peluffo et al., 1984 
Lipoprotein-like cytosolic factor 
from rat liver in in vitro reactions 
Increases activity by sequestering 
18:3(n-6) 
Leikin, and Brenner, 1986 
Low protein diet fed to nursing 
rat dams 
Decreases (60%) activity in pups De Tomas et al., 1980 
Low protein diet fed to rats Decreases activity Narce etal., 1988 
Margarine fed to rats Decreases activity relative to 
hydrogenated coconut oil 
Mahfouz et al., 1981 
Medium-chain triacylglycerols 
fed with com oil to rats 
Decreases activity in liver Periago et al., 1989 
Obese children Increases activity via incrased 
fasting insulin 
Decsi et al., 1996 
Partially hydrogenated marine 
oils fed to rats 
Decrease activity compared with 
hydrogenated peanut oil 
Svensson, 1983; Kirstein et al., 
1983 
Soy protein fed to rats Decreases activity relative to 
casein fed rats 
Madani et al., 1998; Lindholm et 
al.; 1993, Koba etal., 1993 
Spontaneous hypertensive rats Decreases activity de Catalfo and de Gomez-Dumm, 
1996 
Streptozotocin treated rats Increases activity in kidney Clark and Queener, 1985 
trans Fatty acids fed to rats Decreases activity De Schrijver and Privett, 1981; 
Mahvouz etal., 1984 
Triiodothiyonine injections given 
to humans 
Decreases activity based on 
plasma fatty acids, but increases 
activity based on erythrocyte and 
polymorphonuclear leukocyte 
fatty acid composition 
van Doormaal et al., 1986 
Triiodothyronine injections given 
to rats 
Decreases activity Ves Losada and Peluffo, 1989 
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Table 4. Summary of A^-desaturase modulators. 
Agent Effect Reference 
(+)-Sesainin in in vitro assays Decreases activity Shimizu et al., 1991 
Adrenocorticotropic hormone 
injections given to rats 
Decreases activity Mandon et al., 1987 
Casein fed to rats Increases activity when 45% vs 
5% was fed 
Peluffo et al., 1984 
Cholesterol added to hepatic 
microsomes in vitro 
Increases activity Garda and Brenner, 1985 
Cholesterol fed to rats Decreases activity Garg et al., 1986; Leikin and 
Brenner, 1987 
Cholesterol fed to rats with fish 
oil/olive oil 
Increases/decreases activity Muriana et al., 1992 
Cholesterol fed to rats vtfith soy or 
casein protein 
Decreases activity Lindholm et al., 1993 
Cholesterol fed with fish oil or 
linseed oil to rats 
Decreases activity Garg et al., 1988b 
Choline deficient diets fed to rats Decreases activity Leikin and Brenner, 1992 
Cold environments for femle rats Increases activity Gonzalez et al., 1983 
Com oil/coconut oil fed to rats Increases/decreases activity in 
liver 
Pugh and Kates, 1984 
CP-24979 Fed to mice Decreases activity Obukowicz et al. 1998 
Dexamethasone injections given 
to rats 
Decreases activity Marra et al., 1986a 
Diabetic rats Decreases activity that was 
increased with insulin 
Shin et al., 1995 
Epinephrine administered to rats Decreases activity Mills etal., 1995 
Essential fatty acid deficient 
media given to HepG2 cells in 
culture 
Increases activity Melin and Nilsson, 1997 
Ethanol fed to Yucatan barrow 
micropigs 
Decreases activity Nakamura et al., 1994 
Ethanol given to HepG2 cells in 
culture 
Decreases activity Angeletti and de Alaniz, 1996 
fa/fa Rats Decreases activity Blond etal., 1989 
Fat free diet/(n-6) fatty acids fed 
to rats 
Decrease/increase activity in liver Gomez-Dumm et al., 1983 
Fish oil fed to rats Decreases activity compared with 
olive oil 
Muriana et al., 1992 
Fish oil/linseed oil fed to rats Decreases/increases activity 
relative to tallow feeding 
Garg etal., 1988b 
Growth hormone injections given 
to rats 
Decreases activity Gueraud and Paris, 1997 
Hyperglycemic and diabetic rats Decreases activity Mimoimi and Poisson, 1992 
Insidin injections given to 
humans 
Increases activity based on fatty 
acid composition of plasma 
Boustani et al., 1989 
Lipoprotein-like cytosohc factor 
from rat liver in in vitro reactions 
Increases activity by sequestering 
20:4(n-6) 
Leikin, and Brenner, 1989 
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Table 4. (continued) 
Agent Effect Reference 
Low protein diet fed to nursing 
rat dams 
Decreases (60%) activity in pups De Tomas et al., 1980 
Low protein diet fed to rats Decreases activity Narce et al., 1988 
Partially hydrogenated marine 
oils fed to rats 
Decrease activity compared with 
hydrogenated peanut oil 
Svensson, 1983; Kirstein etal., 
1983 
Saturated fatty acid fed to rats Decreases activity Dang etal., 1985 
Spontaneous hypertensive rats Decreases activity de Catalfo and de Gomez-Dumm, 
1996 
trans (n-9) Fatty acids given to 
human fibroblasts in culture 
Inhibits activity whereas trans (n-
7) fatty acids do not 
Rosenthal and Doloresco, 1984 
Triiodothyronine injections given 
to rats 
Decreases activity Ves Losada and Peluffo, 1989 
Fatty Acids 
(n-3) Fatty acids 
Branched-chain fatty acids 
Conjugated linoleic acid 
Medium-chain triacylglycerols 
Polyunsaturated fatty acids 
Sterculic acid 
trans fatty acids 
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Figure 3. Summary of inhibitors and activators of A^-desaturase activity. 
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Figure 4. Summary of inhibitors and activators of A^- and A®-desaturases. 
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INCREASE IN MONOUNSATURATED FATTY ACIDS IN COS-1 
CELLS BY EXPRESSION OF EXOGENOUS MAMMALIAN 
DESATURASE 
A manuscript prepared for submission to Experimental Cell Research 
Travis J. Knight, Janice E. Buss, Gary L. Lindberg, Basil Nikolau, and Donald C. Beitz 
Abstract 
COS-1 cells were transfected transiently with expression vectors encoding stearoyl-
acyl-cairier-protein desaturase (SACPD) from castor bean, stearoyl-CoA desaturase (SCD) 
from mice, and a control vector containing SACPD cDNA in reverse orientation. The 
hypothesis was that both exogenous desaturases would be active in COS-1 cells, thereby 
increasing the proportion of monounsaturated fatty acids produced by the cells. Messenger 
RNA and anti-myc immunoreactive protein was detected at 12 and 24 hours post-transfection 
respectively and increased through 48 hours post-transfection. When acetate was used as the 
fatty acid precursor in cultures for a 24-hour period starting 24 hours post-transfection, the 
ratio of monoimsaturated to saturated fatty acids was increased in the cells expressing SCD 
(P<.05) relative to SACPD-expressing cells and control cells, which did not differ from each 
other. Increased proportions of specific monounsaturated acids were synthesized in cells 
expressing SCD (P<.05), relative to SACPD-expressing and control cells. Control cells were 
numerically intermediate in the production of monounsaturated fatty acids compared with 
SCD- and SACPD-expressing cells. The presence of additional SCD increases the fatty acid 
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desaturase capacity of cells, whereas SACPD is not active in mammalian cells. From this 
research, it is conceivable to think seriously about tailoring the fatty acid composition of food 
products derived from animals by controlling the rates of mammalian desaturation by 
modulating transcription of endogenous or adding exogenous desaturases. 
Introduction 
Animal products clearly are an important part of the Western diet. Data from the Eating 
in America Today edition 11 (EAT 11) study, conducted by the National Livestock and Meat 
Board (National Livestock and Meat Board, A Dietary Pattern and Intake Report, 1994), 
indicate that 55% of dietary fat comes from the meat and milk food groups. Similarly, 64% of 
dietary saturated fatty acids and 70% of dietary protein comes from these animal sources. Many 
people, however, have questioned the wisdom of consumption of animal products vwth regards 
to risk of heart and vascular disease. When asked to identify their major health concern about 
the healthfiilness of the American diet, leading nutritionists most frequently criticize the amount 
of saturated fatty acids consumed daily. In a symposium, the Wisconsin MiUc Marketing Board 
suggested the ideal nutritional fatty acid composition for railk fat would contain 82% 
monounsaturated fatty acids rather than 25%, with the increase occurring at the expense of 
saturated fatty acids (O'Doimell, 1989). Changes of similar magnitude also would be 
appropriate for the fatty acid composition of meat products. This viewpoint is strengthened by 
the Surgeon General's Report on Nutrition and Health in which the number one 
recommendation is that most people should decrease consumption of fat (especially saturated 
fat) and cholesterol (U.S. Department of Health and Human Services, 1988). 
As the effects of specific fatty acids on disease conditions are determined, the need to 
modify the fatty acid composition of the human diet will increase. Many examples of 
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modifying fatty acid composition are already evident in plant-derived lipids such as high-18:0 
soybean oil (Hartmann et al., 1997) and low emcic acid canola oil (Lammerink and Morice, 
1971). Attempts to change the fatty acid composition of animal fats, however, have not been as 
successful on a large scale. The major sources of animal fat in the human diet are beef, pork, 
and milk fat, which all contain greater than 50% saturated fatty acids. Changing fatty acid 
composition of muscle tissue of monogastric animals is relatively easy compared with that in 
ruminants because dietary fatty acids, unlike those in ruminants, are absorbed and used in 
membrane synthesis and for energy storage in the same form that they exist in the diet. There 
are many examples where dietary fats have been fed to pigs to change the fatty acid composition 
of pork fat (Skelley et al., 1975; Wood, 1984; and Miller et al., 1990). In ruminants, however, 
dietary unsaturated fatty acids are saturated in the highly reductive rumen before absorption 
(Ashes et al., 1997). This phenomenon leaves fatty acid desaturase systems of ruminants in 
greater control of milk and meat fatty acid composition. 
Gibson's 1991 review summarizes the potential means for changing fatty acid 
composition in milk fat. There are modest differences of milk fatty acid composition 
between and within breeds of dairy cattle, indicating that traditional breeding practices could 
use selection criteria to develop genetic strains to produce tailor-made fatty acids. He 
indicates that another approach would be to use the tools of genetic engineering to 
manipulate the genes responsible for fatty acid synthesis and modification. Despite the 
probable chances of success in significantly modifying the fatty acids in miUc via traditional 
or modem methods, the likelihood of designing specific strains of cows for specific niche 
markets is unlikely for economic reasons. 
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There are three types of fatty acid desaturases: acyl-CoA desaturases, acyl-ACP 
desaturases, and acyl-lipid desaturases (Murata and Wada, 1995). Acyl-CoA desaturases are 
located in the endoplasmic reticulor membrane of animal cells, yeast, and other fiingal cells 
(Holloway, 1983). Acyl-ACP desaturases are located in the stroma of plant tissue (McKeon 
and Stumpf, 1982). Acyl-lipid desaturases are bound to endoplasmic reticular and 
chloroplast membranes of plant cells (Schmidt and Heinz, 1993) and the thylakoid 
membranes of cyanobacterial cells (Wada et al., 1993). 
To learn about expression of foreign desaturases in mammalian cells, COS-1 cells 
were chosen as a cell line that expresses high levels of recombinant proteins (Tran-Paterson 
et al., 1990). The SACPD from castor bean was selected as an example of a non-membrane 
bound A^-desaturase and SCD from mouse as an example of a typical membrane-bound 
mammalian A®-desaturase. The goal was to increase the total A®-desaturase capacity and 
hence incease 18:l(n-9) and 16:l(n-7) of the cell by targeting the cytosolic site of fatty acid 
synthesis with fatty acid desaturation via SACPD and the endoplasmic reticulum site of fatty 
acid desaturation via excess SCD. 
Materials and Methods 
Vector Preparation 
Polymerase chain reaction (PCR) using primers with 5' overhangs (FIG. lA) was 
used to amplify and modify the ends of the cDNA for SCD from mouse (Ntambi, 1988) and 
the cDNA for stearoyl-acyl carrier protein desaturase (SACPD) from castor bean (Shanklin 
and Somerville, 1991). In the cases of SACPD, the 5' Kozak sequence was modified to the 
consensus mammalian Kozak sequence (.. .CAACCATGG.. .Kozak, 1991) and the 32 amino 
acid leader sequence that is thought to target the protein to the chloroplast or plastid in plants 
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was not included in the expression vector.In the case of SCD, the long 3' untranslated region 
was not included in the expression vector. The PGR products were digested with restriction 
enzymes Nhe I and Xho I and ligated into the mammalian expression vector 
pcDNA3.1(+)zeo (Invitrogen, Carlsbad, CA) that had been modified by inserting paired 
oligonucleotides (FIG. lA) encoding the myc epitope into the Xho I and Xba I restriction 
sites. The final products were SACPD and SCD cDNAs fused in frame with C-temiinal myc 
epitopes in the multiple cloning site of pcDNA3.1(+)zeo (FIG. IB and IC). The control 
plasmid consisted of the Eco RI coding region for SACPD in the reverse orientation in the 
Eco RI restriction site of pcDNA3.1(+)zeo. Host E coli., XL-1 blue, were used to amplify 
plasmids in the presence of 25 |j.g/mL zeocin (Invitrogen, Carlsbad, CA) in Luria-Bertani 
media grown in a shaking flask at 37° C. Qiagen Maxi-500 columns (Qiagen, Chatsworth, 
CA) were used to purify high quality supercoiled plasmids. After purification and before 
transfection, the plasmids were screened with restriction enzymes, the coding region was 
sequenced, and in vitro transcription and translation (TnT Kit, Promega Corp., Madison, WI) 
was used to assure production of a product with the predicted molecular weight. 
Cell culture and Transient Transfection 
COS-1 cells were maintained in Dulbecco's modified Eagle's medium (high glucose) 
containing 10% fetal calf serum with added penicillin (50 lU/mL) and streptomycin (50 
|ig/mL) (complete DMEM). The incubator was maintained at 37° C, 10% CO2, and 
saturating humidity. Transfections were conducted by using the modified calcium phosphate 
transfection protocol of O'Mahoney and Adams (1994). Briefly, 1.5 X 10^ cells, suspended 
in complete DMEM, were seeded into a 3.5-cm dish (9.6 cm^) and allowed to adhere and 
grow for 24 hours. Then, the media was removed and the cells were rinsed with phosphate-
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buffered saline (PBS) (0.14 mol/L NaCl, 2.7 mmol/L KCl, 0.01 mol/L Na2HP04,2 mmol/L 
KH2PO4, pH 7.4). The media was refreshed with 1 mL of Eagle's minimal essential medium 
in Earle's balanced salt solution with non-essential amino acids, 1 mmol/L sodium pyruvate, 
10% fetal calf serum, penicillin (50 lU/mL), and streptomycin (50 ^g/mL) (complete MEM). 
For 4 hours prior to transfection and for 20 hours after transfection, the dishes were 
maintained in 3% CO2. To prepare the transfection solution for one 9.6 cm^ dish, 3 jj,g DNA 
was suspended in 0.05 volumes of 10 mmol/L tris, 1 mmol/L EDTA, and 250 mmol/L CaC^. 
The DNA solution was then mixed with 0.05 volumes of 2X N,N-bis[2-hydroxyethyl]-2-
aminoethanesulfonic acid (BES)-buffered saline (2X BBS), (50 mmol/L BES, 0.28 mol/L 
NaCl, 1.5 mmol/L Na2HP04,pH 7.02). All solutions were adjusted to room temperature 
before use, and the DNA and buffer solutions were allowed to stand for 3.5 minutes before 
being added drop-wise to the media of the cells that had been adjusted to 3% CO2. The 
standing time is critical and must be determined with each new batch of 2X BBS by 
measuring the expression of a reporter plasmid in cells transfected with DNA solutions that 
have standing times differing by 30 seconds or even less. To add the DNA solutions, the 
dishes containing cells for transfection were removed from the incubator for a minimal 
amount of time to maintain an exact CO2 concentration and pH. Twenty-hours after 
transfection, the complete MEM was refreshed with complete DMEM and the cells were 
returned to a 10% CO2 incubator for variable amounts of time, depending on the experiment. 
Northern Blot Analysis 
Total RNA was isolated from COS-1 cells transfected with the SACPD vector 
(TRIzol®, Gibco BRL, Rockville, MD). One-hundred micrograms of total RNA was used to 
isolated polyA RNA by using the PolyATract® system (Promega Corp., Madison, WI). The 
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entire amount of polyA RNA isolated for each sample was electrophoresed in a denaturing 
formaldehyde/agarose gel and transferred to Magna Charge nylon membrane (MSI, 
Westborough, MA) by using capillary transfer with 20X sodium chloride/sodium cirate 
solution (SSC). The membrane was allowed to air-dry and then was placed in a vacuirai 
oven at 80° C for 2 hours. Probe was prepared by using the appropriate linear cDNA as a 
template, the RadPrime labeling kit (Gibco BRL, Rockville, MD), and a-^^P-dCTP. The 
hybridization solution contained 10% dextran sulfate and was left on the membrane for at 
least 12 hours at 65° C in a rotary hybridization oven. Hybridization washing conditions 
were typical and outlined by the manufacturer of the membrane. 
Western Blot Analysis 
Total cellular protein was collected at various times by rinsing cells twice with room 
temperature PBS and using 50 nL of gel-loading buffer (Sambrook et al., 1989) containing a 
cocktail of protease inhibitors (Complete'^^ini Tabs, Boehringer Mannheim, Indianapolis, 
IN). The gelatinous mixture was scraped into a microfuge tube, put through 3 freeze/thaw 
cycles to shear DNA, and then boiled for 5 minutes to denature the proteins. The solution 
was loaded by using a Hamilton syringe with a fine gauge needle. Similar volumes of 
solution were loaded into the wells of a 5%-stacking and 10%-running acrylamide gel. 
Colored molecular weight markers (Sigma, St. Louis, MO) were used to determine how long 
to run the gel, and they also transferred to the membrane as an indicator of transfer 
efficiency. The proteins were electroblotted (Trans-Blot®, Bio-Rad, Richmond, CA) onto 
Immobilon™-P membrane (Millipore, Bedford, MA). Anti-c-myc (Boehringer Maimheim, 
Indianapolis, IN) and the BM Chemiluminescence Western Blotting Kit (Boehringer 
Mannheim, Indianapohs, IN) were used to detect immunoreactive proteins. 
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Desaturase Assays 
Twenty-four hours after transfection, 2 |iCi of "*0-18:0 or 4.5 )iCi of ''^C-acetate were 
added to the dishes for various lengths of time depending on the experiment. Total cellular 
lipids were extracted from trypsinized cell pellets by using CHCI3 extraction (Bligh and 
Dyer, 1959) at the times indicated in each experiment (usually 24 hours). To prepare 
samples for high-performance hquid chromatography (HPLC) analysis, a modification of the 
method of Liu and Hammond (1995) was used. Hexane (0.5 mL) was added to the dried 
lipid extract, and triheptadecanoin and triheptadecenoin (Nu Chek Prep, Elysian, MN) 
internal standards were added to determine efficiency of derivatization and subsequent 
extraction as well as to correct for differences in injection voliraie into the HPLC. To make 
derivatives, 50 \iL of 0.5 mol/L phenylethoxide was added; then the tube was purged with 
nitrogen gas, capped, and heated to 50° C for 20 minutes. The reaction was stopped by the 
addition of 10 |iL of concentrated acetic acid, 5 mL of 1% aqueous NaCl (w/v), and 2 mL 
hexane. The derivatized fatty acids were recovered in the hexane phase and were extracted a 
second time with an additional 2 mL hexane. The hexane fractions were pooled and dried 
with a stream of nitrogen gas. When thin-layer chromatography (TLC) only was used to 
assess the ratio of monounsaturated to saturated fatty acids in a preliminary experiment or 
when gas chromatography (GC) analysis was used, the dry lipid extract was derivatized with 
acetyl chloride and methanol (Lepage and Roy, 1986). Briefly, 2 mL of methanol rbenzene 
(4:1, v/v) was added to the dried lipid extract and then 200 iJ,L of acetyl chloride was added. 
The tube was capped after purging with nitrogen gas and heated to 100° C for 1 hour. The 
methyl esters of fatty acids were extracted by first neutralizing with 5 mL of 6% aqueous 
K2CO3 (w/v) and then by adding 1 mL of hexane for extraction. 
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Thin-Laver Chromatography 
For the preliminary experiment, the methyl esters of saturated and monounsaturated 
fatty acids were separated and isolated by using arginated TLC. Arginated TLC plates were 
prepared by spraying silica gel G plates (Fisher Scientific, Pittsburgh, PA) to near saturation 
with 10% aqueous AgNOa (w/v), allowing them to dry in the dark at room temperature, and 
activating them in a 100° C oven for 2 hours before use. The lipid samples were applied to 
the plates with hexane as the solvent, and the plates were developed in 90% hexane;10% 
ethyl acetate (v/v). Approximately 100 |ig of derivatized 18:0 and 18:l(n-9) were added to 
each sample before TLC for visualization of satiurated and monoimsaturated fatty acids, 
which was accomplished by spraying the plate with dichlorofluorescein in ethanol and by 
using ultraviolet light for detection. The appropriate spots were scraped from the plate by 
using a clean razor blade, and the dry powder was counted by using liquid scintillation 
counting. It should be noted that Scintisafe Econo 1 (Fisher Scientific, Pittsburgh, PA) 
worked well to compensate for the severe color quenching caused by phosphate esters found 
in many scintillation fluids, which react with the AgNOs^. Arginated-TLC with a 90% 
hexane: 10% ethyl ether (v/v) solvent system was used to prepare samples for HPLC analysis. 
This analysis separated saturated phenylethyl esters from monounsaturated phenylethyl esters 
and also removed the unreacted phenylethyl alcohol and phenylethoxide. The visualization 
and recovery of samples from the plate was the same as noted above. The silica powder 
containing the derivatized lipids was extracted twice with the same solvent used in the TLC 




A Waters 6000 HPLC pump (Waters Inc., Milford, MA) was used in conjunction 
with a Rainin CI8 Microsorb column (Rainin Instrument Co., Walnut Creek, CA). 
The isocratic solvent system consisted of 95% methanol:5% water (v/v) and was delivered at 
1 mL/min. The derivatized fatty acids were detected at 214 nm, and the effluent 
corresponding to the peaks of interest was collected manually. The solvent was removed 
under a stream of air, resuspended in 1 mL methanol, and assayed for radioactivity with a 
liquid scintillation counter. 
Gas Chromatography Analysis 
A Varian Star 3400 CX (Varian Inc., Walnut Creek, CA) GC was used with an SP"""^ 
2380 mega bore column (Supelco, Bellefonte, PA). The oven temperature was programmed 
from 120° C to 160° C at a rate of 1.5° C/min. and then continued to 260° C at a rate of 20° 
C/min. The injection port also was temperatxire-programmed from 50° C to 250° C at a rate 
of200° C/min. The detector was maintained at 270° C, and the total run time was 31.67 min. 
Five micrograms of GLC-79 methylated fatty acid standard set (Nu Chek Prep, Elysian, MN) 
was added to each sample vial as a means of identifying fatty acid peaks. The column was 
split near the detector, with 5% of the flow going to the flame-ionization detector and the 
remainder leaving the GC in inactivated glass tubing via a heated exit port. The escaping 
vapor was trapped in a 40-cm section of 4 mm glass tubing with 1 mm wall thickness that 
had one end shaped like a printed capital letter N. After each peak was captured in a glass 
tube, it was flushed sequentially into a glass scintillation vial with 4 mL hexane, 4 mL 
CHCI3, and 4 mL acetone, dried imder a stream of air, resuspended in 1 mL methanol, and 
counted in a liquid scintillation counter. 
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Statistical Analysis 
The data were analyzed by simple one-way or two-way GLM by using SAS. 
Contrasts to determine differences between treatments or time points were calculated. 
Differences are considered significant if P<0.05 unless otherwise noted. 
Results 
Plasmid Validation by Restriction Analysis and in vitro Transcription/Translation 
A single product of predicted molecular weight was observed by using in vitro 
transcription and translation for both the SCD and SACPD plasmids, verifying that all ligated 
junctions were in frame and that the vectors were constructed as planned (FIG. ID). 
Estimates of transfection efficiencies were between 30-50% of cells when based on 
transfection of cells with the P-galactosidase expressing pcDNA3.1(+)zeo vector. 
Northern Blot and Western Blot Analysis and Time-Course Expression 
Northern blotting revealed detectable expression from the SACPD vector 12 hours 
post-fransfection as observed on the original radiogram with increasing amounts of message 
accumulating until at least 48 hours post-transfection (FIG. 2). P-Actin served as a positive 
control and was present at a constant amoimt throughout the time period studied. The time 
course of expression of protein (FIG. 3) demonstrated expression starting at 24 hours post-
transfection for both SCD and SACPD. Cells transfected with either plasmid maintained 
high levels of expression until at least 60 hours post-transfection. 
Analysis of Net Cellular Desaturation in Transiently Transfected Cells 
Initial experiments demonstrated a difference in how COS-1 cells desaturate 18:0 
when transfected with an S ACPD-expressing or control vector. The ratio of 
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Fig. 1. Preparation and validation of expression vectors. (A) Oligonucleotides and primers 
used to insert a myc-coding region into pcDNA3.1(+)zeo, to introduce a mammalian Kozak 
sequence into SACPD, and make both SACPD and SCD amenable to subcloning. (B and C) 
Diagrams of the predicted and resulting expression constructs. (D) Results of expressing the 
plasmids (Lane 1, SCD expressing plasmid; Lane 2, SACPD-expressing plasmid; and Lane 
3, a P-galactosidase expressing plasmid) in an in vitro transcription and translation system to 
verify the expression of a single product of predicted molecular weight. The radiogram is the 
result of ^^S-methionine incorporation. 
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Hours Post-Transfection 
0 6 12 18 24 36 48 
SACPD 
B-Actin 
Fig. 2. Northern blot analysis of SACPD expression. One-hundred )ag of total RNA from 
cells at different times post-transfection were used to isolate polyA RNA for separation on a 
denaturing formaldehyde agarose gel. The mRNA was transferred to a nylon membrane, and 
randomly primed a-^^P-dCTP labeled probe was used to detect SACPD and p-Actin 
expression in two separate hybridizations. 
Fig. 3. Western blot analysis of SACPD and BCD expression. Total proteins were isolated 
at the noted times from transiently transfected cells expressing SCD or SACPD. One-third of 
proteins isolated from each dish were separated on a 5% stacking and 10% resolving 
denaturing acrylamide gel. The proteins were electroblotted onto Imobilon-P, and western 
blotting was conducted by using the commercially available anti-myc antibody, followed by 
chemiluminescent detection. 
Hours Post-Transfection 




cells relative to SACPD transfected cells as determined by simple arginated TLC and 
scintillation coimting (FIG. 4). Experiments to determine incorporation of '"C-acetate into 
different fatty acids showed that cells expressing exogenous SCD had increased desaturation 
of 16 and 18 carbon fatty acids to their respective monounsatxirated acid compared with 
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Fig. 4. Total monounsaturated to saturated fatty acid ratio, an index of A^-desaturase activity 
in transfected cells provided ''*C-18:0. Cells were transfected with SACPD or control 
plasmid and 24 hours later were provided with '''C-l 8:0 in culture for an additional 24-hour 
time period. Total lipids were extracted, methylated, and separated on arginated TLC for 
separation based on number of double bonds. Spots corresponding to monounsaturated and 
saturated fatty acids were scraped and quantified by using liquid scintillation counting. Net 
desaturase activity as measured by fatty acid composition was greater in control cells (n=6 
dishes) than in SACPD-expressing cell (n=6 dishes). Data are expressed as the mean ± 
standard error. 
SACPD-expressing or control cells (FIG. 5). Although the amount of label incorporated into 
monounsaturated fatty acids in control cells was not significantly different fi-om SACPD-
expressing cells, the control cells were always numerically intermediate in desaturase activity 
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compared with the cells expressing SACPD or SCD in this experiment and other similar 
experiments (data not shown). 
Time-Course of Net Cellular Desaturase Activity 
When a time-course analysis of exogenous desaturase expression was conducted, the 
more sensitive and more precise GC method was used (FIG. 6). These data reveal that SCD 
transfected cells had the greatest amount of fatty acid desaturation, the control cells were 
intermediate, and the SACPD transfected cells had the least amount of fatty acid 
desaturation. While the 18:1/18:0 ratios showed more distinct differences between 
treatments, the trends were similar for 16:1/16:0 ratios. The 16:1/16:0 data indicated greater 
desaturase activity in the SCD transfected cells compared with the SACPD-transfected cells. 
The 18:1/18:0 ratios of all three treatments were statistically different. 
Discussion 
The results of this research demonstrate that when SACPD, the non-membrane bound plant 
A^-desaturase, is overexpressed in mammalian cells, it is not active and may even inhibit the 
activity of the endogenous desaturase because net desaturase activity was always numerically 
greater in control cells compared to SACPD-transfected cells. The cDNA for SACPD, when 
expressed in E. coli in previous experiments, displayed desaturase activity only when the 
native cofactors ferredoxin and ferredoxin-oxidoreductase were present in the assay mixture. 
However when membrane-boimd mammalian SCD is overexpressed in mammalian cells in 
addition to the endogenous A^-desaturase, the total desaturase capacity of the cells increases 
as much as 1.5-fold even in transiently transfected cells where the majority of the cells in the 






Fig. 6.16:1/16:0 and 18:1/18:0 ratios, an index of A^-desaturase activity in transfected cells 
as determined by GC separation of specific fatty acids. Transfected cells v^^ere provided '''C-
acetate for 24-ho\ar periods starting at 24 hours after transfection. Isotope was added at 24, 
48, and 72 hours, and total lipids were collected 24 hour later at 48, 72, and 96 hours, 
respectively to generate the three time-points indicated. The lipids were methylated by using 
acetyl chloride and separated by using a mega bore column in a gas chromatograph. The 
column was split, and fractions were collected for counting, while a portion went to the 
detector to visualize the individual peaks. Liquid scintillation coimting was used to quantify 
radioactivity incorporated into 16:0,16:1,18:0, and 18:1. The 16:1/16:0 ratio (A) differed by 
contrast analysis between SCD and SACPD and between SACPD and control cells but not 
between SCD and control cells. The 18:1/18:0 ratio (B) differed for all three treatments as 
determined by contrast analysis. There was no main effect for time when the treatments were 
considered for 16:1/16:0 or 18:1/18:0 ratios. Data points are expressed as the mean of 
triplicate samples ± standard error. 
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In comparing the non-membrane bound SACPD systems in plants and the membrane-
bound SCD system in animals, there are similarities and striking differences. Similarities 
include insertion of a double bond at the A® position of 18:0 to form 18:l(n-9) and the 
requirement of O2 and an electron transport system to keep the oxidation/reduction of the 
terminal desaturase operational. Whereas plant systems rely on ferredoxin and NADPH-
feiredoxin-oxidoreductase for their electron transport system of fatty acid desaturation 
(Nagai and Bloch, 1968), mammals rely on cytochrome bs and NADH-cytochrome bs 
reductase (Jones et al., 1969; Strittmatter et al., 1974). From these results, it could be 
inferred that the mammalian electron transport system can not substitute its cofactors for the 
required ferredoxin and ferredoxin-oxidoreductase to maintain SACPD activity. The 
favored substrates for the respective A'-desaturases are acyl-CoA in animals and acyl-ACP in 
plants. While both are soluble substrates and both plant and mammalian A^-desaturases have 
similar Km and Vmax values for stearoyl-CoA, the kinetics of the plant enzyme indicate that 
stearoyl-CoA would have to be at, or above, the critical micellar concentration for significant 
amounts of 18:l(n-9) synthesis to occur (Enoch et al, 1976). Because of the low 
concentration of stearoyl-CoA in plant tissue, the plant enzyme acts almost entirely on 
stearoyl-ACP when expressed in plants. 
This research indicates that modifying the fatty acid composition of food products 
derived from animals could be achieved by controlling the rates of mammalian desaturation 
by modulating transcription of endogenous desaturases or by adding exogenous desaturases 
or fatty acid binding proteins that could inhibit desaturation. Whereas the plant-derived 
enzymes will probably be of little value in increasing net fatty acid desaturation as we had 
hypothesized, overexpression of mammalian desaturases seems feasible in attempting to 
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increase the net fatty acid desatxirase activity of the cell and hence the amounts of unsaturated 
fatty acids in lipids at the expense of saturated fatty acids. The greatest benefit would be in 
changing the composition of ruminant-derived foods such as dairy products, beef, and lamb. 
Because fatty acids in the diet of ruminants become almost exclusively hydrogenated to the 
most saturated form of a particular acid, the ruminants own desaturase systems have great 
control over the fatty acid composition of their tissues compared with that of monogastric 
animals. Monogastric animals such as pigs, however, can be fed fatty acids that are absorbed 
readily and incorporated into muscle and adipose tissue with the same degree of imsaturation 
that they possessed when added to the diet. Remembering the magnitude of changes that can 
be made in the membrane fatty acid composition of monogastrics by feeding diets with 
extreme fatty acid composition negates some of the concern over health aspects of 
genetically altering the fatty acid composition of food-producing animals. The key to 
success, however, if transgenic animals are to be engineered for specific fatty acid 
composition, will no doubt be in finding the proper promoters that would allow the animal to 
develop normally but produce food products that differ fi-om normal. 
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GENERAL CONCLUSIONS 
Quantity and quality of dietary fat are both of great concern with regard to human 
health. Some disease processes such as atherosclerosis and cancer have been correlated with 
the quality of the dietary fats consumed. As knowledge accumulates concerning specific 
dietary fatty acids and disease status, we will be challenged to "improve" the fatty acid 
composition of dietary fats. Plant scientists have been using traditional and modem genetic 
approaches to modify the fatty acid composition of oil producing crops to better meet dietary 
or industrial needs. Animal scientists, however, have had to rely on dietary manipulation of 
meat and milk producing animals to observe substantial changes in the qualities of animal-
derived fats. It is particularly challenging to change the fatty acid composition of ruminants 
by using dietary manipulation because fatty acids passing through the rumen are 
biohydrogenated to become nearly completely saturated. Studies are currently underway to 
determine if the inherent genetic variation between dairy cows, for example, is great enough 
to develop strains or populations within a herd that would produce milk with a divergent fatty 
acid composition when compared with the general population. 
The major objective of this study was to employ the techniques of molecular biology 
and express both plant-derived and animal-derived cDNAs of fatty acid desaturases in animal 
cells. The long-term goal is to genetically tailor the fatty acid composition of meat, milk, and 
eggs as may be desired for general consumption or for consumption by those with specific 
health concerns. The information obtained by this research may be used in making decisions 
concerning possible future experiments in rodent models as a way to leam about genetically 
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modulating the fatty acid composition in a whole animal system and advancing the long-term 
goal. 
Mammalian expression vectors were prepared containing both stearoyl-CoA 
desaturase and stearoyl-acyl-carrier-protein desaturase cDNAs. The myc epitope was 
engineered into the vector, to be expressed in frame, at the C-terminus of the protein. Both 
cDNAs were transcribed and translated as determined by northem and western analysis, 
respectively, following transfection into COS-1 cells. Messenger RNA could be detected as 
early as 12 hours after transfection and immunoreactive protein could be detected as early as 
24 hours after transfection from both vectors. Detection of both immunoreactive proteins 
confirmed that codon usage differences between plants and animal systems was not of great 
concem in continuing the experiment. 
To determine if the expressed proteins were enzymatically active, radiolabeled 
stearate or acetate was added to the culture media of transfected cells. In an initial 
experiment stearoyl-acyl-carrier-protein desaturase expression inhibited the net desaturase 
capacity of the cells when compared with control transfected cells. When stearoyl-CoA 
desaturase expression was added as another treatment, the cells overexpressing the 
mammalian desaturase had greater net desaturase capacity than the cells expressing the plant 
fatty acid desaturase, with the control cells having intermediate net desaturase capacity. 
In summary, the fatty acid composition of cells in culture can be increased by 
expression of exogenous mammalian desaturase. The inhibition could occur because the 
enzyme binds stearoyl-CoA, but, because the cofactor requirements of the plant enzyme are 
not met in an animal cell, the enzyme is not active. More studies will need to be conducted 
to learn about the application of this technology to whole animal systems. 
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